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General Abstract       
                                                          
The mammalian target of rapamycin (mTOR) complex is a key regulator of protein synthesis, with 
resistance exercise and protein ingestion both shown to increase mTOR activity in human skeletal 
muscle. It has recently been proposed that mTOR activity is regulated via its intracellular localization 
and protein complex interaction, however no research to date has examined this process in human 
skeletal muscle. Accordingly, the aims of this thesis were to (1) develop immunofluorescent-based 
methodologies to study mTOR in human skeletal muscle, and (2) apply this approach to the study of 
mTOR in acute and chronic resistance exercise scenarios.  
Chapter 3 describes the development of an immunofluorescence microscopy technique to observe 
mTOR and interacting proteins in human skeletal muscle in vivo. Antibodies applied to 
immunofluorescence staining were validated systemically to confirm specificity and sensitivity of 
fluorescence signals. In addition, quantification methods based on microscope images were 
established to measure mTOR content and colocalisation with interacting proteins/ organelles.  
In Chapter 4, the immunofluorescent approached established in chapter 3 was applied to examine 
fibre-specific mTOR protein content and cellular distribution in skeletal muscle of young male 
individuals following 10- week resistance exercise training. Interestingly, though muscle strength 
increase was found in participants, mTOR content was not significantly increased post-training, either 
in total muscle or in relation to myosin heavy chain content. As such, chapter 4 demonstrates the 
value of our immunoflurescense approach for detailing skeletal muscle adaptation, and additionally 
suggests that fibre-specific increases in mTOR protein content do not correlate with muscle strength 
performance.   
In Chapter 5, we moved into an acute model of resistance exercise to investigate the effect of 
resistance exercise on mTOR distribution and protein complex formation/regulation, in both fasted 
and fed conditions. In contrast to in vitro studies, we report that mTOR is highly localised to the 
lysosome in basal skeletal muscle, whilst resistance exercise results in mTOR-lysosome complex 
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translocation from the cytoplasm to the plasma membrane post exercise. Importantly, this 
translocation event appears to be functional, as mTOR was observed to interact with the vasculature, 
its positive regulator Rheb and the translation factor eIF3F. As such, our data indicate that 
translocation of mTOR to the cell periphery is critical in its activation following mechanical 
loading/contraction. 
In summary, this thesis describes a novel approach to study mTOR regulation in human skeletal 
muscle in vivo. It is hoped that this approach will provide insight into the cellular regulation of 
skeletal muscle protein synthesis and by extension the control of skeletal muscle mass in humans 
during scenarios of health and chronic disease.  
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1.1 Skeletal muscle  
1.1.1 Importance of skeletal muscle in health and wellbeing 
Skeletal muscle is the most abundant and widely distributed organ in human body. There are more 
than 660 skeletal muscles, accounting for ~45% of total body weight [196]. Skeletal muscle plays an 
indispensible role in connecting the skeleton and supporting body movement, as well as contributing 
to immune system function [197]. As such, maintaining skeletal muscle functional capacity is a 
fundamental issue for human health and wellbeing.  
In addition to maintaining posture, skeletal muscle represents the significant energy storage site, 
reserving the largest amount of peptides and free amino acid (AA) in body [1]. Muscle contraction is 
an ATP- driven mechanical event, requiring high-energy expenditure [198]. As such, improvement in 
skeletal muscle mass augments maximal workload and postpones muscle fatigue [199]. In contrast, a 
reduction in skeletal muscle mass, such as that induced by disuse, trauma, surgery, burn or sepsis can 
impair muscle strength and lead to muscle atrophy [197]. Ageing induced sarcopenia is the gradual loss 
of skeletal muscle mass resulting in deteriorated muscle strength and function [201, 202], affecting 
elderly people worldwide [203].  Collectively, it is therefore pivotal to maintain the skeletal muscle 
mass in human body in the context of health and wellbeing. 
1.1.2 Maintenance of skeletal muscle mass  
The maintenance of skeletal muscle mass is governed by net protein balance (i.e. the combined effect 
of daily fluctuations in rates of protein synthesis and degradation). Net protein balance can be directly 
influenced by physical activity, as resistance type exercise increases protein synthesis, thus increasing 
net protein balance, whereas inactivity/unloading reduces protein synthesis/increases degredation to 
ultimately reduced net protein balance [204-207]. In addition, provision of dietary protein can also 
maintain a positive net protein balance and when combined with resistance exercise lead to further 
enhancement of the stimulatory effects of resistance exercise in human skeletal muscle [221]. Given the 
fact that both resistance exercise and protein ingestion can increase net protein balance, considerable 
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research has been invested into understanding the regulation of skeletal muscle mass at the cellular 
level. Elegant studies in cell, rodent and human models collectively indicate that the mammalian 
target of rapamycin (mTOR) complex may be as a central signal protein regulating skeletal muscle 
protein synthesis [32, 58, 150, 151].  
 
1.2 The mammalian target of rapamycin (mTOR) 
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase (molecular weight, MW= 
~289kDa) with multi domains including a catalytic kinase domain, a FKBP12–rapamycin binding 
(FRB) domain, a putative auto-inhibitory domain (‘repressor domain’) near the C-terminus, ~20 
tandem repeated HEAT (Huntingtin, EF3, A subunit of PP2A and TOR) motifs at the N-terminus, and 
FRAP–ATM–TRRAP (FAT) and FAT C-terminus domains. HEAT motifs facilitate the protein–
protein interaction, whereas FAT and FAT C-terminus domains function in modulating the catalytic 
kinase activity of mTOR [19]. As it’s name would suggest, mTOR is the central component 
constituting the mTOR complex (mTORC). However, the mTOR complex can be found in two 
structurally and functionally distinct complexes, mTORC1 and mTORC2 which differ in composition 
of mTOR interacting proteins. For example, the main composing subunits of mTORC1 include Raptor 
(regulatory-associated protein of mTOR) [20, 21], G-protein β subunit-like protein (GβL, also known as 
mLST8) [22], and PRAS40 (proline-rich Akt substrate 40 kDa) [23]. By contrast, mTORC2 contains 
Rictor (rapamycin-insensitive companion of mTOR) [24], mSin1 (yeast Avo1 homolog) [25], mLST8, 
and Protor (protein observed with ricTOR) [26]. A recent study has identified Deptor as a new protein 
interacting with both mTORC1 and mTORC2 [27]. Functionally, mTORC1 is sensitive to nutrition 
(principally the BCAA Leucine), inhibited by rapamycin and primarily functions to regulate protein 
translation and cell growth. In contrast, mTORC2 is sensitive to insulin, is rapamycin resistant and 
has been implicated in regulating cytoskeleton, cell survival and insulin sensitivity [14, 15].  
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1.3 mTORC1 regulation of protein synthesis in skeletal muscle 
The functions of mTORC1 are greatly dependent on the substrates it regulates. When it comes to the 
regulation of protein synthesis, the best characterized substrates for mTORC1 are the ribosomal 
protein S6 kinase 1 (S6K1) and the eukaryote translation initiation factor 4E binding protein 1 (4E-
BP1), two well-known protein translation regulators. S6K1 is a serine/threonine kinase, which, after 
being catalyzed at phosphorylation site (Threonine 389) by mTORC1, active S6K1 will phosphorylate 
its targets, S6 ribosomal protein and eukaryotic elongation factor 2 (eEF2) kinase [14, 15]. Subsequently, 
S6 and eEF2 kinase can enhance protein translation initiation and elongation, respectively. Ribosomal 
protein S6 is a component of the eukaryotic 40S ribosomal subunit [225]. eEF2 kinase is known to 
inhibit the phosphorylation of eEF2, mediating the GTP-dependent ribosome translocation on mRNA 
during the translation process [58, 226].  
The interaction between mTORC1 and S6K1 is mediated by the eukaryotic translation initiation factor 
3f (EIF3F) complex, a member of the Mov34 family [180, 183]. EIF3F complex provides a scaffold to 
allow interaction between mTORC1 and S6K1 to form the PIC complex [181, 182]. Overexpression of 
EIF3F in muscle cells and in adult skeletal muscle induced hypertrophy associated with an increase of 
sarcomeric proteins. In contrast, repression on EIF3F in differentiated skeletal muscle induced 
atrophy [183].  
In contrast, following mTORC1 mediated phosphorylation at multiple residues (Thr37/46, Thr70, 
Ser65), 4E-BP1 no longer binds to eIF4E, allowing eIF4E binding with mRNA 7-methylguanosine 
cap structure, therefore allowing for recruitment of eIF4G, eIF4A, eIF3, 40S ribosomal subunits and 
the ternary complex (eIF2/Met-tRNA/GTP) to form the translation pre-initiation complex [15, 58].  
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1.4 Mechanisms of mTORC1 activation 
1.4.1 Multi-site phosphorylation regulates mTORC1 function and activity 
The catalytic/kinase activity of mTOR can be modulated by multi-site phosphorylation. Currently 
there are at least four phosphorylation sites characterized in mTOR, Ser2481, Ser2448, Thr2446 and 
Ser1261, respectively. Ser2481 is an autophosphorylation site, found to be closely related to the 
intrinsic catalytic activity of the mTOR [32]. As such, Ser2481 has been used as a biomarker to monitor 
the intrinsic catalytic activity of mTORC1. mTORC1 Ser2448 was reported to be a substrate for Akt 
in vitro and in vivo [35, 36, 37, 38], whereas a recent study identified S6K1 as a second Ser2448 kinase [39]. 
mTOR amino acids 2430–2450 sequence is thought to be a repressor region, deletion of which 
activated mTOR [39, 227]. Spatially, the Thr2446 site is adjacent to the Ser2448 site [32].  Although being 
in close proximity, it has been proposed that Thr2446/Ser2448 are phosphorylated by different 
kinases. For example, in direct evidence for this was provided by Cheng et al who found that Thr2446 
phosphorylation status is inversely correlated with the Ser2448 phosphorylation level [40]. The 
significance of these two phosphorylation sites remains elusive, because substitution of Thr2446 
and/or Ser2448 with alanine did not affect the mTOR activity [37]. In contrast, Ser1261 has been 
suggested to modulate mTOR catalytic activity [32]. Phosphorylated Ser1261 partially promotes 
mTORC1 catalytic activity as monitored by increased S6K1 and 4EBP1 phosphorylation and cell 
growth [41]. Though the work on identifying the Ser1261 kinase is still on going, it has been observed 
that insulin increases both mTORC1- and mTORC2 Ser1261 phosphorylation via PI3K kinase in 
cultured 3T3-L1 adipocytes [32].  
1.4.2 mTORC1 interacting proteins 
Raptor is a critical regulatory protein, directly associated with mTOR activity. Rapamycin and its 
associated protein FKBP12 can form complex and directly bind to the FRB domain of mTOR, 
blocking raptor access to mTOR, therefore uncoupling the mTOR from its substrates. Drummond et 
al found that taking 0.15 mg per kg of body weight rapamycin could effectively prohibit the protein 
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synthesis in skeletal muscle induced by acute bout of resistance exercise [42]. Nutritional status can 
also mediate mTOR activity through raptor. In the absence of nutrients, raptor interacts with mTOR 
via mLST8, which can block substrates accessing to the catalytic domain of the mTOR. In contrast, 
when nutritional supply is ample, the catalytic domain of mTOR will be accessible through disruption 
of Raptor/ mLST8 interaction, enabling accessibility of mTOR to its substrates (e.g.4E-BP1 or S6K1) 
[14].  
Energy stress suppresses mTORC1 complex activity through AMPK mediated phosphorylation of 
raptor at Ser89 [43]. In addition, another interacting protein, PRAS40 (Proline-rich Akt substrate of 40 
kDa), is thought to be a repressor of mTORC1 activity [45- 47]. Evidence demonstrates that PRAS40 
binding to mTORC1 via raptor prevents substrates access to the catalytic domain of mTOR [46]. When 
PI3K/AKT signaling is activated by insulin, activated AKT phosphorylates PRAS40 at Thr246 and 
Ser183/Ser212/Ser221 to changes PRAS40 conformational structure, leading to detachment from the 
mTORC1 complex and allowing mTORC1 interaction with substrates [45]. As a newly characterised 
subunit, Deptor may play an inhibitory role in the mTORC1 activity in a manner similar to PRAS40, 
however understanding Deptor-mTORC1 interaction is still in its infancy [48, 49].  
In addition to direct components of the mTOR complex, there are numerous associating proteins 
thought to be involved in mTOR activation. The two most chartacterised of these proteins are Ras 
homolog enriched in brain (Rheb) and the tuberous sclerosis complex proteins (TSC1 and TSC2). 
Rheb is a ~20kDa GTPase belonging to the Ras GTPase family. Like other small GTPases, Rheb is 
activated when loaded with GTP and become inactivated after hydrolysis of GTP into GDP [50]. Rheb 
is a direct upstream activator binding to mTOR complex. Bai et al found that Rheb prohibited 
FKBP38 (FK506-binding protein 38), an inhibitor of mTORC activity, from binding to mTOR 
complex as an antagonist [14,152,153]. However, the activity of the Rheb GTPase was also found to be 
inhibited by its upstream regulator TSC1/TSC2 complex [32, 50, 51]. The GTPase activating protein 
(GAP) domain in tuberous sclerosis complex 2 (TSC2 - Tuberin) can catalyze the hydrolysis of GTP 
to GDP, thus inactivating Rheb [50].  Mutations on genes encoding TSC1/TSC2 complex promote 
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mTOR complex activation and stimulate cell growth, which have been observed in several cancer cell 
lines with abnormal cell size expansion [14, 51].   
1.4.3 Lipid molecules  
Phosphatidic acid (PA) is a source of lipid widely distributed in cells, thought to act as a second 
messenger [228]. Importantly, mTORC1 and S6K1 are activated in response to increased PA [70] 
although the precise mechanism of this action is still under investigation. The PA synthase PLD2 
(phospholipase D 2) has been reported to bind with mTORC1 subunit Raptor, linking PA generation 
with mTORC1 activation [191]. Alternatively, PA has been suggested to compete with 
Rapamycin/FKBP12 to bind on the FRB domain of mTOR, which blocks rapamycin/FKBP12 from 
inhibiting mTOR activity (Figure. 1.1). However, PA might also activate mTORC1 via alternative 
signalling pathways. Winter et al found that PA activites mTOR complex via upstream Raf-MAPK-
ERK1/2 signalling mediated TSC1/TSC2 inhibition [53]. Rheb is believed to be the direct activator 
upstream PLD enzyme to facilitate mTOR translocation to lysosome membrane to be activated [208]. 
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Figure 1.1 PLD2-generated PA activates mTORC1 through its FRB domain. PA (pink circles) 
and rapamycin/FKPB12 compete for the FRB domain on mTOR. In the presence of rapamycin 
(Rapa)/FKBP12complex, the FRB domain of mTOR is unable to bind PA, thus mTOR being 
unable to phosphorylate its substrates, such as S6K1 kinase. Excess supply of PA to the 
membrane would provide more sites for mTOR binding and compete with rapamycin/FKBP12 
complex binding. The image was re- drawn based on Foster[70]. 
 
1.4.4 mTORC1 subcellular localization regulates intrinsic activity 
The subcellular localisation of mTORC1 is key for its activation [154, 155,156]. Endosomal trafficking is 
thought to transport mTORC1 to specific cellular regions such as late endosome and lysosome (LEL), 
where mTORC1 is thought to undergo AA-induced mTORC1 activation [155, 156]. Furthermore, the 
membrane proteins on LEL are also found tightly associated with mTORC1 localization in response 
to stimulation. The Lysosome-associated membrane protein-2 (Lamp2) is regarded as one of the 
biomarkers on late lysosomes (Figure. 1.2), functioning to maintain the structural integrity of late 
lysosome membrane [157]. Importantly, mTORC1 has been reported to translocate to associate with 
Lamp2 protein-positive lysosome membrane regions after mechanical stimulation in mouse skeletal 
muscle [156].  
Rab7 is an additional biomarker identified on LEL, inserted into the LEL membrane. When early 
endosome is matured during endosomal recycling, transition of Rab5 protein to Rab7 on the 
membrane, represents the formation of late endosome [156]. Many reports have pointed out the tight 
relationship between mTORC1 activity and Rab7, with mTORC1 observed to co-localise with Rab-7 
positive regions during autophagosome maturation in cell model [195]. After AA stimulation, mTORC1 
and Rheb were also observed to translocate to Rab7- positive vesicles in cultured HEK293T cells [99, 
111]. As there is a high spatial association between mTORC1 and Rab7 during cellular events, Rab7 is 
thought be an important biomarker to indicate mTORC1 localization and biological activity. 
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Figure 1.2 Endocytosis and the late endosome/lysosomal. Endocytosis starts from the uptake of 
plasma membrane into primary endocytic vesicles. The vesicles are transported to the early 
endosome characterized by the presence of Rab5 on its cytosolic membrane. The early 
endosome sorts the endocytosed material and returns the majority of endocytosed material to 
the plasma membrane either directly, or with the assistance of the recycling endosome which is 
characterized by the presence of Rab11. The remaining material for degradation is delivered by 
the early endosome to the late endosome compartment. The late endosome is characterized by 
the presence of Rab7 and multivesicular bodies. It also contains the lysosomal membrane 
protein Lamp2 which is delivered, along with endocytosed material, to the lysosome through the 
formation of a hybrid organelle. The hybrid organelle degrades the endocytosed material and 
the lysosome then recycles. The image is taken from Jacobs et al [156]. 
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1.5 Effects of exercise on mTORC1 activation 
Skeletal muscle mass is thought to be regulated in vivo by three physiological conditions; (1) growth 
factors, (2) mechanical loading/contraction and (3) nutrient provision. Each condition is thought to 
stimulate protein synthesis in skeletal muscle via distinct pathways, which ultimately converge on 
mTORC1 to regulate skeletal muscle mass [14].  
1.5.1 Hormone and growth factor regulation of mTORC1 activity 
Exercise induces the secretion of hormones such as growth hormone, insulin and insulin like growth 
factor (IGF) into the bloodstream. As shown in Figure 1.4, insulin/IGF trigger the PI3K-Akt axis 
through binding with their receptors in skeletal muscle [58]. Phosphoinositide 3-kinases (PI3Ks) 
phosphorylates membrane phosphatidylinositol 4, 5-bisphosphate (PIP2) to become phosphoinositide-
3, 4, 5-trisphosphate (PIP3), a signal lipid acting as a docking site for protein kinase-1 (PDK1) and 
Akt [229]. Consequently, PDK1/Akt increase protein synthesis through direct phosphorylation of 
mTORC1, or removing the inhibitory factors (e.g. TSC1/TSC2 complex and PRAS40) binding to 
mTOR complex [15, 52]. Studies have suggested a key role for the Insulin/IGF-1/PI3K/Akt axis in 
regulating skeletal muscle mass, through increases in protein synthesis via mTORC1 activation [209], in 
addition to reducing protein degradation rate through reductions in FOXO signalling and associated 
atrogene expression (MuRF1, MaFbx) [210], all of which contribute to improved net protein balance 
and muscle hypertrophy [211].  
1.5.2 Load-induced regulation of mTORC1 activity  
In addition to hormone signalling, muscle contraction has been shown to regulate skeletal muscle 
protein synthesis. However, the mechano-sensor(s), transducing the effects of muscle contraction on 
mTORC1 activity, is still not fully understood. Based on current studies, muscle contraction is 
thought to active several signal pathways leading to mTORC regulation (Figure 1.4). The first 
evidence of load-specific induced mTORC1 activation was provided when it was demonstrated that 
the PI3- kinase inhibitor, wortmannin, did not prevent stretch- induced mTORC1 activity in isolated 
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extensor digitorum longus muscles [219]. Further research demonstrated that loading induced muscle 
contraction was found to promote mTORC1 activity independent of PI3K- Akt axis [220]. Currently the 
exact mechanism by which contraction increases mTORC1 activity is not known. It has been 
proposed that mTORC1 is mediated through stretch- activated calcium channels or through 
attachment complexes in the cell membrane (i.e. integrins) following contraction. However regulation 
and control of this process is currently unknown [220].   
 
Figure 1.3 The diagram shows multiple signal pathways in skeletal muscle cross-talking on 
mTORC1, to influence protein synthesis as well as muscle cell growth. Insulin stimulates 
mTORC1 via PI3K-Akt axis while energy level modulates mTORC1 through influencing the 
AMPK signal pathway, which is in response to intracellular AMP/ATP ratio. Muscle 
contraction can induce multi-levels response of signaling transduction, which generates 
comprehensive effects on mTORC1 activity as well as the protein synthesis it conducts. The 
mechanical study of AA supplements on regulating mTORC1 activation and muscle protein 
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synthesis are just emerging, which is still poorly understood in many aspects. Image is taken 
from Drummond et al. [58]. 
 
1.5.3 Effects of different exercise modes on muscle protein synthesis 
1.5.3.1 Resistance exercise 
Early studies reported that the skeletal muscle protein turnover was depressed during the acute bout of 
resistance exercise [84, 85]. However, later studies demonstrate that the depression of muscle protein 
synthesis is quickly reversed during post-exercise recovery. Now it is commonly accepted that a 
single bout of resistance exercise can effectively stimulate net protein synthesis in human skeletal 
muscle, even in the fasted state [74- 77]. It should be emphasized that in addition, rates of muscle protein 
breakdown are also accelerated after resistance exercise [78, 79]. However, protein synthesis rates are 
increased to a greater extent than that of protein breakdown, thus stimulating the net increase of 
skeletal muscle protein balance post exercise [75, 76, 78].  
At the molecular level, enhanced mRNA transcription has been observed after resistance exercise 
training, associating with increased muscle protein translation [224]. This can also be reflected by the 
activation of positive translation regulators. For example, S6K1 is reported to consistently be 
phosphorylated in the 1-6h after the bout of resistance exercise, together with increased protein 
synthesis [80, 81]. Meanwhile, another mTORC1 substrate 4E-BP1 is dephosphorylated to become 
inactivated post resistance exercise [80, 82] . Drummond et al found that the dephosphorylation of 4E-
BP1 was only observed during resistance exercise, suggesting that 4E-BP1 might be independent of 
the regulating events in muscle protein anabolism post resistance exercise [58].  
1.5.3.2 Endurance exercise 
Besides resistance exercise, studies have also investigated the muscle protein synthesis response to 
different modes of muscle contraction, such as aerobic endurance exercise. Aerobic endurance 
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exercise is observed to stimulate muscle protein synthesis in both fasted [83-85] and fed conditions [84, 86, 
87], with chronic aerobic exercise also leading to hypertrophy [88, 89]. However, compared with the 
obvious accumulation of myofibrillar proteins after acute bout of resistance exercise, the muscle 
protein turnover in acute aerobic endurance exercise is thought to be primarily caused by increase in 
mitochondrial expansion rather than by myofibrillar protein accretion based on various examinations 
on muscle protein in the fed states [90], except one study reporting the increase in myofibrillar protein 
synthesis after prolonged one-legged kicking exercise [91].  Currently, knowledge on the mechanisms 
of aerobic endurance exercise mediated increased muscle protein synthesis is still limited. There is 
some evidence that mTORC1 may be involved in this process given reports that mTORC1 Ser2448 
phosphorylation is increased post acute aerobic exercise [92- 94], however this is still an area of 
intensive investigation. 
 
1.6 Nutritional regulation of mTORC1 activity  
AA supplementation is a potent activator of mTORC1 in skeletal muscle [98,160,177]. Of all the AA 
species, several are found to exhibit the significant stimulatory effects on mTORC1 activation, 
namely as the branch-chain amino acids (BCAA) [159]. Moreover, Leucine appears to be the most 
potent AA in stimulating mTORC1 activity [82,102].  
1.6.1 Branch- chain amino acid  
There are about three hundreds of AA species in nature, with twenty required for maintaining body 
functions [2]. Based on the needs for diet, nitrogen balance or cell growth, these twenty AAs can be 
generally classified as nutritionally essential (indispensable) or non-essential (dispensable) in human 
metabolism. The definition of essential AA (EAA) is those AAs whose carbon skeletons cannot be 
synthesized, or those that are inadequately synthesized de novo by the body. By contrast, non-
essential AAs (NEAA) are AAs that can be synthesized de novo in adequate amounts by the body to 
meet optimal requirements [98].  
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Oral ingestion of EAAs stimulates muscle protein synthesis in rodents in addition to healthy young 
and old humans, either with or without exercise [96, 97, 99, 100, 150 [223]. Moreover, the stimulatory effect of 
complete mixture of EAAs on skeletal muscle protein turnover is mimicked by providing branched 
chain AA in vitro and in vivo rat experiments [103, 104]. On the contrary, feeding rat an AA mixture 
without the BCAAs showed no effert on muscle protein synthesis [105]. BCAAs belong to EAAs but 
are structurally different from other EAAs owing to their branch chain besides the main C-terminal 
chain, which includes valine, leucine and isoleucine. Of three BCAAs, leucine is found to have the 
most robust effects in stimulating protein synthesis in skeletal muscle [99,101,102,106]. Demonstrated by in 
vitro studies, the stimulating effect of leucine alone is nearly as equal as the mixture of three BCAAs 
together in both incubated diaphragm and perfused gastrocnemius [102, 104]. Moreover, oral ingestion of 
leucine is efficient to boost muscle protein synthesis whereas isoleucine or valine has no stimulatory 
effects [105].  
1.6.2 Mechanistic regulation of mTORC1 by BCAA’s. 
Studies have identified that BCAAs, in particular leucine, are capable of activating mTORC1 and its 
downstream substrates directly, such as 4E-BP1 and p70S6K, to initiate protein synthesis [107, 108]. 
Direct microinjection of leucine into the cytoplasmic compartment of oocytes was effective to 
increase mTORC1 /p70S6K activity [119]. As to how leucine directly activiates mTORC1 is currently 
unclear, however, a number of mechanisms have recently been proposed. It has been suggested that 
BCAA may regulate mTORC1 activity via two proteins, raptor and/or Rheb. There is evidence 
supporting that leucine deprivation is counter-related to the interaction between mTOR and raptor, 
which can be restored by the re-addition of leucine into cell culture medium [105]. Conformational 
change is thought to be responsible for the mTOR- raptor interaction shift, and it is an interesting 
question to understand the roles leucine plays in this transformation [14]. On the other hand, 
overexpression of Rheb proteins can effectively stimulate the mTORC1 signaling in Drosophila S2 
cells, even under the BCAA starvation [15]. By contrast, BCAA is insufficient to active mTORC1 in 
Rheb knock-down cells, suggesting the indispensible roles of Rheb in BCAA-stimulated mTORC1 
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signal transduction [110].  It is still not clear the molecular mechanism how BCAA mediate mTORC1 
and Rheb interaction. It seems not to be through the inhibitory interaction between TSC1/TSC2 
complex and Rheb, as the mTORC1 signaling was still prohibited after AA depletion in TSC2 knock-
out mouse embryonic fibroblasts [109]. It is a question whether AA influence Rheb GTP/GDP 
exchange awaits further investigation [45]. Recent studies reported mTORC1 translocation to the Rheb-
rich lysosomes after BCAA addition. Immunostaining analysis shows that mTOR is diffusely 
cytoplasmic under BCAA-starvation but aggregates onto a Rab7-rich membrane compartment, where 
Rheb is localized, upon re-addition of BCAA [99, 111]. A subfamily belonging to Ras GTPases family, 
named Rag, is identified to mediate BCAA- induced mTORC1 activation. Based on homological 
identity, Rag subfamily can be divided into two subgroups, RagA/B and RagC/D. Members in each 
subgroup are highly identical to each other, whereas the homology between subgroups is low (~20% 
identity between RagA/B and RagC/D) [15]. Functional Rag complexes are heterdimers composed of 
both subgroup members. There is direct evidence demonstrating the interaction of Rag GTPase with 
mTORC1 through association with raptor [111]. Depletion of either Rag complex or raptor by RNAi 
prevented the recruitment of mTOR to the Rab7-positive vesicles upon AA stimulation [99]. Like other 
GTPases, Rag function is controlled by its GTP load status. Binding of Rag to mTORC1 needs 
RagA/B charged GTP and is strengthened by RagC/D if GDP loaded. According to report by Sancak 
et al., the supplementation of AA into culture medium was observed to promote GTP charging of 
endogenous Rag from 44% to 63%, as well as enhancing the association of Rag with mTORC1 [111]. 
So a model is proposed that AA could stimulate the recruitment of mTORC1 to Rheb-positive 
membrane area for activation by enhancing the GTP/GDP exchange of Rag complex. Nevertheless, 
because of lacking C-terminus membrane insertion sequences, it seems a problem for Rag complex 
per se to dock on the Rheb positive endosomal membranes, not to mention assisting mTORC1 
translocation. Sabatini et al. identified additional new binding proteins based on biochemical 
experiments and demonstrated that Rag complex could reside on the Rheb positive membrane 
previously with the assistance of a “Ragulator” complex consisting of MP1, p14 and p18 [99]. 
However, they found AA addition only influenced the GTP loading form of Rag complex rather than 
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mediated the interaction of Rag complex with the regulator. In other words, AA supplements regulate 
the binding of mTORC1 on Rag complex. Intriguingly, the location of regulator complex on Rab7 
positive microdomains is not clear, because there is little homology of the three new proteins with 
other known domains.  
 
Figure 1.4 The diagram demonstrates the potential molecular mechanism of the Rag complex 
modulating mTORC1 activation when sensing nutrition avalibility. The Rag complex is 
heterodimer from two subgroups, RagA/B and Rag C/D. Special AA flux may be sensed by the 
Rag complex, which then assists mTORC1 translocating for activation. Specifically the Rag 
complex binds to Raptor in a GTP-RagA/B-dependent manner, which may be mediated by AA. 
“Ragulator” is consisted of MP1, p14 and p18, interacting with Rag proteins to target mTORC1 
complex on the lysosome membrane, where Rheb and Rab7 is localized. In sum, it is proposed 
that mTORC1 is recruited by the Rag complex to the Rheb-positive compartment (possibly the 
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lysosome) in response to AA. The tertiary AA transporters (e.g. System L SLC7A5/SLC3A3) 
couple with secondary glutamine transport (e.g. System A SLC1A5) to efflux glutamine and to 
import leucine into muscle cells. This bidirectional transport enriches intracellular leucine pool 
to facilitate mTORC1 activation. However, it is not certain if the mammalian ortholog of Vps39 
translocates toward the Rag complex owing to its GEF activity in response to AA. Image was 
adapted and re- drawn from Kim et al [15]. 
Another pertinent question is to how Rag complexes sense increased AA availability. It is reported 
that a PI kinase belonging to class III PI3K, named hVps34, may play the intermediate role between 
AA and mTORC1 [115, 116]. The catalyzed product of hVps34, PI(3)P, is often served as platforms on 
membrane to build trafficking complexes through the interaction of PI(3)P with other proteins owning 
special recognition domains. In these studies, AA was found to activate hVps34, hence inducing the 
accumulation of PI(3)P on endosomal membranes. And depletion of hVps34 could effectively 
suppress AA- stimulated mTORC1 signaling [115, 116]. Gulati et al. found AA addition could promote 
intracellular Ca2+ release and mTORC1 activity was inhibited after depleting the cellular Ca2+ [117].  
They proposed that AA may activate hVps34 by enhancing interaction between hVps34 and 
Ca2+/CaM if Ca2+ levels are increased. As a consequence, PI(3)P concentrations would be elevated on 
endosomal membranes, making it easier to recruit proteins forming functional complex, such as Rag 
and its regulators. In a report, Yan et al. showed that hVps34 bound to CaM. However, Ca2+ chelator 
treatment did not suppress its activity in vivo. In addition, there seemed no influence on hVps34 
activity after removal of CaM by EDTA or EGTA washes in vitro [118]. Another possibility is that 
molecule conformational change is induced by increased cytoplasmic Ca2+ level. AA was previously 
reported to induce the conformational change of mTORC1 to access its substrates, though direct 
evidence is lacking in support of the regulation mediated by Ca2+. So it is still questionable to the 
potential roles hVps34 plays in AA- induced mTORC1 activation. As parts of that, it is interesting to 
investigate the ‘platform’ components hVps34 recruits, especially whether including those reported 
involving in mTORC1 activation.    
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1.7 Immunofluorescence microscopy approaches to study mTORC in vivo 
The intracellular localization of mTORC1 is tightly related with its activity. Advanced microscopy 
techniques have been applied to the molecule localization study, including mTORC1 research. For 
example, use of microscopy techniques have revealed mTORC1 to translocate to LEL compartment 
following the influx of AA into tumor cells [99].  
In exercise physiology studies, the microscopy technique could therefore be a helpful experimental 
approach to study mTORC1 activation in response to muscle contraction. For example, 
immunofluorescence microscopy has been used as an effective way to investigate the spatial 
distribution and expression of mTORC proteins with LEL compartment in myosin heavy chain 2b 
muscle fibres in response to mechanical stimulation in mice skeletal muscle [156]. Moreover, 
immunofluorescence microscopy can be utilized to observe the redistribution of special signal 
molecules in response to stimuli such as nutrients and exercises in human skeletal muscle.  
By virtue of the newly- developed computational semi-quantification techniques on microscope 
images, it is possible to not only visualize the molecule distribution and redistribution of proteins, but 
also to quantify the protein expression in local area, as well as the subcellular association between 
different proteins. The semi-quantification method based on microscopy images has been successfully 
utilized in various studies in skeletal muscle. For example, using semi-quantification method, 
Shepherd et al reported that the lipid droplet (LD)-associated proteins perilipin 2 is reduced in 
association with intramuscular lipid droplets after a single bout of endurance exercise, while the total 
perilipin 2 protein content is not changed in skeletal muscle [179].  
As such, immunofluorescence microscopy is an effective research technique that can be used in 
combined with (semi)quantitative calculations, generating informative images demonstrating spatial 
distribution and local content of specific proteins. With regard to mTOR research, it will allow novel 
investigation into the role and regulation of mTOR biological activity in human skeletal muscle in 
vivo.  
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1.8 Overview of the thesis 
Based on the aforementioned studies, the aim of this thesis is to develop analytical techniques to study 
mTOR cellular localization and protein complex regulation in human skeletal muscle. 
In Chapter 3, we describe the development of new immunofluorescence microscopy methods to 
assess mTOR and its regulators in human skeletal muscle. To specify the immunofluorescence 
staining quality, a series of rigid testing methods were developed to qualify each antibody for 
experimental use. The results document that this novel experimental technique can reliably and 
reproducibly localize and measure skeletal muscle mTOR protein, two biomarkers of LEL membrane 
(Rab7, Lamp2) and its activity associated proteins (Rheb, EIF3F, TSC2), which will be applied in the 
further studies.  
In Chapter4, we examined whether resistance exercise training would alter mTOR protein content 
and localisation in human skeletal muscle in vivo. To test this research question, we utilised the 
immunofluorescence microscopy approaches developed in Chapter 3 to measure mTOR protein 
content in skeletal muscle cross sections obtained from young males in response to 10- week 
resistance exercise training. Further we then made use of the immunofluorescence approach to 
investigate the mTOR protein content relative to different myosin heavy chain subunits. 
In Chapter 5, we changed our focus to investigate the spatial distribution and redistribution of mTOR 
in response to an acute bout of resistance exercise in combination with protein/carbohydrate ingestion. 
We observed high levels of association between mTOR and the lysosome in basal skeletal muscle, 
with a contraction-mediated translocation to the plasma membrane following exercise and nutrition. 
The functional relevance of this cellular redistribution appears to be to allow mTOR to interact with 
its positive regulator Rheb, in addition to the translation initiation factor eIF3f. 
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2.1 Ethical approval 
Human skeletal muscle samples used in chapter 4 were obtained from the School of Sports, Exercise 
and Rehabilitation sciences, University of Birmingham, which was approved by the west midlands 
NHS ethics committee (NHS REC Solihul West Midlands, 14/WM/0088). Human skeletal muscles 
samples used in study 5 and 6 were obtained from the University of Guelph and University of 
McMaster.  
 
2.2 Human skeletal muscle sample analysis 
2.2.1 Sample collection 
Skeletal muscle samples used to develop the immunofluorescence histological microscopy methods 
were obtained from the m. vastus lateralis of one young healthy human volunteer (age, 20 years; body 
mass index (BMI) 25 kg.m-2), using the percutaneous needle biopsy technique [1]. Samples were 
blotted to remove excess blood and dissected free of fat and collagen. Samples were then embedded in 
Tissue-Tek OCT compound (Sakura, 4583) and frozen in liquid nitrogen cooled isopentane solution 
(Sigma Aldrich, 270342). Sample preparation and embedding for immunofluorescence took ~1-2 min 
before samples were frozen in isopentane. After immediate freeznig, samples were stored in an 
aluminium cryotube (Caltag Medsystems, PA6003) and maintained at -80oC until experimental 
analysis was performed. 
2.2.2 Sample preparation for histology 
Embedded muscle samples were fixed on solid ion cylinders by Tissue-Tek OCT under -25 °C 
temperature. Samples were then fixed in position in front of the microtome blade (Bright 5040, Bright 
Instrument Company limited, Huntingdon, England). The angle of the blade and samples were 
adjusted to guarantee that sections were cut in the proper direction (e.g. transverse or longitudinal 
sections), and an optical microscope (x10, Leica) was used for determining section orientation. Once 
the cutting angle was fixed, muscle sections were serially cut (5μm) under temperature maintained at -
 51 
 
25 °C and collected onto room temperature uncoated glass slides (VWR international). Sections were 
left to air dry at room temperature for at least 10min, to remove excess crystallized water of sections 
under storage. Each slide was then observed under the optical microscope before treatment, with only 
fresh sections used for histological experiments. Slides were kept under -20 °C freezer for short- term 
storage (≤ 3 months), or stored at -80 °C for longer- term storage (≥ 3 months).  
 
2.3 Antibodies preparation 
2.3.1 Primary antibody 
When appropriate, monoclonal primary antibodies were applied for immunofluorescence histological 
staining due to their high sensitivity and specificity. If monoclonal antibodies were not available, 
polyclonal antibodies were applied to studies. For both classes of antibodies, a series of validation 
methods were developed to ascertain staining specificity and optimal conditions for application in 
human skeletal muscle.  
2.3.2 Secondary antibody  
Considering species cross- affinity, 5% normal goat serum was pre-incubated with tissue sections to 
reduce potential unspecific binding from secondary antibodies. All secondary antibodies were 
conjugated with Alexa@ series fluorophores (invitrogen, Paisley, UK) unless stated elsewhere. In 
multiple costaining experiments, secondary antibodies targeting different proteins were visually 
distinguished by different Alexa dye fluorophores. For example, mTOR primary antibody was 
detected with secondary antibody conjugated with Alexa 594nm fluophores (red), Lamp2 primary 
antibody incubated with a secondary antibody tagged with Alexa 488nm fluophores (green). 
Validation methods were also developed to preclude potential cross- binding between two secondary 
antibodies during costaining experiments. 
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2.3.3 Other reagents  
Phosphate buffered saline (PBS, 137 mM sodium chloride, 3 mM potassium chloride, 8 mM disodium 
hydrogen phosphate and 3 mM potassium dihydrogen phosphate, pH of 7.4. from Sigma Aldrich) was 
used for dilution of antibodies, goat serum, reagents and antibody washing steps.  
Mowiel (6 g glycerol (Sigma Aldrich, G5150), 2.4 g mowiol 4-88 (Fluka, 81381) and 0.026 g 1,4-
diazobicyclo-[2,2,2]-octane (DABCO) (Fluka, 33490) dissolved in 18 ml 0.2M Tris-buffer (pH 8.5) 
(Sigma Aldrich, T5030)) was used to mount all cover slips and slides. 
 
2.4 Immunofluorescence histological staining method  
2.4.1 Sample Fixation 
Cryosections (5 μm) were fixed in both formaldehyde and acetone/ethanol fixation reagent (3:1) to 
determine the fixative that provided the highest quality images. Formaldehyde approaches can be 
problematic due to reaction with glycol bond to form the methylene (-CH2-) bridges among proteins 
of tissue, which further assembly into a molecular network to help stablise the structural integrity of 
tissue [2, 3]. However, the dense structure fixed over the tissue will also block the access of antibodies 
to their targeted proteins. So it may be necessary to permeate the tissue in the following steps to allow 
for the accessibility of antibodies. In contrast, the acetone/ethanol methods fix the muscle tissue 
through denaturing the biological structure of protein molecules rather than forming bonds. 
Coagulated proteins will lose their original shape, which might lead to the failure of some primary 
antibodies to recognize the specific site on targeted proteins. However, this reaction barely causes 
spatial blocking of antibodies to proteins, which facilitates the staining consistence throughout the 
whole section. In this study, based on the aforementioned justification, acetone/ethanol was selected 
as the universal fixation method unless stated. 
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2.4.2 Antibody incubation 
The appropriate primary antibody dilution, incubation time and temperature were also studied and 
optimised. Initially, primary antibodies were tested at a series of dilutions ranging from 1:25 to 1:200 
with incubation time of 2 hours at room temperature. For secondary antibodies, antibody dilution tests 
were performed at 1:100 and 1:200 and 1:300, with 30min incubation time under room temperature.  
2.4.3 Staining protocols targeting one protein 
Following air-drying for 10min, the prepared sections (5 μm) mounted on slides were fixed in acetone 
and ethanol (3:1) solution (Fisher technology) for 5 min.  Sections were fully washed with 3x 5min in 
phosphate buffered saline (PBS) to remove fixation reagent. Sections were then pre-incubated with 5% 
normal goat serum for 30min. After another 3 x 5min PBS washing, primary antibody solution diluted 
with 5% normal goat serum (NGS, Invitrogen) was incubated with sections for 2 hours at room 
temperature. Sections were then washed 3x5min with PBS to remove unbound primary antibodies. 
Secondary antibody solution targeting specific primary antibodies were prepared in PBS with an 
incubation time of 30min at room temperature. Excess secondary antibodies were removed by 3x 
5min PBS washing after incubation. Sections were finally incubated with wheat Germ Agglutinin 
conjugated with Alexa @ 350(WGA-350) for 20min at room temperature to mark the sarcolemma 
membrane. Following a further 5min PBS wash to preserve the WGA fluorophores, slides were left to 
air dry for 1-2 min at room temperature until the visual water stains evaporated. Sections were then 
mounted with 20µL Mowiol and sealed by glass coverslips to protect the muscle sections and to 
preserve fluorescence signals. Slides were left fully dry overnight before observation under 
microscope.  
2.4.4 Co-staining protocols targeting multiple proteins 
Primary antibodies targeting different proteins were diluted into one mixed solution for simultaneous 
incubation to save time and fluorescences signals, previously described as the ‘cocktail’ method. To 
preclude the possibility of cross reactivity, we verified each antibody compared to negative controls.  
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2.4.5 Antibody validation 
Rigid systemic testing protocols were established to test the specificity of images produced by each 
antibody cocktail. For every primary antibody applied in this thesis, we performed concentration 
optimization testing, double negative controls testing, signal channel specificity testing and 
reproducibility testing. For multiple protein staining experiments, cross-reaction negative control 
testing was applied on co-stained antibodies to establish the specificity of protein signals. More details 
on the staining performance of each antibody applied in the study can be found in the chapter 3. 
 
2.5 Microscopy 
2.5.1 Image capturing 
Prepared slides were observed under a Nikon E600 microscope using a 40×0.75 numerical aperture 
objective. Images per area were captured under three colour filters achieved by a SPOT RT KE colour 
three shot CCD camera (Diagnostic Instruments Inc., MI, USA), illuminated by a 170 W Xenon light 
source. For images capture, DAPI UV (340–380 nm) filter was used to view WGA signals (blue) and 
mTOR stains tagged with Alexa 594 fluorophore (red) was visualised under the Texas red (540–580 
nm) excitation filter. FITC (465–495nm) excitation filter was left to capture signals of mTOR-
associated proteins, which were conjugated with Alexa Fluor 488 fluorophore unless stated elsewhere. 
DAPI UV (340-380 nm) was used to observe the DAPI stained nucleus. Switching among Filters was 
performed using a semi-automated filterwheel (10B 10 Position Filterwheel, Sutter, USA). All 
widefield images were obtained using a 40x objective (0.75 NA). 
To provide enhanced clarity, higher resolution images were captured by an upright confocal 
microscope (Zeiss LSM 510 Meta, Carl Zeiss), using a 40× 1.4 NA water immersion objective. 
Fluorophores were visualised under three laser filters simultaneously. Alexa Fluor 488 fluorophore 
was excited by an argon laser and 498-571 nm emission, while a 594nm line of the helium–neon laser 
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with 601-713 nm emission was used to excite Alexa Fluor 594 fluorophore. WGA conjugated with 
Alexa 350 and DAPI was visualised under the excitation of the 405nm line from a Diode 405-30 filter.  
The image capture setting was optimized following the indication of range indicators. Signal strength 
was controlled by the exposure time and photon sensitivity (“gain”). A range of image capture 
settings were tested to achieve optimal fluorescence signals. All the images in one experiment were 
taken under the same image settings.  
2.5.2 Image analysis 
All microscope images were processed under grey/white raw image format. The association between 
mTOR and cellular organelles, as well as between mTOR and regulating proteins was measured by 
colocalisation analysis. The subcellular distribution of mTOR was measured by quantification 
analysis. 
2.5.2.1 Fluorescence colocalisation analysis  
For colocalisation analysis, five to seven areas per section were randomly selected and imaged under 
the same capture settings. Images were processed and analysed under the Image-Pro Plus 5.1 software 
(Media Cybernetics, MD, USA). Image signals generated by WGA or dystrophin were used to 
estimate cell membrane borders, then merged with the corresponding target proteins images to 
identify the association between these proteins and plasma membrane. Pearson’s correlation 
coefficient was used to measure colocalisation of two proteins in immunofluorescence images [4, 5, 6]. 
This method was also applied into the colocalisation analysis between mTOR and its associated 
proteins. All images analysis methods were kept consistent in the same study.  
2.5.2.2 Fluorescence quantification analysis 
Quantification of mTOR protein signal within nucleus area was achieved by analysing the 
fluorescence intensity of the signal within the dapi- positive area corresponding to the positive 
Alexa®594 staining. Firstly, threshold was optimized to extract the positive fluorescent signal for 
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creating a mask of the area stained positive for the nucleus (stained by Dapi) using routine parameter 
settings. Before quantification, fluorescence signals of proteins were filtered to exclude the 
background noise by setting the adjusted lower limit and upper limit in threshold settings. Then the 
extracted nucleus outline was overlaid onto the corresponding protein images and fluorescence 
intensity of the protein fluorescence was quantified within the outlined nucleus area. Mean fluorescent 
intensity of the signal was measured from five to seven images per section resulting from 70-100 
muscle fibres. The final mean fluorescent intensity was considered from the average of duplicates.  
 
2.6 Statistics 
Reproducibility of antibodies was obtained from repeated colocalisation analysis or fluorescence 
quantification (three duplicate measures) from the same subject before formal studies. The 
reproducibility of duplicate measures for specific antibodies was assessed by the range and coefficient 
of variation (CV) between duplicates. 
In each experimental chapter, all immunofluorescence image analysis was performed in duplicate (2 
sections on 1 slide). The table data for each time point was the mean value of 2 duplicate sections on 1 
slide from 7 persons in each group. For statistical analysis, Pearson’s correlation coefficient values 
achieved from 5-7 areas captured in each section at each time point were successively input into 
statistical analysis software (SPSS for windows version (SPSS, Chicago, IL)), and a two- way 
ANOVA was applied to calculate significance of data among different time points between groups. 
For quantification analysis, mean value of data from protein fluorophore intensity was calculated and 
compared following the same statistic analysis strategy as that of colocalisation analysis in SPSS. 
Significance was set at P < 0.05. Data was presented as means ± S.E.M. 
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3.1 Abstract 
The aim of the chapter was to develop a series of immunofluorescence histology staining methods in 
human skeletal muscle to visualize the mTOR protein complex, as well as mTOR associated proteins. 
All immunofluorescence signals observed were validated through the double negative, signal channel 
specificity and cross binding control approaches to verify specificity of signal capture. For signal 
sensitivity, all immunofluorescence signals were optimized to capture the microscope images with 
strong fluorescence strength versus low background, ensuring accuracy of fluoresecence measured in 
the microscope images. Lastly, the primary antibodies applied in this chapter endured repeatability 
validation testing, which was designed to measure the reliability of experimental data. In conclusion, 
this chapter details a novel analysis method to study mTOR in human skeletal muscle. All antibodies 
applied into the studies in the thesis were validated under a series of methodologies to guarantee the 
specificity, sensitivity and repeatability of fluorescence signals achieved from the 
immunofluorescence microscopy technique. 
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3.2 Introduction 
Immunocytochemistry was first reported in 1942 by Albert et al, who developed a fluorescent- 
labelled antibody to localize the pneumococcal antigen in liver sections [1]. The approach was a 
significant advance as it provided a powerful method utilising antibodies to localize subcellular 
structures in both cultured cells in vitro and tissue sections in vivo. Labelling methods used in 
immunocytochemistry can be divided into three types: fluorescence, enzymes and particulate [2]. As 
one of the derivative methods, immunofluorescence is a widely used immunocytochemistry technique 
that utilises fluorophores to visualize the localisation of proteins stained by antibodies [2, 3].  
The recognition of a primary antibody to a specific antigen is important to guarantee specific staining 
in immunofluorescence experiments. The antibody structure is constituted by a variable region (Fab 
portion) that binds the epitope part of the antigen and the constant region (Fc portion) that is specific 
to the animal where the antibody was raised [4]. Antibody isotypes are categorized based on the 
differences in the AA sequence in the constant region (Fc) of the antibody heavy chains. There are 
five major antibody isotypes, and the immunoglobulin G (IgG) is the most common antibody type 
applied in the immunofluorescence experiment [2]. There are four IgG subclasses (designated 1- 4) 
present in human, mouse and rat [5, 6]. The subclasses differ in the number of disulfide bonds and the 
length and flexibility of the hinge region [6]. In addition to the heavy chain, sequence variations in the 
constant region of the antibody light chain are further subclassified as kappa (κ) and lambda (λ) [7]. 
The antibody that directly binds to the interested antigen through its variable region is referred to as 
the primary antibody. In contrast, the antibody that binds the constant region (Fc portion) of the 
primary antibody in animal specificity type is also known as a secondary antibody [2, 3, 4].  
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Figure 3.1 Diagram to demonstrate IgG antibody structure. Antibody is composed of two 
fragments, the Fab fragment and Fc fragment. Fc fragment is sequence reserved while Fab 
fragment is sequence variable. Antigen binds with the Fab fragment of antibody, while Fc 
fragment determines the isotype of antibody [12]. Image was re- drawn based on Wang et al [12] 
and Edelman [13].  
There are three types of immunocytochemistry controls proposed, primary antibody controls, 
secondary antibody controls and label controls [2]. For direct immunocytochemistry, the primary 
antibody control is used to examine the binding between antibody and antigen. Most primary antibody 
controls are based on gene manipulation methods in transgenic animals. However, there are some key 
principles to follow. Normal serum is incubated on sample to fill the redundant space among cells, 
which reduce the unspecific binding of antibody [2]. And it is recommended that when obtaining the 
primary antibody, those antibodies validated under immunocytochemistry testing are primarily 
considered for experiments [2]. It is also suggested to compare the novelty of the antigen sequence on 
which monoclonal antibody is generated [8, 10]. The published immunocytochemisty data from the 
similar study model is referred to when distinguishing the signals [8]. 
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For indirect immunocytochemistry with an unlabelled primary antibody, and a species- specific 
labelled secondary antibody, secondary antibody controls are needed to show that each secondary 
antibody binds to the correct primary antibody. The secondary antibody control should be applied 
without the primary antibody incubation, under which circumstances no labelled fluorescence should 
be visualized [2, 9]. Utilization of the label conjugated secondary antibody eliminates the unspecific 
binding of labels on antibodies. For multiple antibodies staining experiment, it is important to validate 
the signal emission specificity to guarantee no bleed- through of signals into other channels affecting 
the specificity of signals [8, 10]. For the ‘cocktail’ costaining method, rigid control experiment is 
indispensible to exclude the false signals from the cross-staining between primary antibodies and 
secondary antibodies. 
As highlighted in chapter 2, there is a close relationship between mTOR activity and its intracellular 
distribution. Taking advantage of immunofluorescent approaches, studies have been made in cell and 
rodent models [14, 15]. However, microscopy data in human skeletal muscle is lacking. To develop the 
immmunofluorescence technique obtaining high quality mTOR microscope images from human 
skeletal muscle, all antibodies applied into studies need systemically validation here to guarantee their 
staining specificity and sensitivity. To address these issues, within this chapter we describe 
immunofluorescent approaches to study mTOR and associated proteins in human skeletal muscle.  
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3.3 Antibodies and dyes 
3.3.1 Primary antibodies 
The monoclonal antibody against mTOR was from Merck Millipore Corporation (Billerica, MA; Cat 
No. #05-1592); polyclonal antibody against Lamp2 was from Abgent Technology Company (Suzhou, 
China; Cat No. AP1824d); monoclonal antibody against Rab7 was from Abcam biotech company 
(Cambridge, ENG; Cat No. ab50533); monoclonal antibody against Rheb was from GenWay Biotech, 
Inc (San Diego, CA; Cat No. GWB-2AD39C); polyclonal antibody against EIF3F was from Abcam 
biotech company (Cambridge, ENG; Cat No. ab74568); monoclonal antibody against integrin ß-3 was 
from Cell signaling (USA; Cat No. #13166); Monoclonal antibody against Tuberin was from Abgent 
Technology Company (Suzhou, China; Cat No. S1798); Lectin from Ulex europaeus conjugated with 
FITC was from Sigma- Aldrich Company Ltd. (Gillingham, UK; Cat No. L9006 Sigma); Monoclonal 
antibody against myosin heavy chain I was from Developmental Studies Hybridoma Bank (Iowa, 
USA; Cat No. A4.840); Monoclonal antibody against myosin heavy chain IIx was from 
Developmental Studies Hybridoma Bank (Iowa, USA; Cat No. 6H1); Monoclonal antibody against 
myosin heavy chain I and IIa was from Developmental Studies Hybridoma Bank (Iowa, USA; Cat No. 
N2.261); Wheat Germ Agglutinin conjugated with Alexa Fluor® 350 was from Life Technologies Ltd. 
(Paisley, UK; Cat No. W11263); Monoclonal antibody against dystrophin was from Developmental 
Studies Hybridoma Bank (Iowa, USA; Cat No. MANDYS1(3B7)).  
3.3.2 Secondary antibodies 
If not otherwise stated, secondary antibodies were conjugated with Alexa@ Series 
immunofluorescences dyes. For multiple proteins staining experiment, secondary antibodies with 
different isotypes were used to guarantee that specific fluorescence from each protein was observed 
under distinguished wavelength channel from the others. The following table describes the 
combination of primary antibodies with corresponding secondary antibodies applied in this chapter. 
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     Table 3.1 List of validated primary antibody combined with secondary antibody for study. 
 
3.3.3 Additional antibodies and dyes 
Cellular nuclei were stained by the 4', 6-diamidino-2-phenylindole (DAPI, 1:1000, Sigma D9542). 
Blood vessels were stained by Lectin from Ulex europaeus Agglutinin conjugated with FITC 
fluorescences (Sigma Aldrich, UK, L9006). The plasma membrane (PM) was either outlined by the 
monoclonal antibody against the membrane protein dystrophin (Glenn E. Morris, MANDYS1 clone 
3B7) or stained by another membrane protein Wheat Germ Agglutinin conjugated with Alexa 
Fluor®350 (1:100, Invitrogen, UK), generally depending on the excitation filters of cell membrane 
Primary Antibody Secondary Antibody 
Mouse monoclonal antibody anti- 
mTOR,isotype IgG γ1 kappa  
Goat anti- mouse IgG γ1 Alexa®594 
Rabbit polyclonal antibody anti- 
Lamp2,isotype IgG 
Goat anti- rabbit IgG Alexa®488 
Mouse monoclonal antibody anti- Rab7,isotype 
IgG 2β  
Goat anti- mouse IgG 2β Alexa®488 
Rabbit monoclonal antibody anti- Rheb,isotype 
IgG 
Goat anti- rabbit IgG Alexa®488 
Rabbit polyclonal antibody anti- EIF3F,  
isotype IgG 
Goat anti- rabbit IgG Alexa®488 
Mouse monoclonal antibody anti- Tuberin, 
isotype IgGγ1 
Goat anti- mouse IgG γ1 Alexa®594 
Lectin from Ulex europaeus Agglutinin 
conjugated with FITC fluorescences (UEA-I) 
Alexa Fluor® 488 Conjugated 
Mouse monoclonal antibody anti- myosin 
heavy chain I , isotype IgG M 
Goat anti- mouse IgG M Alexa®488 
Mouse monoclonal antibody anti- myosin 
heavy chain IIx , isotype IgG M 
Goat anti- mouse IgG M Alexa®488 
Mouse monoclonal antibody anti- myosin 
heavy chain I and IIa, isotype IgG G1 
Goat anti- mouse IgG G1 Alexa®594 
Wheat Germ Agglutinin  Alexa Fluor® 350 Conjugated 
Mouse monoclonal antibody anti- dystrophin, 
isotype IgG 2α  
Goat anti- mouse IgG 2α Alexa®488 
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staining signals. To determine different muscle fiber types, the myosin heavy chain I and IIx proteins 
were stained by primary antibodiese purchased from Developmental Studies Hybridoma Bank 
(University of Iowa, USA; Cat No. A4. 840 for MHC I and Cat No. 6H1 for MHC IIx).   
 
3.4 Antibody optimization 
3.4.1 Primary antibody dilution  
Each antibody was tested at a series of dilutions following the same staining procedures and same 
concentration of secondary antibody. The best dilution was selected based on the high signal strength 
as well as low background noise level. Also, the specificity of protein stains was validated by a series 
of negative control staining (in 3.3.3). Phosphate buffered saline was used for the dilution of 
antibodies, reagents and washing steps. The incubation time for primary antibody was 2 hour at room 
temperature if not mentioned elsewhere.  
3.4.2 Secondary antibody dilution  
For secondary antibody, the dilution test was performed at 1:100 and 1:200 with incubation time for 
30min under room temperature. 1:100 and 1:200 dilution exhibited similar stain signal strength, while 
the background fluorescences noise for 1:200 dilution was lower than that of 1:100 dilution. So the 
dilution 1:200 was generally applied for all immunofluorescence staining experiments unless stated 
elsewhere.  
3.4.3 Additional dyes/antibodies dilution  
DAPI was used to stain the nucleus of muscle cells. The dye was optimized at 1:1000 dilution in 
human skeletal muscle, and the incubation time was optimized as long as 5min. Wheat Germ 
Agglutinin conjugated with Alexa Fluor®350 (1:100, W11263, Invitrogen, UK) was optimised to 
incubate with samples for 20min.  
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3.5 Antibody validation 
Antibodies were validated through a series of control experiments, designed to assess signal 
specificity and signal stability for each antibody applied into studies.  
3.5.1 Double negative control 
Double negative control samples were tested for each antibody, in which the immunofluorescence 
staining was completed following the same procedure as positive experiments, with PBS solution 
used to instead of the primary antibody. This allowed for testing of any non-specific staining that may 
occur. For consistency, the secondary antibody was replaced by PBS solution to exclude the 
possibility that unspecific immunofluorescence would be stained by primary antibody itself as a 
negative control. 
3.5.2 Signal channel specificity control 
Signal channel specificity controls were also developed to exclude the chance of data being 
confounded by bleed of signal into different channels. For example, when using the DAPI filter to 
observe the Alexa-350 signals, these images were also acquired with the FITC filter and Texas red 
filter to guarantee that no signal was detected in the other two channels applied to visualise other 
protein signals. This procedure was also carried out for the other secondary antibodies used (Alexa 
Fluor 488 and 594). Cryosections were tested for autofluorescence in the absence of any antibodies, 
simply applying PBS to the section following the fixtation and staining steps required. 
3.5.3 Cross-binding control 
In co-staining experiments, the primary antibodies were validated by cross-reaction negative controls. 
For example, when mTOR and Lamp2 were co-stained, secondary antibody targeting Lamp2 antibody 
was used to stain the mTOR primary antibody. In contrast, Lamp2 primary antibody was also 
incubated with secondary antibody recognizing mTOR primary antibody. This cross-binding test 
identifies unspecific cross- binding between primary antibodies and secondary antibodies. 
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Multiple antibodies 
costaining  
Primary Antibodies costained Secondary Antibodies costained 
3.8.1 Costaining of 
mTOR with Lamp2 
Mouse monoclonal antibody anti- 
mTOR,isotype IgG γ1 kappa  
Goat anti- mouse IgG γ1 Alexa®594 
Rabbit polyclonal antibody anti- 
Lamp2,isotype IgG 
Goat anti- rabbit IgG Alexa®488 
3.8.2 Costaining of 
mTOR with Rheb 
Mouse monoclonal antibody anti- 
mTOR,isotype IgG γ1 kappa  
Goat anti- mouse IgG γ1 Alexa®594 
Rabbit monoclonal antibody anti- 
Rheb,isotype IgG 
Goat anti- rabbit IgG Alexa®488 
3.8.3 Costaining of 
mTOR with Rab7 
Mouse monoclonal antibody anti- 
mTOR,isotype IgG γ1 kappa  
Goat anti- mouse IgG γ1 Alexa®594 
Mouse monoclonal antibody anti- 
Rab7,isotype IgG 2β  
Goat anti- mouse IgG 2β Alexa®488 
3.8.4 Costaining of 
mTOR with EIF3F 
Mouse monoclonal antibody anti- 
mTOR,isotype IgG γ1 kappa  
Goat anti- mouse IgG γ1 Alexa®594 
Rabbit polyclonal antibody anti- 
EIF3F,  isotype IgG 
Goat anti- rabbit IgG Alexa®488 
3.8.5 Costaining of 
Tuberin with Rheb 
Mouse monoclonal antibody anti- 
Tuberin, isotype IgGγ1 
Goat anti- mouse IgG γ1 Alexa®594 
Rabbit monoclonal antibody anti- 
Rheb,isotype IgG 
Goat anti- rabbit IgG Alexa®488 
3.8.6 Costaining of 
Lamp2 with Rab7 
Rabbit polyclonal antibody anti- 
Lamp2,isotype IgG 
Goat anti- rabbit IgG Alexa®594 
Mouse monoclonal antibody anti- 
Rab7,isotype IgG 2β  
Goat anti- mouse IgG 2β Alexa®488 
3.8.7 Costaining of 
mTOR with UEA-I 
Mouse monoclonal antibody anti- 
mTOR,isotype IgG γ1 kappa  
Goat anti- mouse IgG γ1 Alexa®594 
Lectin from Ulex europaeus 
Agglutinin conjugated with FITC 
fluorescences (UEA-I) 
Alexa Fluor® 488 Conjugated 
3.8.8 Costaining of 
mTOR with MHCI 
Mouse monoclonal antibody anti- 
mTOR,isotype IgG γ1 kappa  
Goat anti- mouse IgG γ1 Alexa®594 
Mouse monoclonal antibody anti- 
myosin heavy chain I , isotype IgG M 
Goat anti- mouse IgG M Alexa®488 
3.8.9 Costaining of 
mTOR with MHCIIx 
Mouse monoclonal antibody anti- 
mTOR,isotype IgG γ1 kappa  
Goat anti- mouse IgG γ1 Alexa®594 
Mouse monoclonal antibody anti- 
myosin heavy chain IIx , isotype IgG 
M 
Goat anti- mouse IgG M Alexa®488 
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Table 3.2 List of validated primary antibodies combined with secondary antibodies for 
costaining study. 
3.5.4 Antibody Reproducibility  
Antibody reproducibility was verified by three repeats of staining from the same human skeletal 
muscle sample. For each trial, measurement of protein colocalisation or content was performed in 
duplicates and the average value of one trial was achieved from the duplicates results. Data from three 
experiments was analysised by the coefficient of variance (CV) to represent the reproducibility of 
antibodies on immunofluorescences histological staining. 
3.5.5 Blocking peptide competition assay 
To confirm the targeting specificity of primary antibodies, a designed blocking peptide competitively 
targeting the specific antigen- antibody interaction domain was produced, which was fully mixed with 
primary antibody for 24h at 4°C. Following which, the primary antibody solution pre- incubated 
with blocking peptide was applied to skeletal muscle sections following the same incubation protocol 
stated in 2.4.3. Blockade of antibody recognition site by blocking peptide resulted in diminishing or 
disappearance of fluorescence signals observed in antibody-only staining. 
3.6 Statistics analysis 
 
All immunofluorescence image analysis was performed in duplicate (mean of duplicate sections on 
one slide). Reproducibility validation for individual primary antibody was performed on the same 
sample from one participant. Data was obtained from repeated colocalisation or protein quantification 
analysis of three slides from successive experiments. The reproducibility performance was assessed 
by coefficient of variation (CV) among repeats.  
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Results 
3.7 Single antibody staining validation 
3.7.1 mTOR immunofluorescence method development 
3.7.1.1 mTOR antibody staining concentration  
For mTOR primary antibody dilution optimisation, mTOR primary antibody was serially diluted by 
1:100, 1:200 and 1:400 (Figure 3.7.1.1). The 1: 200 antibody dilution was selected because of its 
higher staining recognition than 1:400, while comparatively lower background noise than 1:100 
dilution.  
 
Figure 3.7.1.1 Optimization of mTOR primary antibody dilution. mTOR primary antibody was 
serially diluted to 1:100, 1:200 and 1:400. The secondary antibody dilution was 1:200, and was 
generally applied into the other primary antibodies concentration optimisaton. The same 
staining procedure was followed in each different dilution. Samples come from the same young 
volunteer. Scale bars 50 μm. 
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3.7.1.2 mTOR antibody double negative control 
mTOR antibody was validated for its specific binding capability to the target proteins. As seen in 
Figure 3.7.1.2, mTOR stains can be visualized when samples were incubated with the primary 
antibody as well as corresponding secondary antibody conjugated with fluorescence (A, Figure 
3.7.1.2). In contrast, whenever sections were incubated with primary antibody alone, or the secondary 
antibody only, mTOR signals were not found in negative control images. This indicates that the 
antibody can specifically recognize mTOR in human skeletal muscle in vivo. The weak fluorescence 
found in negative control was possibly from the auto- fluorescence from muscle samples. 
 
Figure 3.7.1.2 mTOR antibody validation. A) Positive control of mTOR antibody staining. 
mTOR antibody concentration was 1:200; B) Only primary antibody staining negative contorl 
and C) only secondary antibody staining negative control. Cell membrane was stained by the 
wheat germ agglutinin conjugated with Alexa 350 fluorescence. Scale bars 50 μm. 
3.7.1.3 mTOR signal channel specificity controls 
In Figure 3.7.1.2, we validated that mTOR antibody staining was specific. We next further tested the 
specificity of fluorescences signals under different excitation wavelength, which is necessary for 
multiple antibodies co-staining approaches. As seen in Figure 3.7.1.3, mTOR signals stained with 
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Alexa 594nm secondary antibody were only visualised under Texas red filter rather than the other two 
filters. This result indicated that the fluorescence excited from secondary antibody was restricted 
within the specific wavelength ranges. 
 
Figure 3.7.1.3 mTOR signal channel specificity under widefield microscope. A) mTOR stains 
was imaged under Texas red filter. The mTOR antibody concentration was 1:200; B) mTOR 
signal was observed under FITC filter. C) Cell membrane was stained by the wheat germ 
agglutinin conjugated with Alexa 350 fluorescence. Scale bars 50 μm. 
3.7.1.4 mTOR localisation in basal human skeletal muscle 
As shown in Figure 3.7.1.4, mTOR protein was visualized both inside the sarcoplasm and the 
sarcolemma membrane in skeletal muscle cells, in agreement with the previous images from rodent 
studies [14]. When images were magnified, it was found that the localization of mTOR on sarcolemma 
membrane was uneven, with parts of fluorescence stacking in specific plasma membrane area. When 
images were further amplified, it was found that some mTOR stains were located near the inner 
plasma membrane. And mTOR stains in sarcoplasm were not universal in protein size, which was 
possibly due to composition differences among mTOR complex, or the cutting angle of the cryostated 
muscle section. 
 73 
 
 
Figure 3.7.1.4 The basal localization of mTOR in young human skeletal muscle at rest level. A) 
The imaged were taken under widefield microscope with x40 objective len. B, C) Images were 
partially zoomed in by x2 and x4 times to show the mTOR localization details in skeletal muscle 
cells. Cell membrane was stained by the wheat germ agglutinin conjugated with Alexa 350 
fluorescence. Scale bars 50 μm, 25µm and 10µm. 
3.7.1.5 Reproducibility of colocalisation between mTOR and cell membrane 
Reproducibility testing was applied on the immunofluorescences histological experiment studying 
association of mTOR with cell membrane (marked with WGA). Serial sections from the same sample 
were stained three times and imaged at the similar areas under microscope. Data for each repeat was 
the mean value from duplicates section on one slide. The reproducibility was quantified as the 
coefficient of variance (CV). CV value for colocalisation between mTOR and WGA was 5%. 
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Figure 3.7.1.5 Reproducibility testing on colocalisation between mTOR and WGA. mTOR 
antibody was stained with WGA conjugated with Alexa@ 350 on the sections from the same 
sample. Colocalisation was measured and shown as Pearson’s Correlation coefficient under 
Image- Pro software.  
 
3.7.2 Lamp2 immunofluorescence method development 
3.7.2.1 Lamp2 antibody staining concentration optimisation 
Lamp2 primary antibody was serially diluted by 1:50, 1:100 and 1:200. The staining effect was 
evaluated by the signal strength and the background noise. Of the different dilutions, the 1: 100 
dilution (B, Figure 3.7.2.1) was selected because of its higher staining strength than 1:200 (C, Figure 
3.7.2.1), while comparatively lower background noise than 1:50 dilution (A, Figure 3.7.2.1).  
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Figure 3.7.2.1 Optimization of Lamp2 primary antibody dilution. Lamp2 primary antibody was 
serially diluted to 1:50, 1:100 and 1:200. The same staining procedure was followed in each 
different dilution concentration. Samples come from the same young volunteer. Secondary 
antibody dilution was 1:200. Scale bars 50 μm. 
3.7.2.2 Lamp2 antibody double negative control 
As seen in Figure.3.7.2.2, Lamp2 stains were only visualized when samples were incubated with the 
primary antibody as well as corresponding secondary antibody conjugated with fluorescence (A, 
Figure 3.7.2.2). In contrast, whenever sections were incubated with the primary antibody alone, or 
with the secondary antibody only, signals were not found in images (B/C, Figure 3.7.2.2). This 
indicated that the Lamp2 antibody could specifically recognize Lamp2 protein content in human 
skeletal muscle in vivo.  
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Figure 3.7.2.2 Negative control of Lamp2 antibody immunofluorescences staining. A) Lamp2 
was stained with Alexa 488nm secondary antibody (green). The negative control was only 
stained by primary (B) and secondary antibody (C), respectively. Cell membrane was stained by 
the wheat germ agglutinin conjugated with Alexa 350 fluorescence (blue). Scale bars 50 μm. 
3.7.2.3 Lamp2 signal channel specificity  
As seen in Figure 3.7.2.3, Lamp2 signals associated with Alexa 488nm secondary antibody were only 
observed under FITC filter rather than under the other filters. This result suggests that the 
fluorescence signal excited from Lamp2 antibodies was wavelength specific, and can be used for 
multiple antibodies costaining. 
 
Figure 3.7.2.3 Lamp2 signal channel specificity under widefield microscope. A) Lamp2 stains 
were imaged under Texas red filter. B) Lamp2 signal was observed under FITC filter. Lamp2 
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antibody concentration was diluted to 1:100; C) Cell membrane was stained by the wheat germ 
agglutinin conjugated with Alexa 350 fluorescence. Scale bars 50 μm. 
3.7.2.4 Lamp2 localisation in basal human skeletal muscle 
In a similar manner with mTOR distribution, Lamp2 was distributed both in the sarcoplasm and on 
the sarcolemma membrane seen from Figure 3.7.2.4. Some Lamp2 staining was found to stack in 
specific areas of plasma membrane, rather than distribute evenly along the membrane. When images 
were further magnified, Lamp2 stains formed a ‘semicircle’ or ‘palm’ under widefield microscope (C, 
Figure 3.7.2.4). Lamp2 was reported to localise on the cytoplasm organnells like late lysosomes [14, 15].  
 
Figure 3.7.2.4 The basal localization of Lamp2 in young human skeletal muscle at rest level. A) 
The images were taken under widefield microscope with x40 objective. B, C) Images were 
partially magnified x2 and x4 times to show the details of mTOR localization in skeletal muscle 
 78 
 
cells. Cell membrane was stained by the wheat germ agglutinin conjugated with Alexa 350 
fluorescence. Scale bars 50 μm, 25µm and 10µm. 
 
3.7.3 Rheb immunofluorescence method development 
3.7.3.1 Rheb antibody staining concentration optimisation 
Rheb primary antibody was serially diluted by 1:25, 1:50 and 1:100. The staining effect was evaluated 
by the signal strength and the background noise. As shown in Figure 3.7.3.1, the 1: 50 dilution of 
Rheb primary antibody was used because of its higher staining recognition than 1:100, while 
comparatively lower background noise than 1:25 dilution.  
 
Figure 3.7.3.1 Optimization of Rheb primary antibody dilution. Rheb primary antibody was 
serially diluted to 1:25, 1:50 and 1:100. The same staining procedure was followed in each 
different dilutions. Samples come from the same young volunteer. Secondary antibody dilution 
was 1:200. Scale bars 50 μm. 
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3.7.3.2 Rheb antibody double negative control 
Similar with mTOR and Lamp2, Rheb fluorescences stains were validated for the double negative 
control (Figure 3.7.3.2). As exhibited in Figure 3.7.3.2, Rheb signals were not found either in primary 
antibody staining alone control or secondary antibody incubation alone control. This proved the stains 
were from the specific incubation between primary antibody and secondary antibody. 
 
Figure 3.7.3.2 Negative control of Rheb antibody immunofluorescences staining. A) Rheb was 
stained with Alexa 488nm secondary antibody (green). B, C) The negative control was only 
stained by primary and secondary antibodies, respectively. Cell membrane was stained by the 
wheat germ agglutinin conjugated with Alexa 350 fluorescence (blue). Scale bars 50 μm. 
3.7.3.3 Rheb signal channel specificity controls 
As shown in Figure 3.7.3.3, Rheb signals stained with Alexa 488nm secondary antibody were only 
observed under FITC filter rather than under the other filters. This indicated that the fluorescence 
excited from Rheb antibodies was wavelength specific. 
 80 
 
 
Figure 3.7.3.3 Rheb signal channel specificity under widefield microscope. A) Rheb stains were 
imaged under Texas red filter. B) Rheb signal was observed under FITC filter. The Rheb 
antibody concentration was 1:50; C) Cell membrane was stained by the wheat germ agglutinin 
conjugated with Alexa 350 fluorescence. Scale bars 50 μm. 
3.7.3.4 Rheb localisation in basal human skeletal muscle 
As seen in Figure 3.7.3.4, the content of Rheb proteins in basal human skeletal muscle cells was at 
high level. Rheb stains were visualized both in the sarcoplasm and on the sarcoplasm membrane. 
When images magnification was increased, Rheb was found to stack on the specific sarcolemma 
membrane areas rather than evenly distribute along the plasma membrane. In the skeletal muscle of 
this subject, large amounts of Rheb proteins were observed to localize near the inner sarcolemma 
membrane (C, Figure 3.7.3.4), suggesting their tight association with the plasma membrane.   
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Figure 3.7.3.4 The basal localization of Rheb in untrained young human skeletal muscle. A) 
Images were taken under widefield microscope with x40 objective. B, C) Images were partially 
zoomed in by x2 and x4 times to show the details of Rheb localization in skeletal muscle cells. 
Cell membrane was stained by the wheat germ agglutinin conjugated with Alexa 350 
fluorescence. Scale bars 50 μm, 25µm and 10µm. 
 
3.7.4 Rab7 immunofluorescence method development 
3.7.4.1 Rab7 antibody staining concentration optimisation 
Rab7 primary antibody was serially diluted by 1:100, 1:200 and 1:400. The staining effect was 
evaluated by the signal strength and the background noise. As viewed from Figure 3.7.4.1, the 1: 200 
antibody dilution was the best of three dilutions because of its higher staining recognition than 1:400, 
while comparatively lower background noise than 1:100 dilution.  
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Figure 3.7.4.1 Optimization of Rab7 primary antibody dilution. Rab7 primary antibody was 
serially diluted to 1:100, 1:200 and 1:400. The same staining procedure was followed in each 
different dilutions. Samples come from the same young volunteer. Secondary antibody dilution 
was 1:200. Scale bars 50 μm. 
3.7.4.2 Rab7 antibody double negative control 
Rab7 antibody was validated for the double negative specificity (Figure.3.7.4.2) to exclude unspecific 
fluorescences from primary antibody or secondary antibody. The result suggested that that both the 
Rab7 primary antibody and secondary antibody were specific to their targets. 
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Figure 3.7.4.2 Negative control of Rab7 antibody immunofluorescences staining. A) Rab7 was 
stained with Alexa 488nm secondary antibody (green). B, C) The negative control was only 
stained by primary and secondary antibodies, respectively. Cell membrane was stained by the 
wheat germ agglutinin conjugated with Alexa 350 fluorescence (blue). Scale bars 50 μm. 
3.7.4.3 Rab7 signal channel specificity controls 
As seen in Figure 3.7.4.3, Rab7 signals stained with Alexa 488nm secondary antibody were only 
observed under FITC filter rather than the other filters. This result indicated that the fluorescences 
excited from Rab7 signals were wavelength specific for multiple antibodies costaining. 
 
Figure 3.7.4.3 Rab7 signal channel specificity under widefield microscope. A) Rab7 stains was 
not found in image under Texas red filter. B) Rab7 signal was observed under FITC filter. The 
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Rheb antibody concentration was 1:50; C) Cell membrane was stained by the wheat germ 
agglutinin conjugated with Alexa 350 fluorescence. Scale bars 50 μm. 
3.7.4.4 Rab7 localisation in basal human skeletal muscle 
In Figure 3.7.4.4, it was observed that Rab7 stains were much smaller than mTOR, generally because 
its molecular weight is 23kDa as a small GTPase. Rab7 proteins were mostly visualized inside the 
sarcoplasm of muscloskeletal cells. Some Rab7 signals were found near the sarcolemma membrane in 
basal human skeletal muscle(C, Figure 3.7.4.4).  
 
Figure 3.7.4.4 The basal localization of Rab7 in basal young human skeletal muscle. A) The 
imaged were taken under widefield microscope with x40 objective len. B, C) Images were 
partially zoomed in by x2 and x4 times to show the details of Rab7 localization in skeletal 
muscle cells. Cell membrane was stained by the wheat germ agglutinin conjugated with Alexa 
350 fluorescence. Scale bars 50 μm, 25µm and 10µm. 
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3.7.5 EIF3F immunofluorescence method development 
3.7.5.1 EIF3F antibody staining concentration optimisation 
EIF3F primary antibody was serially diluted by 1:75, 1:150 and 1:300. As shown in Figure 3.7.5.1, of 
the three dilutions the 1: 150 antibody concentration exhibited better staining effect than 1:300, while 
comparatively lower background noise than 1:75 dilution.  
 
Figure 3.7.5.1 Optimization of EIF3F primary antibody dilution. EIF3F primary antibody was 
serially diluted to 1:75, 1:150 and 1:300. The same staining procedure was followed in each 
different dilution. Samples come from the same young volunteer. Secondary antibody dilution 
was 1:200. Scale bars 50 μm. 
3.7.5.2 EIF3F antibody double negative control 
EIF3F antibodies were validated for their specificity on antigens. As seen in Figure.3.7.5.2, EIF3F 
stains can be visualized when samples were incubated with the primary antibody as well as specific 
secondary antibody conjugated with Alexa fluorphores. In contrast, whenever staining with the 
primary antibody itself, or with the secondary antibody alone, signals could not be found inside the 
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skeletal muscle cells (B/ C, Figure 3.7.5.2). The background fluorescence in negative control was 
probably from the auto- fluorescence of muscle samples. 
 
Figure 3.7.5.2 Double negative validation on EIF3F antibodies. A) Positive control EIF3F 
antibody staining, EIF3F antibody concentration was 1:150; B) primary antibody staining alone 
negative contorl and C) secondary antibody staining alone negative control. Cell membrane was 
outlined by the wheat germ agglutinin conjugated with Alexa 350 fluorescence. Scale bars 50 
μm. 
3.7.5.3 EIF3F signal channel specificity controls 
As seen in Figure 3.7.5.3, EIF3F signals stained with Alexa 488nm secondary antibody were only 
observed under FITC filter rather than the other two filters. This indicated that the fluorescences 
excited from EIF3F secondary antibody was wavelength specific. 
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Figure 3.7.5.3 EIF3F signal channel specificity under widefield microscope. A) EIF3F stains 
were not found in image under Texas red filter. B) EIF3F signal was observed under FITC filter. 
The EIF3F antibody concentration was 1:150; C) Cell membrane was stained by the wheat 
germ agglutinin conjugated with Alexa 350 fluorescence. Scale bars 50 μm. 
3.7.5.4 EIF3F localisation in human skeletal muscle  
EIF3F stains were visualized on the sarcolemma membrane of the human skeletal muscle cells (A, 
Figure 3.7.5.4). Being similar with mTOR, EIF3F signals were unevenly localizated on the 
sarcolemma membrane, with fluorphores stacking at specific membrane area (B/ C, Figure 3.7.5.4).  
 
Figure 3.7.5.4 The localization of EIF3F in young human skeletal muscle. A) Signals were taken 
under widefield microscope (Nikon), x40 objective. B, C) Images were partially amplified by 
ImagePro software to show the EIF3F subcellular localization. Cell membrane was outlined by 
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the wheat germ agglutinin conjugated with Alexa 350 fluorescence. Sections for staining were 
from the same human muscle sample. Scale bars 50 μm, 25µm and 10µm. 
 
3.7.6 Tuberin (TSC2) immunofluorescence method development 
3.7.6.1 Tuberin antibody staining concentration optimisation 
Tuberin signals were stained and excited under Texas red wavelength. The Tuberin primary antibody 
was serially diluted by 1:25, 1:50 and 1:100. Signal strength was shown in positive relationship with 
the antibody concentration. However, high background noise was observed if the antibody 
concentration was too high to influence the measurement accuracy of protein signals. For Tuberin 
primary antibody, the 1: 50 antibody concentration was used for its brighter staining effect than the 
dim signals under 1:100 dilution (C, Figure.3.7.6.1), while comparatively lower background noise 
than 1:25 dilution (A, Figure.3.7.6.1).  
 
Figure 3.7.6.1 Optimization of Tuberin primary antibody dilution.  Tuberin primary antibody 
was serially diluted to 1:25, 1:50 and 1:100. The same staining procedure was used in each 
dilution trial. Secondary antibody dilution was 1:200, conjugated with Alexa 594nm 
fluorescences. Scale bars 50 μm. 
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3.7.6.2 Tuberin antibody double negative control 
As seen in Figure 3.7.6.2, Tuberin stains can only be visualized when samples were incubated with 
primary antibody and corresponding secondary antibody conjugated with fluorescence (A, Figure 
3.7.6.2). In contrast, whenever incubating with the primary antibody alone (B, Figure 3.7.6.2), or with 
the secondary antibody alone (C, Figure 3.7.6.2), signals can not be observed inside the sections. This 
experiment therefore indicates that Tuberin antibody can specifically recognize the targeted proteins 
in human skeletal muscle in vivo.  
 
Figure 3.7.6.2 Tuberin antibody validation. A) Positive control Tuberin antibody staining, 
Tuberin primary antibody was incubated with its secondary antibody. Tuberin antibody 
concentration was 1:50; B) primary antibody staining alone negative contorl and C) secondary 
antibody staining alone negative control. Cell membrane was stained with the wheat germ 
agglutinin conjugated with Alexa 350 fluorescence. Scale bars 50 μm. 
3.7.6.3 Tuberin signal channel specificity controls 
As seen in Figure 3.7.6.3, Tuberin signals stained with Alexa 594nm secondary antibody were only 
observed under Texas red filter, indicating that the fluorescences excited from Tuberin secondary 
antibody was wavelength specific. 
 90 
 
 
Figure 3.7.6.3 Tuberin signal channel specificity under widefield microscope. A) Tuberin stains 
were not observed in image taken under FITC filter. B) Tuberin signal was observed under 
Texas red filter. The Tuberin antibody concentration was 1:50; C) Cell membrane was stained 
by the wheat germ agglutinin conjugated with Alexa 350 fluorescence. Secondary antibody 
dilution was 1:200. Scale bars 50 μm. 
3.7.6.4 Tuberin localisation in basal human skeletal muscle 
As shown in Figure 3.7.6.4, the majority of Tuberin signals were found to localize along the 
sarcolemma membrane of basal human skeletal muscle cells. When images were magnified, some 
Tuberin stains were found to localize near the the sarcolemma membrane. Also, it was observed that 
the distribution of Tuberin fluorescences was uneven along the plasma membrane.  
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Figure 3.7.6.4 The basal localization of Tuberin in untrained young human skeletal muscle. A) 
Imaged were taken under Nikon widefield microscope, x40 objective. B, C) Images were 
partially amplified by 2 times and 4 times to show the details of Tuberin subcellular localization. 
Cell membrane was outlined by the wheat germ agglutinin conjugated with Alexa 350 
fluorescence. Scale bars 50 μm, 25µm and 10µm. 
 
3.8 Multiple antibodies co-staining validation  
 
3.8.1 Costaining of mTOR with Lamp2 
3.8.1.1 Cross-binding negative control 
Two approaches were used to validate the accuracy of specific binding among antibodies when pairs 
of antibodies were co-stained. Firstly we examined the cross reaction between two primary antibodies 
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(PA negative, Figure 3.8.1.1), or from the unspecific binding between two secondary antibodies (SA 
negative, Figure 3.8.1.1). Secondly, as it is also possible to generate the unspecific signals that with 
the secondary antibody binding to the primary antibody, antibody validation control experiments in 
which the secondary antibodies were incubated with the primary antibody with different isotype were 
performed.  
As shown in Figure 3.8.1.1, there were no signals observed in controls when mTOR and Lamp2 
primary antibodies were costained, or their secondary antibodies were incubated. Results were also 
negative when mTOR primary antibody was stained with secondary antibody targeting Lamp2 
primary antibody, and vice versa. These tests confirmed that the antibodies used in 
immunofluorescence histology costaining experiment were specific to their antigens. The co-staining 
of other protein antibodies were also tested following this method to gurantee the specificity of 
proteins stains achieved in 3.8. 
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Figure 3.8.1.1 Cross binding negative controls on costaining of mTOR and Lamp2 antibodies 
under widefield microscope. The antibodies used for co-staining were tested with double 
negative control. Only primary antibodies (PA negative) or only secondary antibodies (SA 
negaive) were incubated with muscle samples, respectively. mTOR primary antibody was 
stained with secondary antibody targeting Lamp2 primary antibody (mTOR PA+ Lamp2 SA), 
while Lamp2 primary antibody was stained with secondary antibody specific to mTOR primary 
antibody (Lamp2 PA + mTOR SA). Signals were captured under two excitation wavelength 
channels, FITC (A) and Texas red (B). Cell membrane was outlined by the wheat germ 
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agglutinin conjugated with Alexa 350 fluorescence under DAPI UV channel (C). PA is short for 
primary antibody, and SA is short for secondary antibody. Scale bars 50 μm. 
3.8.1.2 mTOR with Lamp2 co-localisation in basal human skeletal muscle 
mTOR and Lamp2 antibodies have been validated as shown in 3.8.1.1. Figure 3.8.1.2 demonstrates 
that mTOR colocalises with Lamp2 positive areas in human skeletal muscle at rest level. Lamp2 
fluorescence areas were much larger in size than that of mTOR, possibly because of Lamp2 proteins 
accumulating on the lysosome/endosome membranes. This can be visualized more clearly for details 
under the advanced confocal microscope images (Figure 3.8.1.3). Some mTOR stains localize on the 
Lamp2-positive ‘palm-like’ area. However, compared wih mTOR signals Lamp2 stains were more 
abundant than mTOR expression in vivo, in keeping with Lamp2’s use as a lysosomal marker. 
Colocalised mTOR/ Lamp2 stains were observed to distribute near the sarcolemma membrane and in 
the sarcoplasm in basal human skeletal muscle.  
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Figure 3.8.1.2 immunofluorescences costaining of mTOR and Lamp2 under widefield 
microscope. mTOR was stained with Alexa 594nm secondary antibody (red), while Lamp2 was 
marked with Alexa 488nm secondary antibody (green). Cell membrane was marked by the 
wheat germ agglutinin conjugated with Alexa 350 fluorescence (blue). Scale bars 50 μm and 
10µm. 
 
Figure 3.8.1.3 Colocalisation image between mTOR and Lamp2 under super resolution confocal 
microscope. mTOR was stained with Alexa 594nm secondary antibody (red) and observed 
under 561nm wavelength, while Lamp2 was marked with Alexa 488nm secondary antibody 
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(green)and visualized under 488nm wavelength. Cell membrane was marked with the wheat 
germ agglutinin conjugated with Alexa 350 fluorescence (blue) and observed under 405nm 
wavelength. Scale bars 50 μm,25 μm, 10 μm and 5µm. 
3.8.1.3 Reproducibility of costaining between mTOR and Lamp2 
Reproducibility testing was applied on the immunofluorescences samples examining association 
between mTOR and Lamp2. Sections from the same sample were repeatedly stained three times and 
images captured at the similar areas under microscope. And the coefficient of variance value for 
colocalisation analysis between mTOR and Lamp2 was 4.8%. 
 
Figure 3.8.1.4 Reproducibility testing on colocalisation between mTOR and Lamp2. mTOR 
antibody was costained with Lamp2 antibody on the serial sections from the same sample. Data 
for each trial was the mean value from duplicates on one slide. Colocalisation value was 
measured as Pearson’s Correlation coefficient under Image- Pro software. Images were taken 
under widefield microscope (x 40). 
 
3.8.2 Costaining of mTOR with Rheb 
3.8.2.1 Cross-binding negative control 
All the four negative control experiments on mTOR and Rheb antibodies, as previously described in 
3.8.1 were applied to mTOR and Rheb costaining. 
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Figure 3.8.2.1 Negative control of mTOR and Rheb antibodies immunofluorescences costaining.  
Co-stained primary antibodies and secondary antibodies were incubated with muscle sections 
from the same sample, respectively. mTOR primary antibody (mouse IgG γ1) was incubated 
with the goat-anti rabbit IgG secondary antibodiy targeting the Rheb primary antibody. 
Reversely, Rheb primary antibody (rabbit IgG) was incubated with the goat-anti mouse IgG γ1 
secondary antibodiy binding to the mTOR primary antibody. Protein stains were validated 
under two excitation wavelength, FITC (A) and Texas red (B). Cell membrane was marked by 
the wheat germ agglutinin conjugated with Alexa 350 fluorescence under DAPI UV channel (C). 
PA is short for primary antibody, and SA is short for secondary antibody. Scale bars 50 μm. 
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3.8.2.2 Colocalisation between mTOR and Rheb in basal human skeletal muscle  
Figure 3.8.2.2 demonstrates the colocalisation between mTOR and Rheb in human skeletal muscle at 
basal status, with the distribution of two proteins in musculoskeletal cells quite disparate. Large 
amounts of Rheb positive stains were found to associate with the sarcolemma membrane at basal level, 
while only a few mTOR stains were visualized to localize near the plasma membrane (B, Figure 
3.8.2.2). Also, the distribution of two proteins in sarcoplasm was also not in correspondence with each 
other. 
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Figure 3.8.2.2 Immunofluorescences costaining of mTOR and Rheb under widefield microscope. 
mTOR was stained with Alexa 594nm secondary antibody (red), while Rheb protein was 
marked with Alexa 488nm secondary antibody (green). Cell membrane was outlined by the 
wheat germ agglutinin conjugated with Alexa 350 fluorescence (blue). Scale bars 50 μm and 
10µm. 
3.8.2.3 Reproducibility of costaining between mTOR and Rheb 
The reproducibility test was applied on the immunofluorescences samples examining association 
between mTOR and Rheb. Serially cryostated sections from the same sample were stained with 
images captured at the similar areas under microscope. The CV value for colocalisation analysis 
between mTOR and Rheb was 6.3%. 
 
Figure 3.8.2.3 Reproducibility testing on colocalisation between mTOR and Rheb. mTOR 
antibody was costained with Rheb antibody on the sections from the same sample. Data of each 
trial was the mean value from duplicates on one slide. Colocalisation was measured and shown 
as Pearson’s Correlation coefficient under Image- Pro software. Images were taken under 
widefield microscope (x40). 
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3.8.3 Costaining of mTOR with Rab7 
3.8.3.1 Cross-binding negative control 
As shown in Figure 3.8.3.1, possible cross binding among antibodies was validated by the negative 
control approaches. No cross reactivity was observed between primary antibodies (PA negative), or 
beween secondary antibodies (SA negative). Also, negative controls indicate there was no cross 
reaction between the mTOR primary antibody and Rab7 secondary antibody, and vice versa. These 
validation methods supported that signals stained by these antibodies were therefore specific to their 
antigens.  
To confirm the fluorescence sensitivity to excitation, different excitation channels were used to 
visualize the specific protein fluorescence. For example, Rab7 stained by Alexa 488nm (green) was 
confirmed under both the FITC channel (green) and the Texa red channel (red). 
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Figure 3.8.3.1 Negative control of mTOR and Rab7 antibodies immunofluorescences costaining.  
The co-stained primary antibodies and secondary antibodies were incubated with samples, 
respectively. mTOR primary antibody (mouse IgG γ1) was incubated with the goat-anti mouse 
IgG 2β secondary antibodiy. Reversely, Rab7 primary antibody (mouse IgG 2β isotype) was 
incubated with the goat-anti mouse IgG γ1 secondary antibodiy targeting the mTOR primary 
antibody. Stains were checked under two-excitation wavelength, FITC (A) and Texas red (B). 
Cell membrane was outlined by the wheat germ agglutinin conjugated with Alexa 350 
fluorescence under DAPI UV channel (C). PA is short for primary antibody, and SA is short for 
secondary antibody. Scale bars 50 μm. 
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3.8.3.2 Colocalisation between mTOR and Rab7 in basal human skeletal muscle  
Figure 3.8.3.2 displays clear colocalisation between mTOR and Rab7. It was observed that partially 
mTOR and Rab7 stains were associated with each other near the sarcolemma membrane and in 
sarcoplasm at basal level, which can be visualized more clearly following magnification.  
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Figure 3.8.3.2 Immunofluorescences histological costaining of mTOR and Rab7 antibodies. 
mTOR was marked with Alexa 594nm secondary antibody (red), while Rab7 primary antibody 
was incubated with Alexa 488nm secondary antibody (green). Cell membrane was outlined by 
WGA conjugated with Alexa 350 fluorescence (blue). WGA was not merged into composite 
image to allow for observing mTOR/ Rab7 signals on cell membrane. B) Images were zoomed in 
x4 to show the details of subcellular colocalisation between mTOR and Rab7. Scale bars 50 μm 
and 10µm. 
3.8.3.3 Reproducibility of costaining between mTOR and Rab7 
Reproducibility testing was applied on the immunofluorescences samples examining association 
between mTOR with Rab7. Sections from the same sample were repeatedly stained three times and 
imaged at similar areas under microscope. The coefficient of variance value for colocalisation 
analysis between mTOR and Rab7 was 4.5%. 
 
Figure 3.8.3.3 Reproducibility testing on colocalisation between mTOR and Rab7. mTOR 
antibody was costained with Rab7 antibody on the sections from the same sample. Data for each 
trial was the mean value from duplicates on one slide. Colocalisation was measured as Pearson’s 
Correlation coefficient under Image- Pro software. Images were taken under widefield 
microscope. 
 
 107 
 
3.8.4 Costaining of mTOR with EIF3F 
3.8.4.1 Cross-binding negative control 
As seen in Figure 3.8.4.1, all negative control experiments on mTOR and EIF3F antibodies indicate 
that antibodies applied to the mTOR and EIF3F costaining were specific to their antigens. 
 
Figure 3.8.4.1 Cross binding negative controls on costaining of mTOR and EIF3F antibodies 
under widefield microscope. Co-staining was tested with double negative control. Only primary 
antibodies (PA negative) or only secondary antibodies (SA negative) were incubated with 
muscle samples, respectively. mTOR primary antibody was stained with secondary antibody 
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recognizing EIF3F primary antibody, while EIF3F primary antibody was stained with 
secondary antibody to stain mTOR primary antibody. Signals were captured under two 
excitation wavelength channels, FITC (A) and Texas red (B). Cell membrane was outlined by 
the wheat germ agglutinin conjugated with Alexa 350 fluorescence under DAPI UV channel (C). 
PA is short for primary antibody, and SA is short for secondary antibody. Scale bars 50 μm. 
3.8.4.2 Colocalisation between mTOR with EIF3F in human skeletal muscle  
EIF3F is an important regulator mediating mTORC signal transduction in eukaryotic cells [16, 17]. As 
shown in Figure 3.8.4.2, EIF3F fluorescences were visualized to localize on the plasma membrane, 
stains of which were associated with mTOR localisation on the plasma membrane in skeletal muscle 
cells (B, Figure 3.8.4.2).   
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Figure 3.8.4.2 Immunofluorescences histological costaining of mTOR and EIF3F antibodies. 
mTOR was stained with Alexa 594nm secondary antibody (red), while EIF3F primary antibody 
was incubated with Alexa 488nm secondary antibody (green). Cell membrane was outlined by 
WGA conjugated with Alexa 350 fluorescence (blue). B) Images were magnified x 4 to show the 
subcellular colocalisation between mTOR and EIF3F. Scale bars 50 μm and 10µm. 
3.8.4.3 Reproducibility of costaining between mTOR and EIF3F 
Reproducibility testing was applied on the immunofluorescences samples to examine association 
between mTOR and EIF3F. Serially cryostated sections from the same sample were stained and 
images captured at similar areas under microscope. The reproducibility was shown as the coefficient 
of variance (CV), which was 8.1% for colocalisation analysis between mTOR and EIF3F. 
 
Figure 3.8.4.3 Reproducibility testing on colocalisation between mTOR and EIF3F. mTOR 
antibody was costained with EIF3F antibody on sections from the same sample. Data for each 
trial was the mean value from duplicates on one slide. Colocalisation was measured and shown 
as Pearson’s Correlation coefficient under Image- Pro software. Images were taken under 
widefield microscope. 
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3.8.5 Costaining of Tuberin with Rheb 
3.8.5.1 Cross-binding negative control 
Figure 3.8.5.1 reports that all negative control experiments on Tuberin and Rheb indicated that 
antibodies applied into the Tuberin and Rheb costaining were specific to their antigens. 
 
Figure 3.8.5.1 Cross binding negative controls on costaining of Tuberin and Rheb antibodies 
under widefield microscope. The co-staining was tested with double negative control. Only 
primary antibodies (PA negative) or only secondary antibodies (SA negative) were incubated 
with muscle samples, respectively. Tuberin primary antibody was stained with secondary 
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antibody recognizing Rheb primary antibody, while Rheb primary antibody was stained with 
secondary antibody to stain Tuberin primary antibody. Signals were captured under two 
excitation wavelength channels, FITC (A) and Texas red (B). Cell membrane was outlined by 
the wheat germ agglutinin conjugated with Alexa 350 fluorescence under DAPI UV channel 
(blue). PA is short for primary antibody, and SA is short for secondary antibody. Scale bars 50 
μm. 
3.8.5.2 Rheb and Tuberin colocalisation in basal human skeletal muscle 
As seen in Figure 3.8.5.2, the Tuberin and Rheb signals were tightly associated with each other on the 
plasma membrane at rest level. Some Tuberin stains were also found inside the sarcoplasm, but they 
were not associated with the Rheb stains. These findings indicate the cell membrane as a main site for 
the colocalisation between Tuberin and Rheb.  
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Figure 3.8.5.2 Immunofluorescences costaining of Tuberin and Rheb antibodies. Tuberin 
primary antibody was stained with Alexa 594nm secondary antibody (red), while Rheb primary 
antibody was incubated with Alexa 488nm secondary antibody (green). Cell membrane was 
outlined by WGA conjugated with Alexa 350 fluorescence (blue). B) Images were magnified x 4 
to show the subcellular colocalisation between Tuberin and Rheb. Scale bars 50 μm and 10µm. 
3.8.5.3 Reproducibility of costaining between Tuberin and Rheb 
Reproducibility testing was applied on the immunofluorescences samples to examine association 
between Tuberin and Rheb. Sections serially cut from the same sample were stained for three repeats 
and microscope images captured under the similar area of each section. The reproducibility was 
shown as coefficient of variance (CV), which was 7.5% for colocalisation analysis between Tuberin 
and Rheb. 
 
Figure 3.8.5.3 Reproducibility testing on colocalisation between Tuberin and Rheb. Tuberin 
antibody was costained with Rheb antibody on the sections from the same sample. Data for each 
trial was the mean value from duplicates on one slide. Colocalisation was measured shown as 
Pearson’s Correlation coefficient under Image- Pro software. Images were taken under 
widefield microscope. 
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3.8.6 Costaining of Lamp2 with Rab7 
3.8.6.1 Cross-binding negative control 
As seen in Figure 3.8.6.1, all negative control experiments on Lamp2 and Rab7 antibodies indicate 
that antibodies applied into the Lamp2 and Rab7 costaining were specific to their antigens. 
 
Figure 3.8.6.1 Cross binding negative controls on costaining of Lamp2 and Rab7 antibodies 
under widefield microscope. The co-staining was tested with double negative control. Only 
primary antibodies (PA negative) or only secondary antibodies (SA negative) were incubated 
with muscle samples, respectively. Lamp2 primary antibody was stained with secondary 
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antibody recognizing Rab7 primary antibody, while Rab7 primary antibody was stained with 
secondary antibody to stain Lamp2 primary antibody. Signals were captured under two 
excitation wavelength channels, FITC (A) and Texas red (B).  Cell membrane was outlined by 
the wheat germ agglutinin conjugated with Alexa 350 fluorescence under DAPI UV channel 
(blue). PA is short for primary antibody, and SA is short for secondary antibody. Scale bars 50 
μm. 
3.8.6.2 Lamp2 and Rab7 co-localisation in basal human skeletal muscle 
As shown in Figure 3.8.6.2, Some Lamp2 and Rab7 stains were visualised to associate near the 
plasma membrane and in sarcoplasm in basal human skeletal muscle, although additional Rab7 stains 
were not observed to colocalise with Lamp2 in the sarcoplasm.  
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Figure 3.8.6.2 Immunofluorescences costaining of Lamp2 and Rab7 antibodies. Lamp2 primary 
antibody was stained with Alexa 594nm secondary antibody (red), while Rab7 primary 
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antibody was incubated with Alexa 488nm secondary antibody (green). Cell membrane was 
marked by WGA conjugated with Alexa 350 fluorescence (blue). B) Images were magnified x 4 
to demonstrate the subcellular colocalisation between Lamp2 and Rab7. Scale bars 50 μm and 
10µm. 
3.8.6.3 Reproducibility of costaining between Lamp2 and Rab7 
Reproducibility testing was applied on the immunofluorescences histological experiment investgating 
the association between Lamp2 and Rab7. Sections serially cut from the same sample were stained for 
three repeats and imaged at the similar areas under microscope. The reproducibility was represented 
as coefficient of variance (CV), value of which was 5.0% for the colocalisation analysis between 
Lamp2 and Rab7. 
 
Figure 3.8.6.3 Reproducibility testing on colocalisation between Lamp2 and Rab7. Lamp2 
antibody was costained with Rab7 antibody on the sections from the same sample. Data for each 
trial was the mean value from duplicates on one slide.Colocalisation was measured and shown 
as Pearson’s Correlation coefficient under Image- Pro software. Images were taken under 
widefield microscope. 
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3.8.7 Costaining of mTOR with UEA-I in basal human skeletal muscle 
As the UEA-I antibody used in the study was conjugated with the Alexa dye, and the mTOR antibody 
has been validated to be specific, cross binding negative control experiments were not applied to the 
costaining between mTOR and UEA-I antibodies. 
3.8.7.1 mTOR and UEA-I co-localisation in basal human skeletal muscle  
Ulex Europaeus Agglutinin (UEA-I) is a biomarker used to indicate the capillaries’ position. As seen 
from Figure 3.8.7.1, skeletal muscle capillaries were localized on the membrane borders between 
adjacent musculoskeletal cells. Only a few mTOR stains were observed to localize on or near the 
blood vessel areas at basal human skeletal muscle.     
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Figure 3.8.7.1 Immunofluorescences co-staining of mTOR and blood vessels staind by UEA-I 
under widefield microscope. A) mTOR was stained with Alexa 594nm secondary antibody (red), 
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while Ulex Europaeus Agglutinin (UEA-I) was conjugated with Alexa 488nm secondary 
antibody (green). Cell membrane was outlined by the wheat germ agglutinin conjugated with 
Alexa 350 fluorescences (blue). B) Images were magnified x 4 to exhibit the subcellular 
colocalisation between mTOR and blood vessels. Scale bars 50 μm and 10µm. 
3.8.7.2 Reproducibility of costaining between mTOR and UEA-I 
Reproducibility validation was applied on the immunofluorescences samples examining association 
between mTOR and UEA-I. Sections from the same sample were serially cut and stained for three 
repeats. Microscope images were captured from the similar areas of each section. The reproducibility 
was quantified as coefficient of variance (CV), which was 8.8% for the colocalisation analysis 
between mTOR and UEA-I. 
 
Figure 3.8.7.2 Reproducibility testing on colocalisation between mTOR and UEA-I. mTOR 
primary antibody incubated with secondary antibody was costained with UEA-I conjugated 
with FITC dye on the sections from the same sample. Data for each trial was the mean value 
from duplicates on one slide. Colocalisation was measured and shown as Pearson’s Correlation 
coefficient under Image- Pro software. Images were taken under widefield microscope. 
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3.8.8 Costaining of mTOR with MHCI 
3.8.8.1 Cross-binding negative control 
As seen in Figure 3.8.8.1, all negative control experiments on mTOR and MHCI antibodies indicated 
that antibodies applied into the mTOR with MHCI costaining were specific to their antigens. 
 
Figure 3.8.8.1 Cross binding negative controls on costaining of mTOR and myosin heavy chain I 
antibodies under widefield microscope. The co-staining was tested with double negative control. 
Only primary antibodies (PA negative) or only secondary antibodies (SA negative) were 
incubated with muscle samples, respectively. mTOR primary antibody was stained with 
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secondary antibody recognizing MHC I primary antibody, while MHC I primary antibody was 
stained with secondary antibody to stain mTOR primary antibody. Signals were captured 
under two excitation wavelength channels, FITC (A) and Texas red (B). Cell membrane was 
outlined by wheat germ agglutinin conjugated Alexa 350 fluorescence under DAPI UV channel 
(blue). Scale bars 50 μm. 
3.8.8.2 mTOR distribution in type I muscle fibers in basal human skeletal muscle 
Myosin heavy chain I antibody is the biomarker used to indicate human type I muscle fibers in 
skeletal muscle. As seen from Figure 3.8.8.2, mTOR signals were observed both on the sarcolemma 
membrane and sarcoplasm in type I muscle fibres. There was no visiable distribution difference of 
mTOR stains between type I muscle fibers and other muscle fibers in basal human skeletal muscle.    
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Figure 3.8.8.2 Immunofluorescences costaining of mTOR antibody with Myosin heavy chain I 
antibody. mTOR primary antibody was stained with Alexa 594nm secondary antibody (red), 
while myosin heavy chain I primary antibody was incubated with Alexa 488nm secondary 
antibody (green). Cell membrane was outlined by WGA conjugated with Alexa 350 fluorescence 
(blue). B) Images were magnified x 4 to exhibit the subcellular localisation of mTOR in type I 
muscle fibres. Scale bars 50 μm and 10µm. 
3.8.8.3 Reproducibility of mTOR fluorescence content quantification 
Reproducibility validation was applied on immunofluorescences samples examining mTOR content in 
different muscle fiber types. Sections serially cut from the same sample were stained for three repeats 
and microscope images captured from the similar areas of each section. The reproducibility was 
quantified coefficient of variance (CV). The CV value for mTOR fluorescence content analysis was 
6.6%. 
 
Figure 3.8.8.3 Reproducibility testing on mTOR fluorescence content measurement. mTOR 
antibody and WGA antibody were stained on the sections from the same sample. mTOR 
content was measured and shown as averaged density of pixel units per fiber under Image- Pro 
software. Data for each trial was the mean value from duplicates on one slide. Images were 
taken under widefield microscope. 
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3.8.9 Costaining of mTOR with MHCIIx in basal human skeletal muscle 
3.8.9.1 Cross-binding negative control 
As seen in Figure 3.8.9.1, all negative control experiments on mTOR and MHCIIx antibodies 
indicated that antibodies applied to the mTOR and MHCIIx costaining were specific to their antigens. 
 
Figure 3.8.9.1 Cross binding negative controls on costaining of mTOR with myosin heavy chain 
IIx antibody under widefield microscope. The co-staining was tested with double negative 
control. Only primary antibodies (PA negative) or only secondary antibodies (SA negative) were 
incubated with muscle samples, respectively. mTOR primary antibody was stained with 
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secondary antibody targeting MHC IIx primary antibody, while MHC IIx primary antibody 
was stained with secondary antibody binding to mTOR primary antibody. Signals were 
captured under two excitation wavelength channels, FITC (A) and Texas red (B). Cell 
membrane was marked by the wheat germ agglutinin conjugated with Alexa 350 fluorescence 
under DAPI UV channel (blue). Scale bars 50 μm. 
3.8.9.2 mTOR distribution in type IIx muscle fibers in basal human skeletal muscle 
Co-staining method of mTOR with myosin heavy chain IIx (MHC IIx) was developed to investigate 
the expression of mTOR in different muscle fibers. As seen in Figure 3.8.9.2, there were no visuable 
distribution differences of mTOR fluorescences between type IIx muscle fibers and the other muscle 
fibers in basal human skeletal muscle. 
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Figure 3.8.9.2 Immunofluorescences costaining of mTOR antibody with Myosin heavy chain IIx 
antibody. mTOR primary antibody was stained with Alexa 594nm secondary antibody (red), 
while myosin heavy chain IIx primary antibody was incubated with Alexa 488nm secondary 
antibody (green). Cell membrane was outlined by WGA conjugated with Alexa 350 fluorescence 
(blue). B) Images were magnified x 4 to exhibit the subcellular localisation of mTOR in type IIx 
muscle fibres. Scale bars 50 μm and 10µm. 
 
3.8.10 Costaining of mTOR with DAPI in basal human skeletal muscle 
DAPI was used to costain the nucleus with mTOR antibody. There was no cross binding negative 
control experments applied into the staining of mTOR antibodies and DAPI. 
3.8.10.1 mTOR with DAPI colocalisation in basal human skeletal muscle 
Nuclei stained by DAPI were observed to locate along the sarcolemma membrane. As seen in Figure 
3.8.10.1, mTOR stains were hardly visualised in the nucleus area. Some mTOR stains localize peri 
nuclear region in magnified microscope images. The other mTOR stains were distributed in the 
sarcoplasm.  
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Figure 3.8.10.1 Immunofluorescences staining of mTOR antibody with nucleus dye DAPI. A) 
mTOR primary antibody was stained with Alexa 594nm secondary antibody (red), while cell 
membrane was outlined with dystrophin primary antibody conjugated with Alexa 488nm 
secondary antibody (green). DAPI (1:1000) solution was incubated with section to stain nucleus 
area (blue). B) Images were magnified x 4 to exhibit the subcellular localisation of mTOR 
around nuclei. Scale bars 50 μm and 10µm. 
3.9 Antibodies validated by blocking peptides competition assay 
 
As shown in Figure 3.9.1, following pre-incubation with blocking peptides, signals generated by Rheb, 
TSC2 and eIF3F antibodies staining were not observed in COMP images, which showed similar 
signal strength as that in no antibody incubation control. These data support that the positive staining 
of Rheb, TSC2 and eIF3F antibodies generated specific fluorescence signals in human skeletal muscle 
invivo. 
 
Figure 3.9.1 Blocking competition assay was applied to validate the recogition specificity of 
primary antibodies used in the study. Images were achived under the similar regions from the 
same sample. COMP is short for competition assay, and No Ab is short for no primary antibody 
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incubation. Cell membrane was outlined by WGA conjugated with Alexa 350 fluorescence 
(blue). Images were taken under x40 objective.  
mTOR specific knock-out mouse sample were obtained from Dr Yann-Gaël Gangloff (Université de 
Lyon) and used to validate mTOR specific staining. As shown in Figure 3.9.2, mTOR signals were 
observed in skeletal muscle of wild type mouse, whist mTOR fluoresecence stained were remarkably 
diminished in mTOR knock- out mouse, similar with no primary antibody incubation control. This 
experiment further proved that mTOR signals from immunofluorescence staining stand for expression 
of mTOR proteins.  
 
Figure 3.9.2 mTOR signals were diminished in mTOR knock- out mouse. Mouse skeletal muscle 
was stained with mTOR primary antibody and secondary antbody conjugated with Alexa@ 594 
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fluorphore. Cell membrane was outlined by WGA conjugated with Alexa 350 fluorescence 
(blue). Imaged were taken under x40 objective lens. Scale bars 50 μm.  
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3.10 Discussion 
This chapter described validation methods for immunofluorescence experiment studying mTOR 
content and distribution in human skeletal muscle in vivo. Through a series of antibody validation 
methods, we have proved that both primary and secondary antibodies applied into 
immunofluorescences experiment specifically target proteins in human skeletal muscle in vivo. Signal 
sensitivity of each antibody was optimized and signal/ background noise ratio was maintained to 
avoid either high background noise or too weak signals.  
A multiple antibodies ‘cocktail’ costaining method was developed to observe association between 
mTOR and associating proteins. All antibodies used in costaining were validated by cross binding 
negative control to exclude potential unspecific staining. It is possible that protein signals may change 
along with the depth of muscle samples sectioned, resulting in data variance. So we introduced 
reproducibility testing on antibodies to guarantee staining experiments repeatability.  
Total mTOR stains were firstly observed as in human skeletal muscle, showing a similar distribution 
with phosphorylated mTOR reported in human [18]. mTOR was observd to disassociate from Rab7 and 
Lamp2 in cultured cells following nutrient starvation [15, 19], whist partial mTOR stains were found 
colocalise with Rab7 and Lamp2 in human at basal level in this study. Reasons resulting in difference 
between cell model and human model are unclear but possibly because of necessity to maintain basal 
mTOR activity under physiological conditions. Korolchuk et al reported mild nutrition condition 
retained mTOR on Lamp2- positive areas in cells in vitro [20]. Taking advantage of super resolution 
microscope, details on mTOR/Lamp2 association were revealed with Lamp2 proteins observed to 
surround mTOR protein for mTOR docking.  
Rheb and TSC2 are reported as mTOR activator [19] and inhibitor [14], respectively. Here microscope 
images demonstrated that these two proteins were primarily colocalised on the cell membrane in basal 
human skeletal muscle, which have never been reported in cell and rodent before. Physiological 
meaning of TSC2 and Rheb localisation on cell membrane is unclear. Colocalisation between Rheb 
and TSC2 indicated Rheb inhibition by TSC2 directly [14], suggesting mTOR docking to lysosome 
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membrane per se did not mean mTOR activation, as mTOR is directly activated by Rheb [21]. In 
consistence, mTOR and Rheb colocalisation images showed disassociation between two proteins in 
basal human skeletal muscle, supporting the deduction.  
In conclusion, we have deleveloped an immunofluorescence-based approach to study mTOR 
localisation and protein complex interaction in human skeletal muscle. Utilizins this technique, the 
data presented herein demonstrates interesting relationships between mTOR and its associating 
proteins in basal human skeletal muscle. This methodological approach will be used in subsequent 
chapters to assess temporal mTOR signalling in response to acute and chronic anabolic stimuli. 
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Chapter 4 
_________________________________________ 
Fiber- specific determination of mTOR protein 
content in skeletal muscle of trained individuals 
following 10- weeks resistance training 
_________________________________________ 
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4.1 Abstract 
Muscle protein synthesis is stimulated by resistance exercise, accompanied by an increase in skeletal 
muscle mass. This study was designed to examine the effects of 10 weeks resistance exercise training 
on mTOR protein content in different muscle fibers in trained human skeletal muscle. 7 healthy male 
strength- trained participants were recruited to take a 10-week long resistance training study. Muscle 
biopsies were taken pre- and post- training and immunofluorescence histological staining applied to 
observe and quantify mTOR protein content. In addition, muscle cross sectional area (CSA) and 
muscle strength were measured to determine muscle hypertrophy.  
Compared with basal status, total fibre mTOR content, CSA and lean muscle mass did not increases 
following the resistance training. In consistence, muscle mass was not increase following training, 
suggesting no muscle hypertrophy found. We then examined mTOR protein content in specific 
muscle fiber types. No significant mTOR protein content increase were found post training in either 
type I or type IIx fibres. Despite no change in mTOR protein content, we did observe an increase of 
the proportion of type IIa fibres from 50% to 62% following resistance training (p=0.002), whist 
proportion of type I fibres was reduced from 41% to 33% post training (p=0.02). In parallel, strength 
as assessed following 1RM was also observed to increase from 764.43±78.92 newtons to 
937.29±91.16 newtons (Mean ± SEM, P<0.05) post training.  
Based on these findings, it would appear that increases in total or fibre-type specific mTOR content 
are not a prerequisite for improvements in strength or fibre-type alterations following a 10-week long 
resistance training in trained group. However, due to the lack of noticeable differences in skeletal 
muscle CSA or mass following the training period, the relationship between fibre-specific gains in 
mass and mTOR protein content are currently unclear.  
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4.2 Introduction 
It is documented that high intensity resistance training results in muscle adaption and muscle 
hypertrophy in human skeletal muscle [1, 2, 3, 4, 35]. Ingestion of PRO/EAA in combination of resistance 
training is shown to further augment gains in muscle size [5]. Many factors, however, mediate the 
hypertrophic response to training such as age, gender, training modes, nutrition and genetic 
background [6]. Mechanistically, muscle hypertrophy originates from the addition of new sarcomeres 
in parallel force- producing arrangement, which requires the synthesis of new myofibrillar proteins [6, 
10]. And resistance exercise training is usually manifested histologically by increased size of Type II 
fibers [55]. 
At the molecular level, training stimulates a series of myogenic events leading to increases in muscle 
fiber size reflected by increase in cross- sectional area (CSA) [11, 12]. The mTOR signalling pathway is 
thought to be one of the key mechanisms regulating muscle protein synthesis in exercise- induced 
muscle hypertrophy [6, 13]. mTOR is mechanically activated by PI3K-Akt dependent- or independent- 
pathways in mammalian cells [13, 14]. Substrates of mTOR (e.g. S6K1, 4E-BP1) are subsequently 
phosphorylated to initiate protein translation events [15]. Following a 8- week resistance training 
leading to muscle hypertrophy in untrained individuals, the expression of phosphorylated mTOR 
Ser2448 was found to be significantly increased via immunoblotting, which was maintained at least 8 
weeks after the training [16]. However, no studies to date have examined the relationship between 
mTOR and muscle CSA, or examined the potential change in mTOR content post training in human 
skeletal muscle.  
Muscle fibers are categored as type I fiber, type IIa fiber and type IIx fiber based on the myosin heavy 
chain protein (MHC) difference, with limited intermediate subtypes found as type I/IIa, type IIax in 
human skeletal muscle [18- 22]. MHC Type I fiber is a slow- twitch fiber characterized by slow 
contractile rate [21, 22], while type IIa and type IIx fibers are fast- twitch fibers [17, 22]. Compared with 
type I fibers, type II fibers experiences muscle fatigue more easily because of quick depletion of ATPs 
generated from glycolysis [18- 22]. Constitution of three muscle fiber types varies depending on skeletal 
muscle subgroups [17, 21]. For example, type I fibers are predominently found in the soleus, while 
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triceps muscle is mainly composed of type IIa fibers [36]. Vastus lateralis muscle is a mixture of both 
type I and type II fibers in human [36]. 
Skeletal muscle is characterized by plasticity with muscle fibers types in adaptation to exercise 
training [23, 25]. Over-representation of Type I fibers were found in individuals following long-term 
endurance training [23].  Currently no literature concerns skeletal muscle fiber composition in trained 
individuals in response to resistance training. Effects of resistance training on skeletal muscle 
remodeling in untrained individuals were not consistent. Whilst some studies found no increase or 
decrease in type IIa fibers proportion [43, 44], significant increase of type IIa fibers percentage was 
reported in other human studies [45, 46, 47, 53].  
Based on these reports, the aim of the study was to investigate the effects of resistance exercise 
training on mTOR protein content in healthy young people. Based on the microscopy technique and 
image quantification method developed in chapter 3, mTOR fluorescence signals will be analysed in 
total muscle fibers and in a muscle fiber type manner. We hypothesised that resistance training would 
enhance mTOR content in type II fibers post training in parallel to an increase in fibre CSA and 
strength post-training. In addition, it was hypothesised that muscle fibers adaptation (shifting towards 
a glycolytic phenotype) would occur following resistance training. 
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4.3 Methods 
4.3.1 Ethical approval 
Ethical approval for this study was granted from the west midlands NHS ethics committee (NHS REC 
Solihul West Midlands, 14/WM/0088).  
4.3.2 Experiment design 
Young healthy male participants who had experienced at least 3 months leg-based resistance exercise 
(n=7, age=23±2y, BMI = 25.2±1.7 kg/m2; means ± SD) were recruited to attend a 10-week resistance 
training programme, two sessions per week including leg press, knee extension, hamstring curl and 
calf extension. For each session, 4 sets were performed until volitional fatigue, with either 1 min or 4 
min rest between sets. Individuals were given a serving of 25g whey protein supplement (Optimum 
Nutrition 100% Whey Gold Standard) following the training.   
Muscle biopsies were taken from the vastus lateralis at pre- training and post- training, respectively. 
Muscle biopsies were collected, frozen and prepared for staining following the procedures mentioned 
in Chapter 2. Briefly, samples were blotted to remove excess blood and dissected free of fat and 
collagen were then embedded in Tissue-Tek OCT compound (Sakura, 4583) and frozen in liquid 
nitrogen cooled isopentane solution (Sigma Aldrich, 270342). After immediate freeznig, samples 
were stored at -80oC until experimental analysis was performed. Muscle samples from pre- and post- 
training were sectioned under -20oC and collected on the same loading slide for immunofluorescence 
histological staining.  
4.3.3 Muscle strength and muscle hypertrophy measurement 
Exercise performance was measured by maximal muscle strength/ 1RM pre- and post- training. 
Muscle strength/ 1RM followed protocols as below:  (1) a warm-up period, easy 10 reps minimum 
with 1 minute rest; (2) load that will allow 4-5 reps maximum by adding around 15 kg with 2 minute 
rest; (3) heavier load that will allow 3-4 reps maximum with 2 minute rest; (4) near maximal load that 
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will allow 2-3 reps maximum with 2 minute rest; (5) weight further increase that allow 1 rep 
maximum. If successful, new load performed after 3 minute rest until load failure. If unsuccessful, 
decreased load performed after 3 minute rest until success.  
A Kin-Com dynamometer (Shelton Technical Ltd., Milton Keynes, UK) was used to determine 
maximal voluntary contraction (MVC) of the knee extensors in the dominant leg. The testing protocol 
was described as below: Participants sat on the dynamometer with their hips and torso securely 
strapped down to prevent any hip-extension or upper-body movements during contraction. And the 
fulcrum of the dynamometer lever arm was aligned with the lateral condyle of the participant’s knee. 
Force measurement was taken at a knee angle of 75º as the isometric torque reached peak value in the 
knee extensors of isometric contraction reported in previous study [56]. Each individual performed one 
familiarization effort, and completed at least 3 trials divided by 2min. The maximum force generated 
was taken and used in statistical analysis. Verbal encouragement was given to participants during 
strength testing. 
DEXA scanning was used to automatically measure muscle lean mass (LM) from both legs, as well as 
lean body mass (LBM) and fat mass (FM) pre- and post- resistance training.  
4.3.4 CSA measurement 
Immunofluorescence staining method was used to determine CSA (see 4.3.6). Sarcoplasm membrane 
area was outlined by WGA conjugated with Alexa@350 and imaged by Image- pro software (see 
4.3.7). Averaged CSA was calculated between pre- and post- training for statistic analysis (see 4.3.8).  
4.3.5 Antibodies and other reagents 
All primary and secondary antibodies applied in this study were validated following the procedures 
developed in Chapter 3. WGA conjugated with Alexa@350 is used as the biomarker indicating cell 
membrane and mTOR antibody was applied for mTOR staining and costaining with antibodies 
binding to myosin heavy chain I and IIx, respectively.  
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4.3.6 Immunofluorescence Staining  
The method for multiple antibodies co-staining is described in Chapter 2. For each study, muscle 
sections from both pre- training and post- training were stained in one trial to standardize staining 
conditions and minimize variability.  
4.3.7 Image Capturing 
Images achieved in one trial were taken under the same image capture settings through all the muscle 
sections (see chapter 2). Specifically, 5- 7 images per section were captured for quantification analysis. 
Image quantification was performed under the same measurement settings using Image-Pro software. 
4.3.8 Statistic analysis 
The mean value of two repeats for each time point was calculated, and values of two time points (pre - 
training and post- training) achieved from each person. SPSS software was used to analyse group data. 
Paired student T- test was used to compare total mTOR content and CSA between pre- training and 
post- training, and one- way ANOVA was used to study mTOR content, CSA and cell number in 
specific muscle fibers. Data was reported as Mean± SEM. Significance was set as P<0.05.  
 
 
 
 
 
 
 
 
 
 147 
 
4.4 Results 
4.4.1 Total mTOR protein content was not altered in trained individuals following 10 weeks 
resistance training  
As seen in Figure 4.4.1 A, mTOR stains (red) were visualized dispersed both on plasma membrane 
and the cytoplasm in both pre training and post training samples. Total mTOR fluorescence in muscle 
fibres was measured (Figure. 4.1 B) and quantification result showed that mTOR content was 
increased by 3% following resistance training compared with that at basal level (15.86±0.83 for post 
training vs. 15.41±0.63 for pre training, P= 0.45). In addition, as shown in Figure 4.4.1 C CSA was 
not different between pre-training and post-training muscle samples (6566±439 µm2 for post training 
vs. 6642±299 µm2 for pre training,  P=0.86). 
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Figure 4.4.1 Total mTOR protein was not increased following 10- week resistance training. (A) 
Widefield images of mTOR stained with Alexa @594 fluophore and WGA conjugated with Alexa 
@350 fluophore. (B) mTOR fluorescence and muscle CSA (C) were both measured to quantify 
mTOR content and muscle hypertrophy in pre- training and post- training human skeletal 
muscle samples. Data presented as mean± SEM (n=7).  
4.4.2 mTOR protein content in type I fibers was not significantly increased in trained invididuals 
following 10 weeks resistance training  
To observe mTOR protein content and distribution in type I muscle fibers, mTOR antibody was co-
stained with myosin heavy chain I antibody, and WGA was used to outline the cell membrane 
(Figure.4.4.2 A). There was no significant difference observed in muscle fiber dependent mTOR 
content between type I fibers and other muscle types at basal level (15.46±0.45 for type I fiber vs. 
15.28±0.51 for rest muscle fibers, p=0.82). mTOR fluorescence in type I muscle fibers increased by 4% 
after resistance training (16.09±0.62 for post training vs. 15.46±0.45 for pre taining, P=0.43). When 
testing mTOR content in other muscle fibers, no increase was found following the training 
(15.76±0.58 for post training vs. 15.28±0.51 for pre training, P=0.54). Measurement of CSA in type I 
fibers showed that there was 12% increase after training, though the increase was not significant 
compared with pre training status (7298±390 µm2 for post training vs. 6537±393 µm2 for pre training, 
P=0.16). Also, no significant change in CSA was shown in all other muscle fibers (6336±413 µm2 for 
post training vs. 6557±291 µm2 for pre training, P=0.68).   
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Figure 4.4.2 mTOR protein content in type I muscle fibers was not significantly increased 
following 10- week resistance training. (A) Widefield images of mTOR stained with Alexa @594 
fluophore, myosin heavy chain I combined with Alexa @488 fluophore and WGA conjugated 
with Alexa @350 fluophore. (B) mTOR fluorescence and muscle CSA (C) were measured to 
quantify mTOR content and muscle hypertrophy in type I muscle fibers in both pre- training 
and post- training human skeletal muscle samples. Data presented as mean± SEM (n=7).  
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4.4.3 mTOR protein content in type IIx fibers was not significantly increased after 10 weeks 
resistance training in trained indivduals 
As shown in Figure.4.4.3 B, there was no significant increase in mTOR content in type IIx fibers 
following resistance training (13.08±0.34 for post training vs. 13.38±0.35 for pre training, P=0.54). 
mTOR content in resting muscle fibers was also not increased post training (12.34±0.28 for post 
training vs. 12.56±0.30 for pre training, P=0.61). When it came to CSA (Figure.4.4.3 C), there was a 
~7% increase of CSA in type IIx fibers post training (6567±367 µm2 for post training vs. 5919±286 
µm2 for pre training, P=0.21), but there was no increase of CSA in other muscle fibers following 
training (6051±312 µm2 for post training vs. 6165±349 µm2 for pre training, P=0.81).  
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Figure 4.4.3 mTOR protein content in type IIx muscle fibers was increased following 10- week 
resistance training. (A) Widefield images of mTOR stained with Alexa @594 fluophore, myosin 
heavy chain IIx combined with Alexa @488 fluophore and WGA conjugated with Alexa @350 
fluophore. (B) mTOR fluorescence and muscle CSA (C) were measured to quantify mTOR and 
muscle hypertrophy in type IIx muscle fibers in both pre- training and post- training human 
skeletal muscle samples. Data presented as mean± SEM (n=7).  
 
4.4.4 Type IIa muscle fibers proportion is increased in trained individuals following 10 weeks 
resistance exercise training  
Taking advantage of immunofluorescence histology technique, we also investigated MHC 
composition in both pre- training and post- training human skeletal muscle samples. We identified 
that the proportion of myosin heavy chain type IIa muscle fibers was increased from 50% pre- 
training to 62% post- training (P=0.002), meanwhile the proportion of type I muscle fibers decreased 
from 41% to 33% after training (P=0.02). The proportion of other muscle fiber types dropped from 9% 
to 5%, which was not significantly different.  
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Figure 4.4.4 Proportion of type IIa muscle fibers is increased following 10- week resistance 
training. (A) Widefield images of type I fibers stained with Alexa @488 fluophore, type IIa fiber 
stained with Alexa @594 fluophore and cell membrane marked by WGA conjugated with Alexa 
@350 fluophore. (B) Numbers of type I fibers and type IIa fibers were quantified to calculate the 
proportion of two muscle fibers accounting for the whole muscle fibers under both pre- training 
and post- training in human skeletal muscle. Proportion calculation was shown in Pie figure and 
cell number counted is listed in table below. Data presented as mean± SEM (n=7). *Significant 
difference to PRE- TRAINING (P<0.05). 
4.4.5 No significant increases of muscle mass in trained individuals following 10- week resistance 
training  
As shown in Table 4.1, muscle mass of participants were analysed by DXEA scanning. Results 
showed that there was no significant increase of muscle mass in both legs of participants, as well as 
no changes on fat mass post training.  However, muscle strength was increased after training exhibited 
by Kin- com study (from 764.43±78.92 N pre- training to 937.29±91.16 N post- training, P = 0.04) 
and 1RM testing (from 1666±75.58 lbs pre- training to 2157±77.19 lbs post- training, P = 0.0002), 
respectively. 
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4.5 Discussion 
There is a well-documented increase in mTOR activation in response to acute resistance exercise [13, 14, 
15]. Leger et al reported that mTOR ser2448 phosphorylation was increased following 8- weeks resistance 
training in untrained individuals [16]. However, little is known regarding fiber specific changes in 
mTOR content in response to resistance training. Six weeks cycle training increased phosphoryalted 
mTOR content in a fiber type II specific manner in sedentary individuals [54]. In this study, we 
measured mTOR protein content using an immunofluorescence histology methodology. Taking this 
approach, we report no changes in mTOR protein content following a 10- week resistance training, 
along with unaltered CSA or increases in lean muscle mass in trained individuals.  
The lack of improvements in CSA and muscle mass were unexpected and the precise explanation 
unclear at this time. Age and exercise training mode may influence the muscle hypertrophy post 
training. For example, participants in study carried by Leger et al [16] or Stuart et al [54] are generally 
10 years older than volunteers we recruited. The other difference between two studies is the training 
background of volunteers. Subjects participating in our study had recreationally training experience 
before taking the training, while volunteers in studies reporting mTOR content increase either had not 
taken resistance training for more than 12 months before the study [16] or sedentary individuals [54]. As 
such, the basal level of mTOR content and skeletal muscle CSA of participants in our study may be 
higher than theirs compromising effects of adaptive response to resistance training., Also, sample 
numbers in this study were much smaller than those in the study by Leger et al [16].  
Muscle protein synthesis rates are different between muscle fibers in rodent, possibly due to different 
muscle fiber- type composition [37]. Basal protein synthesis rates were correlated with the content of 
slow- twitch type II fibers in rat muscle [38]. In addition, rodent studies revealed that protein synthesis 
in slow- and fast- twitch muscle fibers exhibited different sensitivity to anabolic stimuli (e.g. exercise 
and feeding) [31, 39, 40], and mTOR activation was detected predominantly in fibers expressing type IIa 
but not type I in response to contractile activity in Rat hindlimb muscle [41]. Compared with animal 
studies, little information is available regarding the effect of resistance training on muscle protein 
synthesis in different fiber types in human. Protein synthesis rates was not determined by fiber- type 
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composition in response to feeding in human skeletal muscle [37] , which might be because genes 
encoding transcriptional regulators are not expressed in fiber type specific manner [36]. In agreement 
with this, our data suggest that mTOR protein content does not alter between fibres of differing MHC 
content and so by extension does not seem to influence difference in fibre-specific contractile or 
metabolic properties. 
Though we did not find significant muscle hypertrophy as assessed by CSA or muscle mass gains, a 
clear training effect was observed through an increase in peak force of strength/ 1RM following 
training. This may indicate that anatomical CSA per se might not reflect changes in the physiological 
CSA or maximal contractile force [51], since a simultaneous change in muscle fibre pennation angle 
could also occur [51], which also might influence sectioning angle leading to inaccurate CSA 
quantified. Moreover, our immunofluorescence data showed that proportion of type IIa fibers was 
significantly increased following training contributing to increased concentric force. Simultaneously, 
a reduction of type I fibers was reported, suggesting remodeling of muscle fiber composition in 
response to resistance training. A consensus as to the effects of resistance training on skeletal muscle 
remodeling in trained people is not currently apparent. In untrained people, Aagard et al reported 
there was a decrease in type II fibre content following resistance training [51], which might be because 
the study did not analyze type IIa and type IIx fibers, respectively. As in many reports proportion of 
type IIx fibers was reported to decrease following training [32, 43, 45, 47, 53], mixture analysis of two fast- 
twitch myofiber subtypes would compromise the significant increase of type IIa fibers. However, 
some other studies reported a decrease in type IIa fibers following training [43, 44]. In our study, in 
agreement with other reports [32, 45, 46, 47, 53], we observed a significant increase in type IIa fibers 
following resistance training, with a slight reduction in type IIx fibers.  
The molecular mechanisms regulating skeletal muscle phenotypic remodeling are still not fully 
understood. Motor neurons are thought to exert influence on muscle fibers they innervate, as cross- 
connection of neurones in slow- twitch fibers with fast- twitch fibers reduce the contraction speed, 
whist linkage of neurones in fast- twitch fibers with slow- twitch fibers increase the contractile speed 
[49]. Neuronal transduction is believed to influence myofiber gene expression relying calcium as 
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second messenger. Input signals from motor neurons are received by voltage- operated calcium 
channel in the T- tubeles, which interacts with skeletal muscle specific sarcoplasmic reticulum 
calcium- release channel [48, 52]. The latter one releases calcium from sarcoplasmic reticulum in 
response to stimulation, determining contractile pattern, regulating signaling pathways and mediating 
expression of a myriad of genes involving in skeletal muscle remodelling [48]. It will be interesting to 
see whether future investigation can determine the precise control of fibre-type regulation following 
resistance exercise in human skeletal muscle, and determine the contribution of mTOR to this process.  
In conclusion, this study reports a novel immunofluorescence approach to study mTOR content in 
different muscle fiber types in response to a physiological stimulus. Our first hypothesis was that 
mTOR content would be enhanced following resistance training in type II fibers post training along 
with an increase in fibre CSA and strength post-training. Whilst resistance training lead to an increase 
in type IIA fibres and a paralleled increase in skeletal muscle strength, we did not observe increases in 
total or fibre-specific protein content of mTOR post-training. As such, it might be that the temporal 
changes in mTOR activity/signaling following each training bout, as opposed to chronic changes in 
mTOR content/localization are the key determining factors relating to adaptation to resistance training. 
Coupling our immunofluorescence approach with measurements of long-term protein synthesis (i.e. 
D2O incorporation) may help to link acute signaling to chronic adaptation in human skeletal muscle. 
These findings lead us to further discuss the temporal changes of mTOR signaling in response to one 
bout of resistance exercise in the next chapter. 
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Chapter 5 
_________________________________________ 
Resistance exercise initiates mechanistic target 
of rapamycin (mTOR) translocation and 
protein complex co-localisation in human 
skeletal muscle  
_________________________________________ 
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5.1 Abstract 
The mechanistic target of rapamycin (mTOR) is a central mediator of protein synthesis in skeletal 
muscle in response to resistance exercise and nutrition. We utilized immunofluorescence approaches 
to study mTOR localisation and protein-protein interaction in human skeletal muscle in the basal state 
as well as immediately, 1 and 3h after an acute bout of resistance exercise in a fed (FED; 20g 
Protein/40g carbohydrate/1g fat) or energy-free control (CON) state. mTOR and the lysosomal protein 
LAMP2 were highly co-localised in basal samples. Resistance exercise resulted in rapid translocation 
of mTOR/LAMP2 towards the cell membrane. Concurrently, Tuberin (TSC2) and Ras-homolog 
enriched in brain (Rheb) were found to co-localise at the cell membrane at rest level. Resistance 
exercise led to the dissociation of TSC2 from Rheb and subsequent reduction of TSC2 at the cell 
membrane in both FED and CON. Further, there was an increase in the interaction of mTOR and 
Rheb after exercise that was sustained for up to 3h in both FED and CON. In addition, mTOR co-
localised with EIF3F at the cell membrane post-exercise in both groups, with the response 
significantly greater at 1h of recovery in the FED compared to CON. Collectively our data 
demonstrate that cellular trafficking of mTOR occurs in human muscle in response to an anabolic 
stimulus, events that appear to be primarily influenced by muscle contraction. The translocation and 
association of mTOR with positive regulators (i.e. Rheb and eIF3F) is consistent with an enhanced 
mRNA translational capacity after resistance exercise.  
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5.2 Introduction 
Resistance training is an effective strategy to increase muscle strength and muscle hypertrophy, with 
the latter ultimately mediated by an exercise-induced increase in muscle protein synthesis and net 
protein balance [1]. Skeletal muscle protein balance is generally dependent on the activity of the 
serine/threonine protein kinase mechanistic target of rapamycin (mTOR), which when active 
stimulates protein synthesis and attenuates protein degradation [2].  
mTOR exists as 1 of 2 complexes (mTORC1 and mTORC2) and with their respective substrate 
preference and, ultimately, biological activity related to the specific associated subunits [2]. For 
example, mTORC1 contains mTOR, GβL, raptor, DEPTOR and PRAS40 and is inhibited by the 
bacterial macrolide rapamycin [2]. In contrast, mTORC2 consists of mTOR, rictor, GβL, Sin1, 
DEPTOR and Protor/PRR5 and is insensitive to acute rapamycin administration [2].  
Although each mTOR complex responds to unique subsets of biological stimuli and generally localize 
to different subcellular compartments [3], mTORC1 is the most widely studied of the two complexes 
and responds to anabolic stimuli such as insulin, amino acids, and/or resistance exercise [2]. For 
example, acute administration of rapamycin blocks the independent anabolic effects of resistance 
exercise and amino acid ingestion on mTOR signaling molecule phosphorylation and subsequently 
protein synthesis in human skeletal muscle [4, 5]. Collectively, these data highlight a pivotal role for 
mTORC1 activity in the regulation of muscle protein synthesis in response to resistance exercise and 
amino acid ingestion.   
Current understanding regarding the physiological regulation of mTOR in human skeletal muscle has 
come in large part from phosphorylation-specific profiling of the mTOR pathway in response to 
anabolic stimuli [6]. Consistent with the ability of resistance exercise to increase muscle protein 
synthesis in the fasted state [7, 8], phosphorylation of mTOR substrates (as a proxy for mTOR activity) 
has indicated that mTOR is activated following resistance exercise [9] with this response maintained 
for at least 24h post-exercise [10]. Moreover, the provision of exogenous amino acids (either orally or 
intravenously) augments post-exercise rates of muscle protein synthesis [11, 12], which is generally 
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coincident with changes in phosphorylation status of proteins within the mTOR signaling cascade that 
are consistent with an enhanced translational activity [13, 14].  
Beyond immunoblotting approaches, in vitro studies have indicated that cellular localization and 
protein-protein interaction may be fundamentally important in the regulation of mTOR activity in 
response to physiological stimuli [3]. Following mitogen or amino acid stimulation, mTOR has been 
observed to translocate to the lysosome where it associates with GTP bound ras-homolog enriched in 
brain (Rheb) to achieve full activation [15]. In contrast, amino acid removal results in mTOR 
dissociation from the lysosome and cytosolic degradation [15]. mTOR interaction with Rheb is 
restricted in basal conditions due to the enzymatic activity of the tuberous sclerosis complex proteins 
TSC1 and TSC2, which maintain Rheb in a GDP-bound state [16]. However, phosphorylation of TSC2 
by AKT leads to TSC2 inactivation [17], Rheb-TSC2 dissociation, GTP-loading of Rheb and 
interaction with mTOR [18]. Jacobs and coworkers [19] recently reported that mTOR and TSC2 
associate at the lysosome in mouse tibialis-anterior skeletal muscle, with eccentric contractions 
stimulating an increase in mTOR-lysosomal interaction and subsequent dissociation of TSC2 from the 
lysosome. Collectively these studies would suggest that targeting of mTOR to the lysosome is a 
fundamentally important event to initiate cellular protein synthesis [20].  
The aim of the present study was to examine cellular distribution and co-localization of proteins 
involved in mTOR assembly/activity in human skeletal muscle in response to resistance exercise. 
Immunofluorescences staining techniques, as well as quantitative methods developed in Chapter 3 
were applied to observe and quantatively identify translocation of mTOR and its regulatory proteins 
in response to one bout of resistance exercise in human skeletal muscle. In addition, we also evaluated 
the effect of post-exercise protein/carbohydrate ingestion on mTOR complex assembly and 
localisation. We hypothesized that resistance exercise would increase mTOR abundance at the 
lysosomal surface to facilitate interaction with Rheb and that post-exercise nutrients would augment 
these responses. 
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5.3 Methods 
5.3.1 Subjects  
Fourteen healthy, recreationally active males volunteered to participate in the study. Participants were 
informed about the experimental procedure to be used as well as the purpose of the study and all 
potential risks prior to obtaining written consent. All participants were deemed healthy based on their 
response to a routine medical screening questionnaire. The study carried approval by the local 
Research Ethics Board of McMaster University and Hamilton Health Sciences and the University of 
Guelph Research Ethics Board and conformed to all standards for the use of human subjects in 
research as outlined in the Declaration of Helsinki. 
5.3.2 Experimental Design  
Participants were randomly assigned into groups that received either a protein-carbohydrate beverage 
(FED; n=7, age=25±2y, BMI = 26.1±2.3 kg/m2; means±SD) or an energy-free control (CON; n=7, 
age=24±3y, BMI=26.3±2.6 kg/m2) after exercise. Participants reported to the laboratory after an 
overnight fast having refrained from strenuous exercise for at least 48h. A single biopsy was taken 
from the vastus lateralis of a randomly selected thigh under local anesthesia (2% xylocaine), as 
previously described [21]. Participants performed an intense bout of bilateral leg resistance exercise 
consisting of 5 sets each of leg press and knee extension (with an inter-set rest period of 2-min) using 
a predetermined weight that elicited voluntary failure in 8-10 repetitions. Similar exercise protocols 
have been shown to elicit a robust increase in muscle protein synthesis over 3h of recovery in both the 
fasted [22] and fed states [23]. A second muscle biopsy was taken 10 min after completion of the 
exercise bout from the same thigh as the first biopsy to determine mTOR co-localization early in 
recovery. Participants were then randomly assigned to consume a commercially available beverage 
(Gatorade Recover®, Gatorade, IL, USA) providing 20/44/1g of protein/carbohydrate/fat (FED) or an 
energy-free control (CON). As such, the 20g of high quality milk-based protein consumed by FED 
would be expected to maximize muscle protein synthesis [24] and the 44g of carbohydrate would elicit 
a marked insulin response [25] to enhance mTOR signalling [26]. Subsequently, muscle biopsies were 
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taken 1 and 3h after the beverage ingestion from separate incisions on the contralateral thigh from the 
initial biopsies to determine the time-dependent changes in mTOR co-localization during recovery in 
CON and FED. 
5.3.3 Skeletal muscle immunohistochemistry 
Biopsy samples (~25mg) were blotted and freed from any visible fat and connective tissue prior to 
being mounted in Optimal Cutting Temperature Compound (Tissue-Tek®, VWR) and frozen in 
isopentane cooled by liquid nitrogen prior to storage at -80°C for subsequent immunofluorescence 
analysis. Embedded muscle samples were fixed on the position in front of the blade of the microtome 
(Bright 5040, Bright Instrument Company limited, Huntingdon, England) and serial sections (5μm) 
collected onto room temperature uncoated glass slides (VWR international, UK). Sections were left to 
air dry at room temperature for 10min to remove excess crystallized water inside sections under 
storage.  
Sections (5 μm) were fixed in acetone and ethanol (3:1) solution (Fisher technology) for 5 min and 
then washed for 3 x 5min in phosphate buffered saline (PBS) to remove fixation reagent. Sections 
were subsequently pre-incubated with 5% normal goat serum for 30min, the PBS wash step repeated, 
prior to incubation (2h) in primary antibody solution diluted 1:200 with 5% normal goat serum 
(Invitrogen, UK). Following incubation, sections were washed for 3 x 5min in PBS and incubated in 
the appropriate secondary antibody for 30min at room temperature. Sections were finally incubated 
with wheat Germ Agglutinin (WGA-350) for 20min at room temperature to mark the sarcolemmal 
membrane. Slides were left to air dry until the visual water stains evaporated for 1-2 min at room 
temperature. Then sections were mounted with 20µL Mowiol® 4-88 (Sigma-Aldrich, UK) and sealed 
by glass coverslips to protect the muscle sections and to preserve fluorescence signals. Slides were 
left overnight before observation. All primary antibodies used and their corresponding secondary 
antibodies are listed in Table 2.1.  
5.3.4 Image capture  
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Prepared slides were observed under a Nikon E600 microscope using a 40×0.75 numerical aperture 
objective. Images per area were captured under three colour filters achieved by a SPOT RT KE colour 
three shot CCD camera (Diagnostic Instruments Inc., MI, USA), illuminated by a 170 W Xenon light 
source. For images capture, DAPI UV (340–380 nm) filter was used to view WGA-350 (blue) signals 
and mTOR stains tagged with Alexa 594 fluorophore (red) was visualised under the Texas red (540–
580 nm) excitation filter. FITC (465–495nm) excitation filter was left to capture signals of mTOR-
associated proteins, which were conjugated with Alexa Fluor 488 fluorophore unless stated otherwise 
(Table 3.1). DAPI UV (340-380 nm) was also used to observe the DAPI stained nucleus. All 
widefield images were obtained using a 40x objective (0.75 NA). Co-localisation experiments 
between mTOR and associated proteins were performed on an upright confocal microscope (Zeiss 
LSM 510 Meta, Carl Zeiss), using a 40× 1.4 NA water immersion objective. Fluorophores were 
visualised under three laser filters simultaneously. Alexa Fluor 488 fluorophore was excited by an 
argon laser and 498-571 nm emission, while a 594nm line of the helium–neon laser with 601-713 nm 
emission was used to excite Alexa Fluor 594 fluorophore. WGA conjugated with Alexa 350 and 
DAPI could be visualised under the excitation of the 405nm line from a Diode 405-30 filter.  
For total protein quantification, 3 slide replicates for each individual were stained, imaged and 
quantified. At least 7 images were captured per section. All image processing and quantitation was 
carried out in ImagePro Plus 5.1 and kept constant between images. Total protein fluorescence 
intensity was quantified by measuring the signal intensity within the intracellular regions of a mask 
created by a specific membrane marker (dystrophin, WGA). For colocalisation analysis, five to seven 
areas per section were randomly selected and imaged under the same capture settings. Images were 
processed and analysed under the Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA). Prior 
to colocalisation analysis, all images underwent a no neighbour deconvolution algorithm as a filter. 
Image signals generated by WGA or dystrophin were used to estimate cell membrane borders, which 
were merged with the corresponding target protein images to identify the association between the 
protein of interest and the plasma membrane. Pearson’s correlation coefficient (Image-Pro software) 
was used to quantify localization with the plasma membrane and mTOR associated proteins. 
 172 
 
5.3.5 Statistical Analysis 
Immunofluorescence image analysis was performed in duplicate, with 5- 7 regions per cross section 
used for analysis. Pearson’s correlation coefficient values at each group/time point were analyzed 
using a two-way ANOVA (SPSS) with Tukeys post-hoc analysis where appropriate. Significance was 
set at P<0.05. Data are presented as fold change (Mean ± SEM) in relative to the baseline biopsy (i.e. 
-40min timepoint) in CON and FED group, respectively (PRE-EX CON). 
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5.4 Results 
5.4.1 Translocation of mTOR protein to cell membrane in response to one bout of resistance exercise 
in young healthy human skeletal muscle 
As shown in Figure 5.4.1 a/b/c, mTOR was observed to randomly distribute in basal human skeletal 
muscle skeletal. Some mTOR signals were also associated with the plasma membrane areas 
(0.30±0.03 for CON; 0.29±0.02 for FED, shown as Pearson’s correlation coefficient). More mTOR 
fluorescences translocated to cell membrane immediately post resistance exercise (0.31±0.01 for CON, 
0.33±0.03 for FED, p<0.05), maintaining localisation on membrane 1h post exercise (0.34±0.02 for 
CON, 0.33±0.02 for FED group, p<0.05) and 3h post exercise (0.32±0.03 for CON and 0.32±0.01 for 
FED, p<0.05).  
 
Figure 5.4.1a mTOR translocates to the plasma membrane in response to one bout of resistance 
exercise in human skeletal muscle. A) mTOR primary antibody was stained with secondary 
antibody conjugated with Alex fluor® 594nm fluorophore. Images were taken under HeNe 
594nm laser, Zeiss LSM510 confocal microscope, x40 /1.2 NA (water) objective. B) Plasma 
membrane was stained with WGA conjugated with Alexa Fluor® 350nm fluorescences. Images 
were captured under 405nm Diode laser, Zeiss LSM510 confocal microscope, x40 /1.2 NA 
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(water) objective len. PRE-EX stands for the pre exercise, and POST- EX 0h, 1h, 3h stand for 0 
hour, 1 hour and 3 hours post exercise, respectively. Scale bar 50μm. 
 
Figure 5.4.1b mTOR translocates to the plasma membrane in response to one bout of resistance 
exercise combined with nutrition supplementation in human skeletal muscle. A) mTOR primary 
antibody was stained with secondary antibody conjugated with Alex fluor® 594nm fluorophore. 
Images were taken under HeNe 594nm laser, Zeiss LSM510 confocal microscope, x40 /1.2 NA 
(water) objective len. B) Plasma membrane was stained with WGA conjugated with Alexa 
Fluor® 350nm fluorescences. Images were captured under 405nm Diode laser, Zeiss LSM510 
confocal microscope, x40 /1.2 NA (water) objective lense. PRE-EX is short for pre exercise, and 
POST- EX 0h,1h,3h stand for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 
50μm. 
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Figure 5.4.1c Quantification of mTOR association with cell membrane marker WGA following 
resistance exercise. Circles represent CON (energy- free group), squares represent FED 
(nutrition group). All data presented relative to the Pre exercise CON.Data presented as mean ± 
SEM (n=7/group). * Significantly different to PRE-CON (P<0.05). 
 
5.4.2 mTOR does not translocate to the nucleus in response to one bout of resistance exercise in 
young healthy male skeletal muscle 
As shown in Figure 5.4.2 a/b/c, part of mTOR stains distributed at the nucleus area in basal human 
skeletal muscle (39.93±4.59 for CON; 40.58 ±3.95 for FED). During 3h post exercise, it was not 
observed significant translocation of mTOR to nucleus area, either at immediately post exercise 
(35.02±4.89 for CON; 37.72±3.91 for FED), 1h post exercise (37.70±5.40 for CON; 41.23±3.35 for 
FED) or 3h post exercise (37.54±5.70 for CON; 41.84±4.75 for FED).  
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Figure 5.4.2a mTOR is not found translocate to nucleus area in response to one bout of 
resistance exercise in human skeletal muscle. A) mTOR primary antibody was stained with 
secondary antibody conjugated with Alex fluor® 594nm fluorophore. Images were taken under 
HeNe 594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 confocal microscope. B) 
Nucleus was stained by Dapi dye dilution. Images were taken under 405nm Diode laser, x40 /1.2 
NA (water) objective len. C) Composite images were merged between mTOR signal and Dapi 
fluorescence. D) Plasma membrane was stained by dystrophin primary antibody combined with 
corresponding secondary antibody conjugated with Alex fluor® 488nm fluorophore. Images 
were taken under 488nm Argon laser, x40/1.2 NA (water) objective len. PRE-EX means pre 
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exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour and 3 hours after resistance exercise, 
respectively. Scale bar 50μm.  
 
 
Figure 5.4.2b mTOR is not found translocate to nucleus area in response to one bout of 
resistance exercise combined with nutrition supplementation in human skeletal muscle. A) 
mTOR primary antibody was stained with secondary antibody conjugated with Alex fluor® 
594nm fluorophore. Images were taken under HeNe 594nm laser, x40/1.2 NA (water) objective 
len, Zeiss LSM510 confocal microscope. B) Nucleus was stained by Dapi dye dilution. Images 
were taken under 405nm Diode laser, x40 /1.2 NA (water) objective len. C) Composite images 
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were merged between mTOR signal and Dapi fluorescence. D) Plasma membrane was stained 
by dystrophin primary antibody combined with corresponding secondary antibody conjugated 
with Alex fluor® 488nm fluorophore. Images were taken under 488nm Argon laser, x40/1.2 NA 
(water) objective len. PRE-EX means pre exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 
hour and 3 hours after resistance exercise, respectively. Scale bar 50μm. 
 
Figure 5.4.2c Quantification of mTOR in nucleus area following resistance exercise. Circles 
represent CON (energy- free group), squares represent FED (nutrition group). All data 
presented relative to the Pre exercise CON. Data presented as mean ± SEM (n=7/group). * 
Significantly different to PRE-CON (P<0.05). 
 
5.4.3 mTOR translocates to blood vessel in response to one bout of resistance exercise in young 
healthy male   
As shown in Figure 5.4.3 a/b/c, mechanistic contraction resulted in immediate translocation of mTOR 
to associate with blood vessels (0.32±0.03 for CON; 0.30±0.03 for FED, p<0.05) compared with basal 
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level (0.27±0.02 for CON; 0.27±0.03 for FED) in human skeletal muscle. And the association 
between mTOR and blood vessels lasted for 1h post exercise (0.35±0.03 for CON; 0.37±0.03 for FED, 
P<0.05) and 3h post exercise (0.34±0.04 for CON; 0.30±0.03 for FED, p<0.05).  
 
Figure 5.4.3a mTOR translocates to blood vessel area in response to one bout of resistance 
exercise in human skeletal muscle. A) mTOR primary antibody was stained with secondary 
antibody conjugated with Alex fluor® 594nm fluorophore. Images were taken under HeNe 
594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 confocal microscope. B) 
Capillaries were stained by Ulex Europeus Agglutinin (UEA-I) lectin conjugated with Alex 
fluor® 488nm fluorophore. Images were taken under 488nm Argon laser, x40/1.2 NA (water) 
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objective len. C) Composite images were merged between mTOR signal and UEA-I fluorescence. 
D) Plasma membrane was stained with WGA conjugated with Alexa Fluor® 350 fluorescences. 
Images were taken under 405nm Diode laser, Zeiss LSM510 confocal microscope, x40 /1.2 NA 
(water) objective len. PRE-EX means before resistance exercise, and POST- EX 0h, 1h, 3h stand 
for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 50μm. 
 
Figure 5.4.3b mTOR translocates to blood vessel area in response to one bout of resistance 
exercise combined with nutrition supplementation in human skeletal muscle. A) mTOR primary 
antibody was stained with secondary antibody conjugated with Alex fluor® 594nm fluorophore. 
Images were taken under HeNe 594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 
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confocal microscope. B) Capillaries were stained by Ulex Europeus Agglutinin (UEA-I) lectin 
conjugated with Alex fluor® 488nm fluorophore. Images were taken under 488nm Argon laser, 
x40/1.2 NA (water) objective len. C) Composite images were merged between mTOR signal and 
UEA-I fluorescence. D) Plasma membrane was stained with WGA conjugated with Alexa 
Fluor® 350 fluorescences. Images were taken under 405nm Diode laser, Zeiss LSM510 confocal 
microscope, x40 /1.2 NA (water) objective len. PRE-EX means before resistance exercise, and 
POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 
50μm. 
 
Figure 5.4.3c Quantification of mTOR translocation to the microvasculature following 
resistance exercise. Circles represent CON, squares represent FED. All data presented relative 
to the Pre exercise CON. Data presented as mean ± SEM (n=7/group). * Significantly different 
to PRE-CON (P<0.05). 
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5.4.4 Association between mTOR and Lamp2 was not changed following one bout of resistance 
exercise in young healthy skeletal muscle 
As seen in Figure 5.4.4 a/b/c, mTOR colocalised with Lamp2 stains in basal human skeletal muscle 
(0.46±0.02 for CON; 0.46±0.01 for FED). In response to exercise stimulation, both mTOR and 
Lamp2 translocated to plasma membrane. However, colocalisation between mTOR and Lamp2was 
not changed during the 3h post exercise (immediately post exercise, 0.47±0.03 for CON and 
0.49±0.01 for FED; 1h post exercise, 0.46±0.02 for CON and 0.46±0.02 for FED; 3h post exercise, 
0.47±0.02 for CON and 0.47±0.01 for FED). 
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Figure 5.4.4a mTOR colocalises with Lamp2-positive stains consistently from pre exercise to 3h 
post exercise in human skeletal muscle. A) mTOR primary antibody was stained with secondary 
antibody conjugated with Alex fluor® 594nm fluorophore. Images were taken under HeNe 
594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 confocal microscope. B) Lamp2 
proteins were stained by primary antibody combined with secondary antibody conjugated with 
Alex fluor® 488nm fluorophore. Images were taken under 488nm Argon laser, x40/1.2 NA 
(water) objective len. C) Composite images were merged between mTOR signal and Lamp2 
fluorescence. D) Plasma membrane was stained with WGA conjugated with Alexa Fluor® 350 
fluorescences. Images were taken under 405nm Diode laser, x40 /1.2 NA (water) objective len. 
PRE-EX means before resistance exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour 
and 3 hours post exercise, respectively. Scale bar 50μm. 
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Figure 5.4.4b mTOR colocalises with Lamp2-positive stains consistently from pre exercise to 3h 
post exercise combined with nutrition supplementation in human skeletal muscle. A) mTOR 
primary antibody was stained with secondary antibody conjugated with Alex fluor® 594nm 
fluorophore. Images were taken under HeNe 594nm laser, x40/1.2 NA (water) objective len, 
Zeiss LSM510 confocal microscope. B) Lamp2 proteins were stained by primary antibody 
combined with secondary antibody conjugated with Alex fluor® 488nm fluorophore. Images 
were taken under 488nm Argon laser, x40/1.2 NA (water) objective len. C) Composite images 
were merged between mTOR signal and Lamp2 fluorescence. D) Plasma membrane was stained 
with WGA conjugated with Alexa Fluor® 350 fluorescences. Images were taken under 405nm 
Diode laser, x40 /1.2 NA (water) objective len. PRE-EX means before resistance exercise, and 
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POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 
50μm. 
 
Figure 5.4.4c Quantification of mTOR colocalisation with LAMP2 following resistance exercise. 
Circles represent CON, squares represent FED. All data presented relative to the Pre exercise 
CON. Data presented as mean ± SEM (n=7/group). * Significantly different to PRE-CON 
(P<0.05). 
 
5.4.5 Association between mTOR and Rab7 in response to one bout of resistance exercise 
As shown in 5.4.5 a/b/c, mTOR and Rab7 were obsersed partially colocalised in basal human skeletal 
muscle (0.31±0.01 for CON; 0.31±0.02 for FED, shown as Pearson’s correlation coefficient). In 
response to exercise, both mTOR and Rab7 translocated to plasma membrane immediately post 
exercise (0.36±0.02 for CON; 0.38±0.02 for FED, p<0.05) and maintained colocalisation with each 
other 1 h post exercise (0.35±0.02 for CON; 0.40±0.02 for FED, p<0.05) and 3h post exercise 
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(0.36±0.03 for CON; 0.38±0.02 for FED, p<0.05).  It is noticed that significance difference between 
group was found at 1h post exercise (p<0.05). 
 
Figure 5.4.5a mTOR translocates to Rab7-positive area in response to one bout of resistance 
exercise in human skeletal muscle. A) mTOR primary antibody was stained with secondary 
antibody conjugated with Alex fluor® 594nm fluorophore. Images were taken under HeNe 
594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 confocal microscope. B) Rab7 
proteins were stained by primary antibody combined with secondary antibody conjugated with 
Alex fluor® 488nm fluorophore. Images were taken under 488nm Argon laser, x40/1.2 NA 
(water) objective len. C) Composite images were merged between mTOR signal and Rab7 
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fluorescence. D) Plasma membrane was stained with WGA conjugated with Alexa Fluor® 350 
fluorescences. Images were taken under 405nm Diode laser, x40 /1.2 NA (water) objective len. 
PRE-EX means before resistance exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour 
and 3 hours post exercise, respectively. Scale bar 50μm. 
 
 
Figure 5.4.5b mTOR translocates to Rab7-positive area in response to one bout of resistance 
exercise combined with nutrition supplementation in human skeletal muscle. A) mTOR primary 
antibody was stained with secondary antibody conjugated with Alex fluor® 594nm fluorophore. 
Images were taken under HeNe 594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 
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confocal microscope. B) Rab7 proteins were stained by primary antibody combined with 
secondary antibody conjugated with Alex fluor® 488nm fluorophore. Images were taken under 
488nm Argon laser, x40/1.2 NA (water) objective len. C) Composite images were merged 
between mTOR signal and Rab7 fluorescence. D) Plasma membrane was stained with WGA 
conjugated with Alexa Fluor® 350 fluorescences. Images were taken under 405nm Diode laser, 
x40 /1.2 NA (water) objective len. PRE-EX means before resistance exercise, and POST- EX 0h, 
1h, 3h stand for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 50μm. 
 
Figure 5.4.5c Quantification of mTOR co- localisation with Rab7 following resistance exercise. 
Circles represent CON, squares represent FED. All data presented relative to the Pre exercise 
CON. Data presented as mean ± SEM (n=7/group). * Significantly different to PRE-CON 
(P<0.05). §Significantly different between groups (P<0.05). 
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5.4.6 Association between Rab7 and Lamp2 in response to one bout of resistance exercise in young 
healthy male skeletal muscle  
As seen in Figure 5.4.6a/b/c, compared with association between Rab7 and Lamp2 in basal human 
skeletal muscle (0.38±0.02 for CON; 0.39±0.01 for FED), resistance exercise stimulated Rab7 and 
Lamp2 translocating to plasma membrane to colocalise with each other immediately post exercise 
(0.43±0.02 for CON; 0.45±0.01 for FED, p<0.05). And their colocalisation lasted 1h post exercise 
(0.43±0.02 for CON; 0.47±0.01 for FED, p<0.05) and 3h post exercise (0.43±0.02 for CON; 
0.45±0.01 for FED, p<0.05).  
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Figure 5.4.6a Lamp2 associates with Rab7-positive in response to one bout of resistance exercise 
in human skeletal muscle. A) Lamp2 primary antibody was stained with secondary antibody 
conjugated with Alex fluor® 594nm fluorophore. Images were taken under HeNe 594nm laser, 
x40/1.2 NA (water) objective len, Zeiss LSM510 confocal microscope. B) Rab7 proteins were 
stained by primary antibody combined with secondary antibody conjugated with Alex fluor® 
488nm fluorophore. Images were taken under 488nm Argon laser, x40/1.2 NA (water) objective 
len. C) Composite images were merged between Lamp2 signal and Rab7 fluorescence. D) 
Plasma membrane was stained with WGA conjugated with Alexa Fluor® 350 fluorescences. 
Images were taken under 405nm Diode laser, x40 /1.2 NA (water) objective len. PRE-EX means 
before resistance exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour and 3 hours post 
exercise, respectively. Scale bar 50μm. 
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Figure 5.4.6b Lamp2 associates with Rab7-positive in response to one bout of resistance exercise 
combined with nutrition supplementation in human skeletal muscle. A) Lamp2 primary 
antibody was stained with secondary antibody conjugated with Alex fluor® 594nm fluorophore. 
Images were taken under HeNe 594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 
confocal microscope. B) Rab7 proteins were stained by primary antibody combined with 
secondary antibody conjugated with Alex fluor® 488nm fluorophore. Images were taken under 
488nm Argon laser, x40/1.2 NA (water) objective len. C) Composite images were merged 
between Lamp2 signal and Rab7 fluorescence. D) Plasma membrane was stained with WGA 
conjugated with Alexa Fluor® 350 fluorescences. Images were taken under 405nm Diode laser, 
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x40 /1.2 NA (water) objective len. PRE-EX means before resistance exercise, and POST- EX 0h, 
1h, 3h stand for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 50μm. 
 
Figure 5.4.6c Quantification of Lamp2 co- localisation with Rab7 following resistance exercise. 
Circles represent CON, squares represent FED. All data presented relative to the Pre exercise 
CON. Data presented as mean ± SEM (n=7/group). * Significantly different to PRE-CON 
(P<0.05). §Significantly different between groups (P<0.05). 
5.4.7 Association between mTOR and Rheb in response to one bout of resistance exercise in young 
healthy male skeletal muscle 
As shown in Figure 5.4.7a/b/c, colocalisation between mTOR and Rheb was increased immediately 
post exercise on the plasma membrane (0.39±0.02 for CON; , 0.43±0.02 for FED, p<0.05) compared 
with basal level (0.34±0.01 for CON; 0.35±0.01 for FED). And this colocalisation maintained 
significant 1h post exercise (0.43±0.04 for CON; 0.45±0.02 for FED, P<0.05) and 3h post exercise 
(0.41±0.04 for CON; 0.42±0.01 for FED, P<0.05).  
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Figure 5.4.7a mTOR translocates to Rheb-positive area in response to one bout of resistance 
exercise in human skeletal muscle. A) mTOR primary antibody was stained with secondary 
antibody conjugated with Alex fluor® 594nm fluorophore. Images were taken under HeNe 
594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 confocal microscope. B) Rheb was 
stained by primary antibody combined with secondary antibody conjugated with Alex fluor® 
488nm fluorophore. Images were taken under 488nm Argon laser, x40/1.2 NA (water) objective 
len. C) Composite images were merged between mTOR signal and Rheb fluorescence. D) 
Plasma membrane was stained with WGA conjugated with Alexa Fluor® 350 fluorescences. 
Images were taken under 405nm Diode laser, x40 /1.2 NA (water) objective len. PRE-EX means 
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before resistance exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour and 3 hours post 
exercise, respectively. Scale bar 50μm. 
 
 
Figure 5.4.7b mTOR translocates to Rheb-positive area in response to one bout of resistance 
exercise combined with nutrition supplementation in human skeletal muscle. A) mTOR primary 
antibody was stained with secondary antibody conjugated with Alex fluor® 594nm fluorophore. 
Images were taken under HeNe 594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 
confocal microscope. B) Rheb was stained by primary antibody combined with secondary 
antibody conjugated with Alex fluor® 488nm fluorophore. Images were taken under 488nm 
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Argon laser, x40/1.2 NA (water) objective len. C) Composite images were merged between 
mTOR signal and Rheb fluorescence. D) Plasma membrane was stained with WGA conjugated 
with Alexa Fluor® 350 fluorescences. Images were taken under 405nm Diode laser, x40 /1.2 NA 
(water) objective len. PRE-EX means before resistance exercise, and POST- EX 0h, 1h, 3h stand 
for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 50μm. 
 
Figure 5.4.7c Quanticication of mTOR and Rheb interaction following resistance exercise. 
Circles represent CON, squares represent FED. All data presented relative to the Pre exercise 
CON. Data presented as mean ± SEM (n=7/group). * Significantly different to PRE-CON 
(P<0.05). 
 
5.4.8 Association between mTOR and EIF3F in response to one bout of resistance exercise in young 
healthy male skeletal muscle 
EIF3F is the component constituting the translation initiation box, which is reported to associate 
mTORC activating downstream proteins. As shown in Figure 5.4.8a/b/c, EIF3F signals were observed 
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to associate with mTOR on the plasma membrane immediately post exercise (0.40±0.03 for CON; 
0.44±0.01 for FED, p<0.05) compared with basal level (0.33±0.01 for CON; 0.35±0.01 for FED). 
Association between mTOR and EIF3F was further increased 1h (0.41±0.03 for CON; 0.48±0.02 for 
FED, p<0.05). This association lasted to 3h post exercise (0.42±0.03 for CON; 0.45±0.01 for FED, 
p<0.05). It is noticed that association between mTOR and EIF3F was significantly different between 
two groups at 1h post exercise.  
 
Figure 5.4.8a mTOR associates with EIF3F in response to one bout of resistance exercise in 
human skeletal muscle. A) mTOR primary antibody was stained with secondary antibody 
conjugated with Alex fluor® 594nm fluorophore. Images were taken under HeNe 594nm laser, 
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x40/1.2 NA (water) objective len, Zeiss LSM510 confocal microscope. B) EIF3F was incubated 
with the primary antibody combined with secondary antibody conjugated with Alex fluor® 
488nm fluorophore. Images were taken under 488nm Argon laser, x40/1.2 NA (water) objective 
len. C) Composite images were merged between mTOR signal and EIF3F fluorescence. D) 
Plasma membrane was stained with WGA conjugated with Alexa Fluor® 350 fluorescences. 
Images were taken under 405nm Diode laser, x40 /1.2 NA (water) objective len. PRE-EX means 
before resistance exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour and 3 hours post 
exercise, respectively. Scale bar 50μm. 
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Figure 5.4.8b mTOR associates with EIF3F in response to one bout of resistance exercise 
combined with nutrition supplementation in human skeletal muscle. A) mTOR primary 
antibody was stained with secondary antibody conjugated with Alex fluor® 594nm fluorophore. 
Images were taken under HeNe 594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 
confocal microscope. B) EIF3F was incubated with the primary antibody combined with 
secondary antibody conjugated with Alex fluor® 488nm fluorophore. Images were taken under 
488nm Argon laser, x40/1.2 NA (water) objective len. C) Composite images were merged 
between mTOR signal and EIF3F fluorescence. D) Plasma membrane was stained with WGA 
conjugated with Alexa Fluor® 350 fluorescences. Images were taken under 405nm Diode laser, 
x40 /1.2 NA (water) objective len. PRE-EX means before resistance exercise, and POST- EX 0h, 
1h, 3h stand for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 50μm. 
 
Figure 5.4.8c Quantification of mTOR and eIF3f interaction following resistance exercise. 
Circles represent CON, squares represent FED. All data presented relative to the Pre exercise 
CON. Data presented as mean ± SEM (n=7/group). * Significantly different to PRE-CON 
(P<0.05). § Significantly different between groups (P<0.05). 
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5.4.9 Disassociation between Rheb and its inhibitor Tuberin in response to one bout of resistance 
exercise in young healthy male skeletal muscle 
As shown in Figure 5.4.9a/b/c, Tuberin is found mainly localized on the plasma membrane, 
colocalsiing with Rheb in basal human skeletal muscle (0.45±0.02 for CON; 0.46±0.01 for FED). It 
was observed Tuberin disassociated from Rheb immediately post resistance exercise (0.41±0.02 for 
CON; 0.41±0.01 for FED, p<0.05), and kept on decreasing 1h post exercise (0.39±0.03 for CON; 
0.40±0.01 for FED, p<0.05). Disassociation between Tuberin and Rheb was also significant 3h post 
exercise (0.41±0.01 for CON; 0.36±0.01 for FED, p<0.05).  
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Figure 5.4.9a Tuberin disassociates from Rheb- positive area in response to one bout of 
resistance exercise in human skeletal muscle. A) Tuberin (TSC1/TSC2) primary antibody was 
stained with secondary antibody conjugated with Alex fluor® 594nm fluorophore. Images were 
taken under HeNe 594nm laser, x40/1.2 NA (water) objective len, Zeiss LSM510 confocal 
microscope. B) Rheb proteins were incubated with the primary antibody combined with 
secondary antibody conjugated with Alex fluor® 488nm fluorophore. Images were taken under 
488nm Argon laser, x40/1.2 NA (water) objective len. C) Composite images were merged 
between Tuberin signal and Rheb fluorescence. D) Plasma membrane was stained with WGA 
conjugated with Alexa Fluor® 350 fluorescences. Images were taken under 405nm Diode laser, 
x40 /1.2 NA (water) objective len. PRE-EX means before resistance exercise, and POST- EX 0h, 
1h, 3h stand for 0 hour, 1 hour and 3 hours post exercise, respectively. Scale bar 50μm. 
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Figure 5.4.9b Tuberin disassociates from Rheb- positive area in response to one bout of 
resistance exercise combined with nutrition supplementation in human skeletal muscle. A) 
Tuberin (TSC1/TSC2) primary antibody was stained with secondary antibody conjugated with 
Alex fluor® 594nm fluorophore. Images were taken under HeNe 594nm laser, x40/1.2 NA 
(water) objective len, Zeiss LSM510 confocal microscope. B) Rheb proteins were incubated with 
the primary antibody combined with secondary antibody conjugated with Alex fluor® 488nm 
fluorophore. Images are taken under 488nm Argon laser, x40/1.2 NA (water) objective len. C) 
Composite images were merged between Tuberin signal and Rheb fluorescence. D) Plasma 
membrane was stained with WGA conjugated with Alexa Fluor® 350 fluorescences. Images 
were taken under 405nm Diode laser, x40 /1.2 NA (water) objective len. PRE-EX means before 
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resistance exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour and 3 hours post exercise, 
respectively. Scale bar 50μm. 
 
Figure 5.4.9c Quantification of TSC2 and Rheb dissociation following resistance exercise. 
Circles represent CON, squares represent FED. All data presented relative to the Pre exercise 
CON. Data presented as mean ± SEM (n=7/group). * Significantly different to PRE-CON 
(P<0.05). 
 
5.4.10 Disassociation between Tuberin and plasma membrane in response to one bout of resistance 
exercise in young healthy male skeletal muscle 
To verify disassociation of Tuberin from cell membrane, colocalisation between Tuberin and plasma 
membrane area was further investigated. As shown in Figure 5.4.10a/b, Tuberin disassociateed from 
plasma membrane immediately post resistance exercise (0.22±0.02 for CON; 0.25±0.01 for FED, 
p<0.05) compared with basal level (0.28±0.02 for CON; 0.30±0.02 for FED). Then the association 
between Tuberin and cell membrane is partially increased in both groups at 1h and 3h post exercise, 
though deassociation of Tuberin from cell membrane was also significant compared with pre exercise 
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(1h post exercise, 0.23±0.02 for CON and 0.29±0.01 for FED, p<0.05; 3h post exercise, 0.28±0.02 for 
CON and 0.26±0.02 for FED, p<0.05).  
 
Figure 5.4.10a Tuberin disassociates from cell membrane in response to one bout of resistance 
exercise in human skeletal muscle at energy- free (CON) and nutritional (FED) conditions. 
Tuberin (TSC1/TSC2) primary antibody was stained with secondary antibody conjugated with 
Alex fluor® 594nm fluorophore and cell membrane. Images were taken under HeNe 594nm 
laser, x40/1.2 NA (water) objective len, Zeiss LSM510 confocal microscope. Plasma membrane 
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was stained with WGA conjugated with Alexa Fluor® 350 fluorescences. Images were taken 
under 405nm Diode laser, x40 /1.2 NA (water) objective len. PRE-EX means before resistance 
exercise, and POST- EX 0h, 1h, 3h stand for 0 hour, 1 hour and 3 hours post exercise, 
respectively. Scale bar 50μm. 
 
Figure 5.4.10b Quantification of TSC2 dissociation from plasma membrane following resistance 
exercise. Circles represent CON, squares represent FED. All data presented relative to the Pre 
exercise CON. Data presented as mean ± SEM (n=7/group). * Significantly different to PRE-
CON (P<0.05). 
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5.5 Discussion 
The protein complex mTORC1 is critical for regulating skeletal muscle mass [27]. Numerous studies in 
humans have demonstrated that mTORC1 activity is increased during the post-exercise period both 
with and without nutrient (e.g. amino acids) ingestion [1]. Inhibition of mTORC1 activity using the 
mTORC1 specific inhibitor rapamycin blocks resistance-exercise mediated increases in protein 
synthesis, indicating that mTORC1 activity is required to activate muscle protein synthesis in humans 
[4, 5]. Despite this body of work, additional research is warranted to better understand how mTORC1 is 
activated in skeletal muscle in response to anabolic stimuli such as resistance exercise (both with and 
without nutrient ingestion) and how mTORC1 activates pathways regulating mRNA translation and, 
hence, muscle protein synthesis [28]. To this end, utilising immunofluorescence approaches in human 
skeletal muscle we have detailed, for the first time, intracellular mTOR localisation and protein 
complex co-localisation in response to an anabolic stimulus. We demonstrate that mTOR co-localises 
with the lysosome in basal conditions and that these complexes translocate to the cell periphery, in 
close proximity to capillaries, in response to resistance exercise. In parallel, we also observed that 
resistance exercise stimulates TSC2 dissociation from Rheb and that this leads a reduction in TSC2 
abundance at the cell membrane, which would be consistent with an enhanced mTOR kinase activity. 
Although post-exercise ingestion of PRO/CHO had little effect on mTOR translocation or TSC2-
Rheb-mTOR interaction, nutrient ingestion did increase mTOR and eIF3f association post exercise; 
this interaction may contribute to the well-documented enhancement of muscle protein synthesis after 
exercise in the fed state [11, 12]. 
Recent work from the Hornberger lab [19] in mice has suggested that recruitment of the catalytic 
component of mTORC1 (mTOR) to the late lysosomal membrane is an important event initiating the 
protein synthetic response. We therefore sought to utilise immunofluorescence approaches to detail 
this event in human skeletal muscle in response to resistance exercise during a post-exercise period in 
which rates of muscle protein synthesis are known to be elevated [7, 8]. Additionally, we investigated 
whether consumption of a protein/carbohydrate beverage post exercise, which would further enhance 
the muscle protein synthetic response [13, 23, 25], would augment the mTOR compartmentalisation 
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during recovery compared to an energy-free control. In contrast to cell and rodent studies, we 
observed interaction of mTOR with the lysosome in basal conditions, an interaction that is retained 
during the 3h post-exercise recovery period independently of concomitant protein/carbohydrate 
ingestion. Thus, recruitment of mTOR to the late-lysosome compartment does not appear to be 
enhanced relative to basal conditions in response to anabolic stimuli such as amino acids and/or 
muscle contraction in human skeletal muscle, which is in contrast to reports in cell [15] and rodent [19] 
models. The explanation for the discrepancy between the present and previous data is not readily 
apparent; however may be due to different nutrient availability in human skeletal muscle compared to 
cell-based models. For example, dissociation of mTOR from the lysosome in cell-based models has 
been observed in amino acid free conditions [15], which is a scenario that would be more reflective of 
chronic fasting that could initiate an autophagic response [29]. Interestingly, in the same in vitro model, 
mild amino acid reduction does not result in mTOR dissociation from the lysosome and therefore 
mTOR activity is unaltered [29]. Similar results could also be expected in human muscle given that 
muscle protein breakdown (as part of the normal ‘turnover’ of muscle protein pools) functions to 
replenish the intracellular amino acid pool to support basal rates of muscle protein synthesis [30]; as 
such, even in the fasted state there may be sufficient intracellular amino acids to maintain mTOR 
localization with the lysosomal membrane. Thus, constant mTOR association with the lysosome may 
reflect amino acid availability and the requirement of mTOR to maintain basal protein synthesis in 
resting human skeletal muscle.  
Our initial hypothesis was that mTOR translocation to the lysosome would be the key activation event 
for mTOR in response to an exercise stimulus. In contrast, our data clearly demonstrates that 
mTOR/LAMP2 translocation to the cell periphery is a principal event relocating mTOR following 
resistance exercise. The direct physiological relevance of this event is currently unclear, however it 
has previously been suggested that lysosome migration to the cell periphery can act as a stimulus for 
mTORC1 activation [29]. Nutrition depletion resulted in decreased cells characterised with peripheral 
lysosome distribution, while nutrition replenishment recovered the lysosome peripheral position [29]. 
Overexpression of two kinesin superfamily members (KIF1Bβ and KIF2) that target lysosomes to the 
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cell periphery increased mTORC1 activity. In contrast, siRNA-mediated knockdown of KIF1Bβ and 
KIF2 targeted lysosomes to peri-nuclear regions, which subsequently reduced mTORC1 activity, and 
initiated autophagy [29]. As such, lysosomal distribution would appear to be a key initial event in the 
increased activity of mTOR in response to nutrient stimulation. Our finding of a similar 
mTOR/LAMP2 translocation event following resistance exercise that is uninfluenced by 
protein/carbohydrate ingestion would suggest that mTOR/LAMP2 translocation is important for the 
initial activation of mRNA translation after exercise in human skeletal muscle. 
It has been reported that mTOR associates with Rab7 following activation in cultured cells in vitro [40]. 
In consistence, our study in human skeletal muscle also found that mTOR translocated to colocalise 
with Rab7- positive compartment on the plasma membrane following exercise in both fast and fed 
status. Although Rab7 and Lamp2 both participate in regulating late lysosome formation, they may 
involve in disparate activities [20]. Rab7 is a key protein controlling the traffic between early and late 
endosome [20], while Lamp2 is important for maintaining the integrity of peri- lysosome membrane [20]. 
Endosome membrane marked with Rab7 is thought to be matured late endosome, which then infuses 
with lysosome to form the late lysosome [20]. In our investigation around the relationship between 
Rab7 and Lamp2, it was found that Rab7 translocated to colocalise with Lamp2 in response to muscle 
contraction, indicating the formation of late lysosome. In combination with result between mTOR and 
Rab7, these finding suggest that Rab7 is associated with mTOR activation on late lysosome 
membrane in response to mechanistic contraction in human skeletal muscle. Moreover, association 
between mTORC with Rab7 was enhanced 1h post exercise in fed status, revealing important roles of 
nutrition supplementation in stimulating mTOR/ Rab7 interaction.  
Previous studies have demonstrated that mTOR interaction with GTP bound Rheb is required to elicit 
complete mTORC1 activation [31]. Rheb is a small GTPase [31] and is activated by the GTPase 
activating protein TSC2, which converts GTP-Rheb into GDP-Rheb rendering it unable to activate 
mTORC1 [32, 18]. Rheb is able to bind to the catalytic domain of mTOR [33, 34] only when associated 
with GTP [35]. It was recently reported that eccentric contraction in mouse skeletal muscle leads to 
TSC2 dissociation from the lysosome, which would facilitate the mTOR and GTP-Rheb interaction 
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[19]. In contrast, we observed TSC2 to be located at the plasma membrane, co-localising with Rheb as 
opposed to at the lysosome. In our hands, TSC2 dissociated from the membrane following resistance 
exercise, leaving Rheb and the mTOR/LAMP2 complex to co-localise. It is unclear why the location 
of this event is different in human as opposed to murine skeletal muscle. It may be reflective of 
muscle fibre-type differences (predominantly fast-twitch in mouse vs mixed fibres in human), the 
mode of exercise (eccentric vs concentric), the degree of contraction/recruitment, the nutrient 
availability in each scenario, and/or interspecies differences. Irrespective, our data are in agreement 
with Jacobs et al [19] reporting that TSC2 dissociation from mTOR positive regions appears to be a 
key post-exercise event following an anabolic stimulus in human skeletal muscle.  
In addition to TSC2-Rheb-mTOR co-localisation, we next sought to examine whether mTOR 
translocation to the plasma membrane may serve to direct mTOR/LAMP2 to other substrates involved 
in the initiation of protein synthesis. We report novel data indicating that mTOR associates with the 
regulatory subunit of the eukaryotic initiation factor 3 complex, eIF3f, post-exercise in both the CON 
and FED groups. The eIF3 complex is key to the initiation of protein synthesis serving as a scaffold 
for mTOR and S6K1 interaction, leading to the assembly of the pre-initiation complex [36, 37]. mTOR 
and eIF3f co-localisation occurred rapidly post-exercise in both the CON and FED groups, which is 
consistent with the ability of resistance exercise to enhance amino acid uptake and muscle protein 
synthesis early in recovery [7, 38]. However this interaction was significantly greater in the FED group 
1h post exercise, suggesting that feeding may enhance mTOR-eIF3f assembly post-exercise. Given 
that muscle protein synthesis and the phosphorylation of mTORC1 substrates is amplified post-
exercise following protein/carbohydrate ingestion [13, 25], it would appear that the increased mTOR-
eIF3f interaction observed in the FED group may be an important mediator of post-exercise nutrition 
on mTORC1 dependent signaling and potentially muscle protein synthesis. 
In addition, we also observed that mTOR/LAMP2 complexes associated with the microvasculature 
(UEA-I positive regions) at the plasma membrane post exercise. The precise reason for this response 
is currently unclear, however mTOR association with the microvasculature would in theory position 
mTOR in close proximity to nutrient provision delivered from the bloodstream. mTOR interaction 
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with UEA-I  positive cells increased equally post-exercise in both the CON and FED groups 
suggesting that mTOR interaction with the microvasculature is not influenced by protein/carbohydrate 
ingestion in healthy young men after exercise. Collectively, this adds further support to the hypothesis 
that mTOR translocation is a mechanically driven event and that protein/carbohydrate facilitating 
mTOR interaction with protein partners (eIF3f) rather than altering the localisation of mTOR/LAMP2 
complexes. 
In summary, utilising immunofluorescence approaches in human skeletal muscle, we have detailed for 
the first time intracellular mTOR localisation and protein complex co-localisation in response to an 
anabolic stimulus. We demonstrated that mTOR co-localised with the lysosome in basal conditions 
and that these complexes translocated to the cell periphery in response to resistance exercise. In 
parallel, resistance exercise stimulates TSC2 dissociation from Rheb and leads a reduction in TSC2 
abundance at the cell membrane, which would be consistent with an enhanced mTOR kinase activity. 
Although post-exercise ingestion of protein/carbohydrate had little effect on mTOR translocation or 
TSC2-Rheb-mTOR interaction, nutrient ingestion did increase mTOR and eIF3f association post 
exercise; this effect may contribute to the well-documented enhancement of muscle protein synthesis 
after exercise in the fed state. Collectively, our data highlight the potential importance of mTOR-
lysosomal cellular partitioning for mTORC1 function following a growth stimulus and illustrates 
another level of complexity to the molecular control of protein synthesis following resistance exercise 
and nutrition in human skeletal muscle. Future studies could include concurrent measures of muscle 
protein synthesis and/or effector enzyme activity [39] to further elucidate the physiological significance 
of mTORC1 complex assembly and intracellular translocation in human skeletal muscle after exercise. 
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6.1 Introduction 
Maintenance of skeletal muscle mass and function are of great importance to human wellbeing and 
health. Deterioration in skeletal muscle mass and strength lead to muscle atrophy, as well as other 
associated chronic diseases [1]. Resistance exercise is an efficient strategy to increase muscle strength 
and muscle hypertrophy in human skeletal muscle, the latter of which is mediated by exercise- 
induced increase in muscle protein synthesis, which subsequently increases net protein balance [2]. 
Nutritional supplementation of protein also increases protein synthesis, with the combination of 
protein ingestion and resistance exercise having an additive stimulatory effect on protein synthesis 
beyond either in isolation [3]. 
The molecular regulation of skeletal muscle mass is generally regarded to be mediated by the serine/ 
threonine protein kinase mTOR, which when active stimulates protein synthesis and attenuates protein 
degradation [4]. mTOR forms a protein complex (mTORC) which is constituted by two subtypes, 
mTORC1 and mTORC2. Structural differences between the two subtypes lies in the associated 
subunits constituting mTORC, which alters the different substrates they bind to, as well as the 
downstream processes they regulate [4]. mTORC1 contains raptor, GßL, DEPTOR and PRAS40 and is 
sensitive to rapamycin inhibition [5]. In contrast, mTORC 2 consists of rictor, GßL, Sin1, DEPTOR 
and Protor/PRR5, and is insensitive to rapamycin [5]. mTORC1 is widely studied and reported to 
activate protein translation initiation events in response to anabolic stimuli such as insulin and 
nutrition supplementation [4, 5]. Acute administration of rapamycin blocks the anabolic effects of 
resistance and AA ingestion in human skeletal muscle [6, 7].   
As mTOR plays a pivotal role in activating protein synthesis and muscle hypertrophy, it is relevant to 
investigate the molecular mechanisms of mTOR activation. Current knowledge regarding the 
physiological regulation of mTOR activity in human skeletal muscle is mainly from phosphorylation- 
specific profiling of the mTOR signaling cascade via the immunoblotting technique [8]. The other 
strategy examining mTOR activity is to measure the downstream substrates mTOR regulates (e.g. 
S6K1, 4E-BP). Consistent with the stimulatory effects of resistance exercise on muscle protein 
synthesis in the fasted state [9, 10], the phosphorylation of mTOR substrates is also increased, indicating 
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the activation of mTOR signal pathway following resistance exercise [11] with this response 
maintained for at least 24h post- exercise in young men [12]. Furthermore, ingestion of nutrients 
including glucose and AA (either orally or intravenously) augments the rate of the protein synthesis in 
human skeletal muscle post exercise [13, 14]. 
Beyond immunoblotting approaches, studies in vitro have revealed that subcellular distribution of 
mTOR and protein- protein association between mTOR and its regulators may be important to mTOR 
activation in response to physiological stimuli [17]. For example, following AA stimulation, mTOR is 
visualized to translocate to the lysosome area to associate with the GTP loaded ras- homolog enriched 
in brain (Rheb) to be fully activated [18]. This phenomenon is reversed by the removal of AA, which 
results in the dissociation of mTOR from the lysosome and mTOR degradation [18]. The interaction 
between mTOR and Rheb is maintained at basal levels through restricting Rheb under the GDP-bound 
status mediated by the activity of tuberous sclerosis complex (TSC) proteins TSC1 and TSC2 [19]. 
Phosphorylation of TSC2 by Akt causes TSC2 inactivation [20], leading to Rheb disassociated from 
TSC2 reloading GTP to bind mTOR [21]. From skeletal muscle studies in vivo, it was recently reported 
that mTOR associated with TSC2 on lysosome in basal mouse tibialis- anterior skeletal muscle [22]. 
Eccentric muscle contraction induced disassociation of TSC2 from the lysosome, while association 
between mTOR and the lysosome was enhanced [22]. These reports emphasize the close relationship 
between mTOR intracellular distribution/ protein complex assembly and activity.  
Resistance training increases the muscle protein turnover in human skeletal muscle [24]. Muscle 
protein synthesis is increased following resistance training, contributing to the muscle hypertrophy in 
human skeletal muscle [24, 25]. The mTOR signaling pathway is reported to play a key role in 
regulating muscle hypertrophy, as well as preventing muscle atrophy [26]. As such, increased content 
of phosphorylated mTOR has been reported in recovery stage following resistance training suggesting 
enhancement of mTOR activity is an important factor in response to the training stimulus [44].  
It is known that different muscle fiber types contribute to muscle hypertrophy in a different manner 
[28]. Cross sectional area in type II fibers is increased more in response to resistance training than the 
 220 
 
type I muscle fiber in human skeletal muscle, contributing to mean cross sectional area increase in 
mixed muscle fibers [28]. On the other hand, muscle fiber type composition is adapted to specific 
exercise training. Endurance exercise promotes the transformation of glycolytic muscle fibers to 
oxidative muscle fibers [53, 54]. Oxidative type I fibers were detected predominantly existing in skeletal 
muscle of athletes following long term endurance training [29]. Proportion of type IIa fibers were 
reported to increase following high intensity resistance training contributing to muscle hypertrophy [28, 
55, 56].  
Muscle protein synthesis rates were different in a muscle fiber type dependent manner in rodent 
models [27, 57]. Basal protein synthesis rates were correlated with the content of slow- twitch fibers in 
rat muscle [57]. Protein synthesis rates were decreased more significantly in type 2X and 2B fibers than 
other fiber types in the mouse plantaris muscle following a 48h food deprivation [27]. However, data 
on human skeletal muscle protein synthesis in different muscle fibers is limited now. Isotype infusion 
tracer experiment did not show significant variation of protein synthesis rates between muscles 
following feeding [58], revealing different metabolic composition of human myofibers from rodents. 
mTOR is the critical kinase participating in muscle protein synthesis regulation and resistance 
exercise- induced muscle hypertrophy [4, 5].  
 
6.2 Novel findings in this thesis and relevance to the existing literature 
6.2.1 Development of mTOR immunofluorescence staining approaches for human skeletal muscle 
mTOR activation is important for regulating muscle protein synthesis in response to contraction and 
protein ingestion [5, 7]. Immunofluorescence data have been reported in cell and rodent models, 
highlighting the importance of mTOR cellular distribution as a critical event for its activation [18, 22, 23]. 
However, to date, no research has examined mTOR localization in human skeletal muscle. To address 
this gap in knowledge, here we report a novel immunofluorescence method to visualize mTOR and 
it’s associating proteins in human skeletal muscle. 
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Systematical methods were established to validate mTOR antibodies applied in immunofluorescent 
staining in human skeletal muscle. We report that the antibodies we identified are specific to their 
targets and provide reproducible results in isolation, in addition to antibody cocktail approaches. 
Taking advantage of this technique, for the first time mTOR distribution was reported in human 
skeletal muscle in vivo.  
A multiple antibody costaining method was developed in human skeletal muscle to further investigate 
mTOR translocation and protein interaction. Relying on this costaining method, microscope images 
about association between mTOR and regulating proteins were firstly reported in human skeletal 
muscle in vivo. Moreover, based on high quality microscopy images, image quantification 
methodology on mTOR and associated proteins were developed to measure mTOR content and 
association between mTOR and regulators/organelles in human skeletal muscle in vivo. Thus, the 
immunofluorescence staining method developed herein greatly facilitates the progression of research 
regarding mTOR regualtion in human skeletal muscle in vivo.  
6.2.2 Effect of chronic resistance training on mTOR protein content in skeletal muscle 
Reports emphasize the effects of resistance training on stimulating muscle protein anabolism in 
human [24, 25]. Acute resistance exercise activates the mTOR signal pathway for ~ 24h post exercise 
recovery [12] whilst mTOR protein content has been reported to increase in human skeletal muscle 
following resistance training [44]. Therefore, we hypothesized that total mTOR content would increase 
following resistance training and that the magnitude of this increase/activation would parallel gains in 
muscle mass in skeletal muscle. We were able to address this question as the mTOR 
immunofluorescence approach developed in chapter 3 allowed us to measure mTOR protein content 
in total muscle fibres relative to their CSA, in addition to specific muscle fibres depending on their 
MHC profile.  
In contrast to our initial hypothesis, we found no significant increases in total mTOR content in 
human skeletal muscle following 10 weeks high intensity resistance training, nor any fibre-specific 
alteration in mTOR content relative to MHC abundance. It should also be noted that the resistance-
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training program failed to elicit hypertrophy as quantified by fibre CSA or muscle mass assessed via 
DEXA. The lack of obvious hypertrophy in our participants was surprising and against what we 
expected. Importantly we did observe an increase in strength in the training group, indicating that 
there was training adaptation, however the lack of obvious synergy between mTOR protein content 
and muscle CSA may be due to the limited hypertrophy we observed in this study.   
We next investigated mTOR content in different muscle fiber types. In agreement with data of total 
mTOR content, we did not observe an increase in mTOR content in either type I fibers or type IIx 
fibers. However, when we profiled the muscle fiber type composition, our data demonstrated that 
percentage of type IIa fibers was significantly increased post training, while proportion of type I 
muscle fibers was decreased following training. Exercise training has well-established effects to 
change MHC isoform expression by transforming a fiber type switch from type IIb to IIx and IIa and 
in rare cases also to type I muscle fibers [67, 68]. The mechanisms leading to muscle fiber shifting in 
response to resistance exercise is not clear. Motor neuron unit is thought to play an important role in 
regulating metabolism and signals pathway in different muscle fibers via calcium as a second 
messenger [60]. Myocyte enhancer factor- 2 (MEF-2) transcription factors, a muscle- enriched 
transcription factor, were reported to be a critical regulator in muscle formation through activating 
muscle- specific genes [60]. MEF2/ histone deacetylase (HDAC) signaling pathway is thought to play 
an indispensible role in the transformation of myofibers in response to intracellular calcium signals 
incurred by external physiological signals [60]. Calcineurin is another reported regulator involving in 
myofibers transformation, which is a sernser of contractile activity by sensing calcium fluctuations 
[60].Calcineurin is also found to be the upstream regulator of MEF2 [60]. Our results indicate that in 
response to resistance training, type IIx fibers might transform to type IIa fibers. However, it is not 
clear of the reduction in type I fibers proportion, which, though, has also been reported in several 
resistance training studies [70, 71, 72]. In our data, reduction in type IIx fibers was only 4%, while 
increase of type IIa fibers was 12%. Provided there were no increase of muscle fibers following 
training, it is interesting to investigate the increase of  type IIa fibers. Considering the decrease of type 
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I fiber composition, it suggests a potential mechanism resulting in myofibers transformation from 
oxidative to glycolytic type in adaptation to training mode.   
Collectively, we conclude 10 weeks high intensity resistance training in trained individuals remodels 
muscle fibre composition and gains in strength, rather than increasing mTOR protein content and 
muscle CSA either in mixed fibers or specific fibre-types after 10 weeks.  
6.2.3 Effects of resistance exercise on mTOR distribution and colocalisation in the fed and fasted state. 
It is well documented that resistance exercise with or without ingestion of exogenous AA stimulates 
mTORC1 activity in human skeletal muscle [2]. Inhibition of mTORC1 activity using the mTORC1 
specific inhibitor rapamycin blocks increases in protein synthesis mediated by resistance exercise, 
suggesting the indispensible function of mTORC1 in activating muscle protein anabolism in humans 
[6, 7]. Despite these findings, little is known of the mechanisms of mTORC1 activation in skeletal 
muscle in response to the anabolic stimuli, as well as the mechanism of mTORC1 regulates 
translation and, hence, muscle protein synthesis [31]. 
Recent rodent studies have suggested that recruitment of the catalytic component of mTORC to the 
late lysosomal membrane is important to initiate protein synthesis [22]. Therefore utilizing our 
immunofluorescence methodology to investigate this event in human skeletal muscle in response to 
resistance exercise, during a post- exercise period in which rates of muscle protein synthesis are 
known to be elevated [9, 32]. In Addition, consumption of a protein/carbohydrate beverage post exercise 
has been proved to exaggerate the benefits of muscle protein balance in human [15, 16, 33]. Here we 
investigated if nutritional beverage ingestion post exercise would augment the mTOR 
compartmentalization in comparison with the energy- free exercise group.  
In contrast to cell and rodents models, we visualized the association of mTOR with the late lysosome 
(marked by Lamp2) at basal level, and this interaction is retained during the 3h post- exercise 
recovery period. It suggests that recruitment of mTOR to the late- lysosome compartment is not an 
exclusive event initiated by the anabolic stimuli in human skeletal muscle as has been reported in cell 
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and rodent studies [18, 22]. It is not readily apparent on the discrepancy between the present and the 
previous data. However, the different nutrient availability among human skeletal muscle and rodent/ 
cell models may be a possible explanation. For example, dissociation of mTOR from the lysosome 
compartment in cell model has been visualized under AA free conditions [18], a scenario that would be 
more reflective as the chronic fasting to initiate the autophagic response [34]. Intriguingly, in the same 
in vitro model, reduction on AA availability does not induce the mTOR dissociation from the 
lysosome and therefore mTOR activity is unaltered [34]. In human muscle, the intracellular AA 
availability is maintained at basal level through the normal degradation of muscle proteins, which is 
sufficient to support the basal rates of muscle protein synthesis [35]. Therefore, the constant mTOR 
association with the lysosome may reflect the basal AA availability and the requirement of mTOR to 
maintain basal protein anabolism in resting human skeletal muscle. 
The initial hypothesis was that translocation of mTOR to the lysosome compartment would be the key 
event for mTOR activation in response to the anabolic stimuli. However, our findings clearly 
demonstrate that mTOR/ Lamp2 translocation to the cell membrane is a principle event relocating 
mTOR following resistance exercise. It is still unclear on the physiological relevance of this event on 
mTOR activity. However, it has been suggested previously that lysosome translocation to the cell 
membrane can be considered as a stimulus for mTORC1 activation [34]. Overexpression of two kinesin 
superfamily members (KIF1Bß and KIF2) that target lysosome to the cell membrane increased 
mTORC1 activity. In contrast, knockdown of KIF1Bß and KIF2 targeted lysosome to the peri- 
nuclear regions, which reduced the mTORC1 activity subsequently [34]. Thus, the lysosome 
distribution would be a key initial event in activating mTOR in response to the nutrient stimulation. 
Our findings of a similar mTOR/Lamp2 translocation to the plasma membrane following resistance 
exercise would suggest that this event is important for the initiation of protein translation post exercise 
in human skeletal muscle. 
Previous studies have demonstrated that mTOR interaction with the GTP loaded Rheb is required to 
elicit the complete mTORC1 activation [36]. Rheb is a small GTPase and is activated by the GTPase 
activating protein TSC2, which converts GTP- Rheb into GDP- Rheb rendering it unable to activate 
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mTORC1 [21, 37]. Rheb is able to bind to the catalytic domain of mTORC [38, 39] only when loaded with 
GTP [40].  It is recently published that eccentric contraction results in TSC2 dissociation from the 
lysosome, which would facilitate the association between mTOR and GTP- Rheb [22]. However, then, 
we did not observe the dissociation of TSC2 from lysosome but visualized its localisation on the 
plasma membrane, colocalising with Rheb as opposed to at the lysosome. Further investigation shows 
that TSC2 dissociated from the cell membrane following resistance exercise, leaving Rheb and 
mTOR/ Lamp2 translocated to interact on the cell membrane. It is not clear as to why the location of 
this event is different in human as opposed to the murine skeletal muscle. It may because of the 
muscle fiber difference (predominantly fast- twitch in mouse vs. mixed fibers in human), the mode of 
exercise (eccentric vs. concentric), the degree of contraction/ recruitment and/ or the nutrient 
availability. Irrespective, our results are in agreement with the studies from Jacobs et al [22] reporting 
TSC2 dissociation from mTOR positive regions appears to be a key event following an anabolic 
stimulus in human skeletal muscle. 
In addition to TSC2- Rheb- mTOR colocalisation, we further examined whether mTOR translocation 
to the plasma membrane may serve to direct mTOR/Lamp2 to other substrates involved in the 
initiation of protein synthesis. We reported the novel data indicating that mTOR associates with the 
regulatory subunit of the eukaryotic initiation factor 3 complex (EIF3F) post exercise in both the 
exercise group and nutrition group. The eIF3 complex is critical to initiate protein synthesis serving as 
a scaffold for mTOR and S6K1 interaction, leading to the assembly of the pre- initiation complex [41, 
42]. Our data is the first to demonstrate colocalisation between mTOR and EIF3F in human skeletal 
muscle. mTOR and EIF3F are observed to colocalise immediately post exercise in both the exercise 
and nutrition groups, which would be consistent with the effects of resistance exercise on enhancing 
AA update and muscle protein synthesis early in recovery [9, 43]. It is noticed that this interaction is 
significantly greater in the nutrition group 1h post exercise, suggesting beneficial effects of beverage 
ingestion on mTOR- EIF3F assembly post exercise. Given the evidence that muscle protein synthesis 
and phosphorylation of mTORC1 substrates is amplified post exercise following PRO/CHO ingestion 
[15, 33], it would appear that the increased mTOR- EIF3F interaction found in nutrition group may be an 
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important mediator of post- exercise nutrition on mTORC1 conducted signal pathway and potentially 
muscle protein synthesis. 
Furthermore, based on the observation that mTOR fluorscence is not evenly distributed on the plasma 
membrane, we further investigated this issue and found that mTOR/Lamp2 complex accumulates 
around the microvasculature (marked by UEA-I) on the cell membrane post exercise. It is unclear of 
the precise reason for this response to exercise, however the association of mTOR with the 
microvasculature would theoretically place mTOR in close proximity to nutrients provision from the 
bloodsteam transportation. In addition, the increased interaction between mTOR and microvasculature 
are found in both the exercise group and nutrition group, which suggests the spatial association is not 
influenced by the PRO/CHO ingestion in healthy young men post exercise. Collectively, this further 
supports the hypothesis that mTOR translocation to cell membrane is a mechanically driven event and 
that PRO/CHO ingestion facilitates mTOR interaction with the EIF3F rather than altering the 
localisation of mTOR/ Lamp2.  
 
6.3 Does mTOR association with the cell membrane facilitate mTOR activation  
Not only does the plasma membrane maintain integrity of cells, but also serves as a scaffold to 
facilitate signal transduction from the extracellular environment to intracellular cytoplasm. Crosstalk 
can be mediated by number of receptors, such as insulin receptor and IGF receptor localise as the 
transmembrane proteins [45]. Once binding with ligands, conformational change of receptors leads to 
their activation and interaction with downstream substrates [46]. PI3K- Akt is repoted to be one of the 
upstream pathways mediating mTOR activation [47]. As demonstrated in Figure 6.3, phosphoinositide 
3-kinase (PI3K) activated by growth factor receptor converts membrane lipid phosphatidylinositol- 
4,5- bisphosphate (PIP2) to phosphatidylinositol- 3, 4, 5- trisphosphate(PIP3) [47]. PIP3 can bind with 
various signaling proteins including serine-threonie kinases, tyrosine kinases and exchange factors to 
activate functions of these proteins [47]. In unstimualted cells, these signaling proteins are located in 
the cytoplasm and accumulate to plasma membrane once phosphatidylinositol lipid is phospharylated 
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[47]. Akt is recruited from cytosol to plasma membrane to be activated [47]. Mechanism of Akt 
activating mTOR is not fully understood, yet two regulatory pathways have been proposed. Firstly, 
Akt phosphorylate Ser2448 on mTOR [48, 49]. Secondly, Akt mediates mTOR activity through 
inhibiting TSC1/TSC2 and PRAS40, both of which participate in mTOR inhibition [50, 51]. Via these 
two signal pathways mTOR activity is increased to stimulate protein synthesis [26, 52].  
However, recent studies suggest that mTORC1 induced skeletal muscle hypertrophy can be 
independent of PI3 kinase activation [62, 63]. Specific inhibition of PI3K by wortmannin did not prevent 
stretch- induced activation in S6K1 in isolated extensor digitorum longus muscles [62]. Moreover, Akt 
was not required for S6K1 activation by stretch [62]. Mechanism on contractile induced mTOR 
activation is not clear now, potentially via a stretch- activated calcium channel, integrins, integrin 
linked kinases and/or amino acids [64].      
Our data show that Rheb and TSC2 are colocalized on the plasma membrane in human skeletal 
muscle at basal level, with TSC2 disassociation from cell membrane in response to exercise, whist 
Rheb colocalise with mTOR. TSC2 on plasma membrane would be phosphoryalted and inhibited by 
Akt translocated to cell membrane. TSC2 degradation release Rheb activity, leaving mTOR and Rheb 
association with each other [21, 22, 37, 38, 39]. The event mTOR translocation to cell membrane would 
facilitate mTOR spatially access to Rheb to be directly activated. In addition, distribution of mTOR 
on cell membrane is correlated with microvasculture, suggesting mTOR sensing to nutrients 
availability carried by blood stream transport. In conclusion, in response to exercise mTOR 
translocation to cell membrane would enhance its interaction with activator Rheb, the latter one being 
released by degraded plasma membrane TSC2. 
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Figure 6.1 Overview of potential mechanisms explaining why mTOR translocation to cell 
membrane in response to anabolic stimuli. It is illustrated that the event mTOR translocate to 
membrane would facilitate interaction between mTOR and Rheb, both of which translocates to 
the plasma membrane in response to stimulatory signals. In this study, TSC2 was observed to 
distribute near plasma membrane. In response to exercise, TSC2 on cell membrane was 
degraded, possibily by Akt, to release active Rheb. mTOR translocated to cell membrane was 
found interacte with Rheb to be activated. Image is drawn by the author. 
 
6.4 Suggestions for future research 
Léger et al reported increased phosphorylated mTOR Serine 2448 content by immunoblotting post 
resistance training [44]. Another study in cycle training showed significant increase of phosphorylated 
mTOR content in fast- twitch fibers in human following a 6 weeks training [59]. It would be interesting 
to examine mTOR phosphorylation and mTOR substrate activity in muscle samples between pre- 
training and post- training, as total mTOR fluorescence content per se may not be sufficient to reflect 
mTOR activation level. Training status is another issue which may have influenced mTOR activity in 
muscle fibers. Individuals in the current study have recreationally training experience which might 
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compromise the training effect. So it worthy investigating effects of resistance training on mTOR 
content in skeletal muscle of untrained or sedentary people.  
Though mTOR translocation to cell membrane would facilitate its activation, the biological function 
and regulation of mTOR translocation to plasma membrane need further investigation, given that it is 
currently unclear as to how this translocation contributes to mTOR signaling transduction, as well as 
muscle protein synthesis. In our results, mTOR was found always associated with lysosome, which is 
different from findings in rodent studies [22, 23]. Korolchuk et al reported that mild nutrition availability 
could retain mTOR on lysosome without mTOR activation in cell model [34]. So it is interesting to 
investigate which factors or mechanisms retain mTOR on lysosome surface in human cells, and what 
factors result in the different mTOR/ lysosome distribution between human and rodents at basal level, 
which might help better understand the physiological variance between two models. Reports show 
that lysosome translocation to cell membrane happens in human skeletal muscle when cell membrane 
is damaged by mechanistic contraction [65]. mTOR associated with lyososome may be transported to 
cell membrane via this mechanism or other mechanisms. In addition, studies can be done on 
mechanism leading to mTOR/ lysosome translocation. Lysosome positioning has been revealed to be 
important for mTOR activity in autophagy [34], though it is not clear of the physiological functions of 
lysosome translocation in rodent and human in vivo. Hela cell study found that when lysosome 
localized to nucleus area, mTOR activity was inhibited; conversely, mTOR activity was activated 
when lysosome translocated to cell membrane [34]. Kinesin kinase belongs to motor protein which is 
reported to conduct lysosome intracellular transportation [66]. Genetic manipulation of two kinesin 
protein, KIF1Bß and KIF2, could determine lysosome positioning [34]. As our results show mTOR was 
tightly associated with lysosome, it is hypothesized that these two kinesin proteins would colocalise 
with mTOR/ lysosome to facilitate mTOR translocation in response to exercise in human skeletal 
muscle. We used two biomarkers, Rab7 and Lamp2, to indicate late lysosome positioning. However, 
immunofluorescence data showed different distribution patterns between two proteins. Lamp2 always 
associated with mTOR under both basal status and post exercise status, while Rab7 translocated to 
associate with mTOR in response to exercise stimulation. Reasons are not very clear as late lysosome 
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formation is a dynamic process which is difficult to be monitored. It is reported that Rab7 appears on 
the late endosome membrane to conduct vehicles sorting, while Lamp2 primarily locates on lysosome 
to protect lysosome membrane integrity [23]. Endosomes sorted by Rab7 are then infused with 
lysosome to form late lysosome [23]. It seems that our results support this theory as Rab7 was observd 
to translocate to colocalise with Lamp2/ mTOR following exercise, suggesting contraction induced 
mTOR docking on matured late lysosome. However, this hypothesis needs to be supported by more 
evidence.  
 
6.5 Final conclusions 
In summary, we have developed an immunofluorescence staining technique to examine mTOR and 
associating proteins in human skeletal muscle in vivo. Taking advantage of immunofluorescence 
histology approaches, for the first time we report the intracellular localisation and protein complex 
association of mTOR in basal and in response to acute and chronic anabolic stimuli in human skeletal 
muscle. It is hoped that this experimental approach will unveil numerous process relating to mTOR-
mediated regulation of protein synthesis in healthy human skeletal muscle in response to anabolic 
stimuli, and in skeletal muscle in individuals with chronic disease in which muscle growth is 
compromised. 
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